# EDGAR Filing Document

**Accession Number:** 0001035443
**File Stem:** 0001035443-25-000182
**Filing Date:** 2025-7
**Character Count:** 375296
**Document Hash:** c5bb3bac4814773e7a260dcc9be67981
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001035443-25-000182.hdr.sgml**: 20250721

**ACCESSION NUMBER**: 0001035443-25-000182

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 64

**CONFORMED PERIOD OF REPORT**: 20250721

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250721

**DATE AS OF CHANGE**: 20250721

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALEXANDRIA REAL ESTATE EQUITIES, INC.
- **CENTRAL INDEX KEY:** 0001035443
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 954502084
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12993
- **FILM NUMBER:** 251137441

**BUSINESS ADDRESS:**
- **STREET 1:** 26 NORTH EUCLID AVENUE
- **CITY:** PASADENA
- **STATE:** CA
- **ZIP:** 91101
- **BUSINESS PHONE:** 6265780777

**MAIL ADDRESS:**
- **STREET 1:** 26 NORTH EUCLID AVENUE
- **CITY:** PASADENA
- **STATE:** CA
- **ZIP:** 91101

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ALEXANDRIA REAL ESTATE EQUITIES INC
- **DATE OF NAME CHANGE:** 19970311

?xml version='1.0' encoding='ASCII'? are-20250721

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): July 21, 2025

**ALEXANDRIA REAL ESTATE EQUITIES, INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Maryland** | **1-12993** | **95-4502084** |
| (State or other jurisdiction of<br>incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

**26 North Euclid Avenue, Pasadena, California 91101** 

(Address of principal executive offices) (Zip code)

Registrant's telephone number, including area code: **(626) 578-0777** 

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value per share | ARE | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On July 21, 2025, Alexandria Real Estate Equities, Inc. (the "Company") issued a press release entitled "Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2025 Financial and Operating Results." The press release referred to certain supplemental information that is available on the Company's website at www.are.com. A copy of the press release and supplemental information are attached hereto as Exhibit 99.1.

The information contained in this Item 2.02, including the exhibit referenced herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

**Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[99.1](a2025ex991supp.htm)&nbsp;&nbsp;&nbsp;&nbsp; [Alexandria Real Estate Equities, Inc.'s Earnings Press Release and Supplemental Information](a2025ex991supp.htm) for the Second Quarter Ended June 30, 2025

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

**Forward-Looking Statements**

This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. These statements include words such as "forecast," "guidance," "goals," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," "targets," or "will," or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company's filings with the Securities and Exchange Commission, including the Company's most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | ALEXANDRIA REAL ESTATE EQUITIES, INC. | ALEXANDRIA REAL ESTATE EQUITIES, INC. |
| July 21, 2025 | By: | /s/ Joel S. Marcus |
|  |  | Joel S. Marcus |
|  |  | Executive Chairman |
|  | By: | /s/ Peter M. Moglia |
|  |  | Peter M. Moglia |
|  |  | Chief Executive Officer and <br>Chief Investment Officer |
|  | By: | /s/ Marc E. Binda |
|  |  | Marc E. Binda |
|  |  | Chief Financial Officer and Treasurer |

---

## Exhibit 99.1

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<br>

![frontcoverv5.jpg](frontcoverv5.jpg)

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<br>

![campuspointvda.jpg](campuspointvda.jpg)

**JUST ANNOUNCED**

**ALEXANDRIA EXECUTES LARGEST LIFE SCIENCE LEASE IN COMPANY**

**HISTORY WITH A LONG-STANDING MULTINATIONAL PHARMACEUTICAL TENANT** 

**IN JULY FOR A466,598 RSF BUILD-TO-SUIT RESEARCH HUB AT OUR CAMPUS** 

**POINT BY ALEXANDRIA MEGACAMPUS**<sup>™</sup> **IN SAN DIEGO**

---

| | |
|:---|:---|
| **HIGHLIGHTS** | **HIGHLIGHTS** |
| •  | 16-year lease term with a <br>credit tenant |
| •  | Underscores uniquely <br>targeted demand for <br>our leading life science <br>destination in <br>San Diego |
| •  | R&D hub embedded <br>in an amenity-rich <br>Megacampus<br>ecosystem that enables <br>tenants to recruit and <br>retain top talent |

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<br>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Table of Contents** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **COMPANY HIGHLIGHTS** | Page |  |  |
| [Mission and Cluster Model](#i97e12a746f8347daae03a6c076b22350_7)..................................................................... | [iii](#i97e12a746f8347daae03a6c076b22350_7) |  |  |
| **EARNINGS PRESS RELEASE** | Page |  | Page |
| Second Quarter Ended June 30, 2025[Financial and Operating](#i97e12a746f8347daae03a6c076b22350_91)<br>[Results](#i97e12a746f8347daae03a6c076b22350_91)...................................................................................................<br>| [1](#i97e12a746f8347daae03a6c076b22350_91) | [Consolidated Statements of Operations](#i97e12a746f8347daae03a6c076b22350_118).......................................... | [8](#i97e12a746f8347daae03a6c076b22350_118) |
| [Guidance](#i97e12a746f8347daae03a6c076b22350_97)................................................................................................... | [5](#i97e12a746f8347daae03a6c076b22350_97) | [Consolidated Balance Sheets](#i97e12a746f8347daae03a6c076b22350_121)............................................................ | [9](#i97e12a746f8347daae03a6c076b22350_121) |
| [Dispositions and Sales of Partial Interests](#i97e12a746f8347daae03a6c076b22350_109).......................................... | [6](#i97e12a746f8347daae03a6c076b22350_109) | [Funds From Operations and Funds From Operations per Share](#i97e12a746f8347daae03a6c076b22350_124) | [10](#i97e12a746f8347daae03a6c076b22350_124) |
| [Earnings Call Information and About the Company](#i97e12a746f8347daae03a6c076b22350_115)........................... | [7](#i97e12a746f8347daae03a6c076b22350_115) |  |  |
| **SUPPLEMENTAL INFORMATION** | Page |  | Page |
| [Company Profile](#i97e12a746f8347daae03a6c076b22350_130)....................................................................................... | [13](#i97e12a746f8347daae03a6c076b22350_130) | **External Growth / Investments in Real Estate** |  |
| [Investor Information](#i97e12a746f8347daae03a6c076b22350_133)................................................................................. | [14](#i97e12a746f8347daae03a6c076b22350_133) | [Investments in Real Estate](#i97e12a746f8347daae03a6c076b22350_172)................................................................ | [32](#i97e12a746f8347daae03a6c076b22350_172) |
| [Financial and Asset Base Highlights](#i97e12a746f8347daae03a6c076b22350_136)..................................................... | [15](#i97e12a746f8347daae03a6c076b22350_136) | New Class A/A+ Development and Redevelopment Properties: | New Class A/A+ Development and Redevelopment Properties: |
| [High-Quality and Diverse Client Base](#i97e12a746f8347daae03a6c076b22350_139)................................................. | [17](#i97e12a746f8347daae03a6c076b22350_139) | [Recent Deliveries](#i97e12a746f8347daae03a6c076b22350_181)........................................................................... | [34](#i97e12a746f8347daae03a6c076b22350_181) |
| **Internal Growth** |  | [Current Projects](#i97e12a746f8347daae03a6c076b22350_184).............................................................................. | [35](#i97e12a746f8347daae03a6c076b22350_184) |
| [Key Operating Metrics](#i97e12a746f8347daae03a6c076b22350_151)............................................................................. | [20](#i97e12a746f8347daae03a6c076b22350_151) | [Summary of Pipeline](#i97e12a746f8347daae03a6c076b22350_190)...................................................................... | [39](#i97e12a746f8347daae03a6c076b22350_190) |
| [Same Property Performance](#i97e12a746f8347daae03a6c076b22350_154).................................................................. | [21](#i97e12a746f8347daae03a6c076b22350_154) | [Construction Spending](#i97e12a746f8347daae03a6c076b22350_193)........................................................................ | [44](#i97e12a746f8347daae03a6c076b22350_193) |
| [Leasing Activity](#i97e12a746f8347daae03a6c076b22350_157)......................................................................................... | [22](#i97e12a746f8347daae03a6c076b22350_157) | Capitalization of Interest..................................................................... | [45](#i97e12a746f8347daae03a6c076b22350_2199023258326) |
| [Contractual Lease Expirations](#i97e12a746f8347daae03a6c076b22350_160)............................................................... | [23](#i97e12a746f8347daae03a6c076b22350_160) | [Joint Venture Financial Information](#i97e12a746f8347daae03a6c076b22350_202)................................................... | [50](#i97e12a746f8347daae03a6c076b22350_202) |
| [Top 20 Tenants](#i97e12a746f8347daae03a6c076b22350_163)......................................................................................... | [24](#i97e12a746f8347daae03a6c076b22350_163) | **Balance Sheet Management** |  |
| [Summary of Properties and Occupancy](#i97e12a746f8347daae03a6c076b22350_166).............................................. | [25](#i97e12a746f8347daae03a6c076b22350_166) | [Investments](#i97e12a746f8347daae03a6c076b22350_205).......................................................................................... | [52](#i97e12a746f8347daae03a6c076b22350_205) |
| [Property Listing](#i97e12a746f8347daae03a6c076b22350_169)........................................................................................ | [26](#i97e12a746f8347daae03a6c076b22350_169) | [Balance Sheet](#i97e12a746f8347daae03a6c076b22350_2504)...................................................................................... | [53](#i97e12a746f8347daae03a6c076b22350_2504) |
|  |  | [Key Credit Metrics](#i97e12a746f8347daae03a6c076b22350_208)............................................................................... | [54](#i97e12a746f8347daae03a6c076b22350_208) |
|  |  | [Summary of Debt](#i97e12a746f8347daae03a6c076b22350_211)................................................................................. | [55](#i97e12a746f8347daae03a6c076b22350_211) |
|  |  | **Definitions and Reconciliations** |  |
|  |  | [Definitions and Reconciliations](#i97e12a746f8347daae03a6c076b22350_220).......................................................... | [60](#i97e12a746f8347daae03a6c076b22350_220) |

---

---

| |
|:---|
| **CONFERENCE CALL**<br>**INFORMATION:**<br>|
| Tuesday, July 22, 2025<br>2:00 p.m. Eastern Time<br>11:00 a.m. Pacific Time<br>|
| (833) 366-1125 or<br>(412) 902-6738<br>|
| Ask to join the conference call for <br>Alexandria Real Estate Equities, Inc.<br>|
| **CONTACT INFORMATION:** |
| Alexandria Real Estate Equities, Inc.<br>corporateinformation@are.com<br>|
| **JOEL S. MARCUS**<br>Executive Chairman &<br>Founder <br>|
| **PETER M. MOGLIA**<br>Chief Executive Officer & <br>Chief Investment Officer<br>|
| **MARC E. BINDA**<br>Chief Financial Officer & <br>Treasurer <br>|
| **PAULA SCHWARTZ**<br>Managing Director,<br>Rx Communications Group<br>(917) 633-7790<br>|

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | iii |

---

![insidednav4.jpg](insidednav4.jpg)

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | iv |

---

![competitiveadvantagev3a.jpg](competitiveadvantagev3a.jpg)

---

| |
|:---|
| **ALEXANDRIA'S**<br>**MEGACAMPUS**<sup>™</sup><br>**PLATFORM**<br>|
| **75%**<br>**OF OUR ANNUAL** <br>**RENTAL REVENUE**<br>|

---

As of June 30, 2025. Refer to "Definitions and reconciliations" in the Supplemental Information for additional details.

---

| |
|:---|
| LARGEST, HIGHEST-QUALITY<br>ASSET BASE CLUSTERED IN <br>THE BEST LOCATIONS<br>|
| SECTOR-LEADING CLIENT <br>BASE OF ~750 TENANTS<br>|
| HIGH-QUALITY CASH FLOWS |
| PROVEN UNDERWRITING |
| FORTRESS BALANCE SHEET |
| LONG-TENURED, HIGHLY <br>EXPERIENCED MANAGEMENT TEAM<br>|

---

**LIFE SCIENCE REAL ESTATE**

WE INVENTED IT.

WE DOMINATE IT.

**THE MOST TRUSTED BRAND IN**

**LIFE SCIENCE REAL ESTATE**

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | v |

---

![megacampusplatformv3.jpg](megacampusplatformv3.jpg)

**ALEXANDRIA'S MEGACAMPUS**<sup>™</sup> **PLATFORM DRIVES** 

**SUPERIOR OPERATING RESULTS**

---

| |
|:---|
| **ALEXANDRIA'S**<br>**MEGACAMPUS PLATFORM** |
| **75%**<br>of Annual Rental Revenue<br>|

---

**ALEXANDRIA'S MEGACAMPUS OCCUPANCY** <br>**OUTPERFORMS THE MARKET**<sup>(1)</sup><br>

**17%**<br>Occupancy <br>Outperformance<br>

---

| | |
|:---|:---|
| **91%**<br>Megacampus | **74%**<br>Market |

---

As of June 30, 2025. Refer to "Definitions and reconciliations" in the Supplemental Information for additional details.

(1)Represents the occupancy at Alexandria's Megacampus ecosystems within the Greater Boston, San Francisco Bay Area, and San Diego markets as of June 30, 2025, compared to the average market occupancy for these markets per the

Q1 2025 U.S. Life Sciences Report published by CBRE Research.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | vi |

---

![innovationv2.jpg](innovationv2.jpg)

(1)Source: U.S. House Committee on Energy and Commerce, "The 21st Century Cures Discussion Document White Paper," January 27, 2015.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | vii |

---

![lifescienceinnovation.jpg](lifescienceinnovation.jpg)

(1)Source: U.S. House Committee on Energy and Commerce, "The 21st Century Cures Discussion Document White Paper," January 27, 2015.

(2)Source: PhRMA, "Medicines in Development for Chronic Diseases: 2024 Report."

(3)Source: Centers for Disease Control and Prevention, "Heart Disease Facts," October 24, 2024. Represents the latest published data, which reflects U.S. estimate for 2022.

(4)Source: National Cancer Institute, "Cancer Statistics," updated May 7, 2025. Represents the latest published data, which reflects 2018–2021 data, not including 2020 due to COVID.

(5)Source: Alzheimer's Association, "2025 Alzheimer's Disease Facts and Figures." Represents the latest published data, which reflects the U.S. estimate for 2025.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | viii |

---

![top20pharmav2.jpg](top20pharmav2.jpg)

(1)Source: Evaluate Pharma, May 27, 2025. Represents percentage of top 20 biopharma product sales generated from M&A and partnerships in 2024. M&A includes company and product acquisitions. Partnerships include products

sourced by a company through in-licensing deals.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved.©](#i97e12a746f8347daae03a6c076b22350_4)2025 | ix |

---

**ALEXANDRIA'S HISTORICALLY CONSISTENT AND SOLID DIVIDENDS**

![dividendv2a.jpg](dividendv2a.jpg)

---

| | |
|:---|:---|
| **2Q25** | **2Q25** |
| **7.3%** | **Dividend** <br>**Yield**<br>|
| **57%** | **Dividend Payout**<br>**Ratio**<br>|
| **2021–2025** | **2021–2025** |
| **$2.3B** | **Net Cash Provided by**<br>**Operating Activities**<br>**After Dividends**<br>|

---

![chart-a561b74201ec481aa05.gif](chart-a561b74201ec481aa05.gif)

**ANNUAL COMMON STOCK DIVIDEND PER SHARE**

<sup>(1)</sup>

<sup>(2)</sup>

<sup>(3)</sup>

(1)Dividend yield is calculated as the dividend declared for the three months ended June 30, 2025of $1.32 per common share annualized divided by the closing price of our common stock on June 30, 2025 of $72.63.

(2)Represents the aggregate sum for the years ended December 31, 2021 through 2024 and the midpoint of our 2025 guidance range. Refer to "Guidance" in the Earnings Press Release for additional details.

(3)Represents the common stock dividend declared of$1.32 per share for the three months ended June 30, 2025 annualized.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>1</sub>

![logo.jpg](logo.jpg)

**Alexandria Real Estate Equities, Inc. Reports:**

**2Q25 and 1H25Net Loss per Share – Diluted of $(0.64)and $(0.71), respectively; and**

**2Q25 and 1H25 FFO per Share – Diluted, as Adjusted, of $2.33 and $4.63, respectively**

PASADENA, Calif. – July 21, 2025 – Alexandria Real Estate Equities, Inc. (NYSE: ARE)

announced financial and operating results for the second quarter ended June 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Key highlights</u>** |  |  |  |  |
| *<u>Operating results</u>* | 2Q25 | 2Q24 | 1H25 | 1H24 |
| Total revenues: |  |  |  |  |
| In millions | $762.0 | $766.7 | $1520.2 | $1535.8 |
| Net (loss) income attributable to Alexandria's common stockholders – diluted: | Net (loss) income attributable to Alexandria's common stockholders – diluted: | Net (loss) income attributable to Alexandria's common stockholders – diluted: | Net (loss) income attributable to Alexandria's common stockholders – diluted: | Net (loss) income attributable to Alexandria's common stockholders – diluted: |
| In millions | $(109.6) | $42.9 | $(121.2) | $209.8 |
| Per share | $(0.64) | $0.25 | $(0.71) | $1.22 |
| Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: | Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: | Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: | Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: | Funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted: |
| In millions | $396.4 | $405.5 | $788.4 | $809.4 |
| Per share | $2.33 | $2.36 | $4.63 | $4.71 |

---

*<u>A sector-leading REIT with a high-quality, diverse tenant base and strong margins</u>*

---

| | |
|:---|:---|
| *(As of June 30, 2025, unless stated otherwise)* |  |
| Occupancy of operating properties in North America | 90.8%<br> <sup>(1)</sup> |
| Percentage of annual rental revenue in effect from Megacampus™ platform | 75% |
| Percentage of annual rental revenue in effect from investment-grade or publicly <br>traded large cap tenants<br>| 53% |
| Operating margin | 71% |
| Adjusted EBITDA margin | 71% |
| Percentage of leases containing annual rent escalations | 97% |
| Weighted-average remaining lease term: |  |
| Top 20 tenants | 9.4<br> years |
| All tenants | 7.4<br> years |
| Sustained strength in tenant collections: |  |
| July 2025 tenant rents and receivables collected as of July 21, 2025 | 99.4% |
| 2Q25 tenant rents and receivables collected as of July 21, 2025 | 99.9% |

---

(1)Reflects temporary vacancies aggregating 668,795 RSF, or 1.7%, which are now leased and expected to be

occupied upon completion of building and/or tenant improvements. The weighted-average expected delivery date

is January 2, 2026.

*<u>Strong and flexible balance sheet with significant liquidity;</u><u>top 10%</u> <u>credit rating ranking among all</u>*

*<u>publicly traded U.S. REITs</u>*

• Net debt and preferred stock to Adjusted EBITDA of 5.9x and fixed-charge coverage ratio of

4.1x for 2Q25 annualized,with 4Q25 annualized targets of ≤5.2x and 4.0x to 4.5x,

respectively.

• Significant liquidity of $4.6 billion.

• Only 9% of our total debt matures through 2027.

• 12.0 years weighted-average remaining term of debt,longest among S&P 500 REITs.

• Since 2021, our quarter-end fixed-rate debt averaged 97.2%.

*•*Total debt and preferred stock to gross assets of 30%.

• $297.3 million of capital contribution commitments from existing real estate joint venture

partners to fund construction from 3Q25 through 2027 and beyond, including $116.7 million

from 3Q25 to 4Q25.

*<u>Leasing volume and rental rate increases</u>*

• Leasing volume of769,815RSF during 2Q25.

• In July 2025, we executed the largest life science lease in company history with a long-

standing multinational pharmaceutical tenant for a16-year expansion build-to-suit lease,

aggregating466,598 RSF, located on the Campus Point by Alexandria Megacampus in our

University Town Center submarket. If this were included in the leasing volume for 2Q25, the

total leased RSF would have increased to1.2 million RSF for 2Q25 from769,815 RSF. Refer

to "Subsequent events" in the Earnings Press Release for additional details.

• Rental rate increases on lease renewals and re-leasing of space of 5.5% and 6.1% (cash

basis) for 2Q25 and 13.2% and 6.9% (cash basis) for 1H25.

• 84% of our leasing activity during the last twelve months was generated from our existing

tenant base.

---

| | | |
|:---|:---|:---|
|  | 2Q25 | 1H25 |
| Total leasing activity – RSF | 769815 | 1800368 |
| Lease renewals and re-leasing of space: |  |  |
| RSF (included in total leasing activity above) | 483409 | 1367817 |
| Rental rate increase | 5.5% | 13.2% |
| Rental rate increase (cash basis) | 6.1% | 6.9% |
| Leasing of development and redevelopment space – RSF | 131768 | 138198 |

---

*<u>Dividend strategy to share net cash flows from operating activities with stockholders while</u>*

*<u>retaining a significant portion for reinvestment</u>*

• Common stock dividend declared for 2Q25of$1.32 per share aggregating $5.26per

common share for the twelve months ended June 30, 2025, up 18 cents, or 3.5%, over the

twelve months ended June 30, 2024.

• By maintaining our recent dividend at$1.32 per share, over $40 million of additional liquidity

and equity capital can be reinvested annually.

• Dividend yield of7.3% as of June 30, 2025.

• Dividend payout ratio of57% for the three months ended June 30, 2025.

• Significant net cash flows provided by operating activities after dividends retained for

reinvestment aggregating $2.3 billion for the years ended December 31, 2021 through 2024

and the midpoint of our 2025 guidance range.

*<u>Ongoing execution of Alexandria's 2025 capital recycling strategy</u>*

We expect to fund a significant portion of our capital requirements for the year ending

December 31, 2025 through dispositions of non-core assets, land, partial interest sales, and

sales to owner/users. We expect dispositions of land to represent20%–30% of our total

dispositions and sales of partial interests for 2025.

---

| | | |
|:---|:---|:---|
| *(in millions)* |  |  |
| Completed dispositions | $261 |  |
| Our share of pending transactions subject to non-refundable deposits, <br>signed letters of intent, and/or purchase and sale agreement <br>negotiations<br>| 525 |  |
| Our share of completed and pending 2025 dispositions | 786 | 40% |
| Additional targeted dispositions | 1164 | 60 |
| 2025 guidance midpoint for dispositions and sales of partial interests | $1950 | 100% |

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>2</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Second Quarter Ended June 30, 2025 Financial and Operating Results (continued)**  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

*<u>Alexandria's development and redevelopment pipeline delivered incremental annual net operating</u>*

*<u>income of</u> <u>$15 million</u> <u>commencing during</u> <u>2Q25</u><u>,</u><u>with an additional</u> <u>$139 million</u><u>of incremental</u>*

*<u>annual net operating income anticipated to deliver by</u> <u>4Q26</u> <u>primarily from projects</u><u>84%</u> <u>leased/</u>*

*<u>negotiating</u>*

• During 2Q25, we placed into service development and redevelopment projects aggregating

217,774 RSF that are 90%occupied across three submarkets and delivered incremental

annual net operating income of $15 million.

• A significant 2Q25 delivery was 119,202 RSF at 10935, 10945, and 10955 Alexandria Way

located in this asset at the One Alexandria Square Megacampus in our Torrey Pines

submarket.

• Improvements of 100 bps and 110 bps in initial stabilized yield and initial stabilized yield

(cash basis), respectively, were primarily driven by leasing space at higher rental rates

than previously underwritten and a$23 million reduction in total investment due to

construction cost savings from overall project efficiencies.

• Annual net operating income (cash basis) from recently delivered projects is expected to

increase by$57 million upon the burn-off of initial free rent, which has a weighted-average

burn-off period of approximately three months.

• During 1Q25-4Q26, we expect to deliver annual net operating income representing nearly 9%

of the total net operating income for 2024.

• 74% of the RSF in our total development and redevelopment pipeline is within our

Megacampus ecosystems.

---

| | | | |
|:---|:---|:---|:---|
| Development and Redevelopment Projects | Incremental <br>Annual Net <br>Operating Income<br>| RSF | Occupied/<br>Leased/<br>Negotiating<br>Percentage |
| *(dollars in millions)* |  |  |  |
| Placed into service: |  |  |  |
| 1Q25 | $37 | 309494 | 100% |
| 2Q25 | 15<br><sup>(1)</sup> | 217774 | 90 |
| Placed into service in 1H25 | $52<br><sup>(1)</sup> | 527268 | 96% |
| Expected to be placed into service: |  |  |  |
| 3Q25 through 4Q26 | $139<br><sup>(2)</sup> | 1155041<br><sup>(3)</sup> | 84%<br><sup>(4)</sup> |
| 2027 through 2028<sup>(5)</sup> | 261 | 3270238 | 28% |
|  | $400 |  |  |

---

(1)Excludes incremental annual net operating income from recently delivered spaces aggregating 22,005 RSF

that are vacant and/or unleased as of June 30, 2025.

(2)Includesexpected partial deliveries through 4Q26 from projects expected to stabilize in 2027 and beyond,

including speculative future leasing that is not yet fully committed. Refer to the initial and stabilized occupancy

years under "New Class A/A+ development and redevelopment properties: current projects" in the

Supplemental Information for additional details.

(3)Represents the RSF related to projects expected to stabilize by 4Q26. Does not include RSF for partial

deliveries through 4Q26 from projects expected to stabilize in 2027 and beyond.

(4)Represents the leased/negotiating percentage of development and redevelopment projects that are expected

to stabilize during 2H25 and 2026.

(5)Includes one100% pre-leased committed near-term project expected to commence construction in the next

year.

*<u>Significant leasing progress on temporary vacancy</u>*

---

| | |
|:---|:---|
| Occupancy as of June 30, 2025 | 90.8%<br><sup>(1)</sup> |
| Temporary vacancies now leased with future delivery | 1.7<br><sup>(2)</sup> |
| Occupancy as of June 30, 2025, including leased, but not yet delivered space | 92.5% |

---

(1)Refer to "Summary of properties and occupancy" in the Supplemental Information for additional details.

(2)Represents temporary vacancy as of June 30, 2025 aggregating 668,795 RSF, primarily in the Greater Boston,

San Francisco Bay Area, and San Diego markets, which is leased and expected to be occupied upon

completion of building and/or tenant improvements. The weighted-average expected delivery date is

January 2, 2026.

*<u>Key operating metrics</u>*

• Net operating income (cash basis) of$2.0 billion for 2Q25 annualized, up$111.4 million, or

5.8%, compared to 2Q24 annualized.

• Same property net operating income changes of (5.4)% and 2.0% (cash basis) for 2Q25 over

2Q24 and (4.3)% and 3.4% (cash basis) for 1H25 over 1H24, which include lease expirations

that became vacant during 1Q25 aggregating 768,080 RSF across six properties and four

submarkets with a weighted-average lease expiration date of January 21, 2025. Excluding

the impact of these lease expirations, same property net operating income changes for 2Q25

would have been (2.1)% and 6.5% (cash basis). As of June 30, 2025,153,658RSF was

leased with a weighted-average lease commencement date of April 30, 2026, and we expect

to favorably resolve the remaining 614,422 RSF over the next several quarters.

• General and administrative expenses of $59.8 million for 1H25, representing cost savings of

$31.9 million or 35%, compared to 1H24, primarily the result of cost-control and efficiency

initiatives on reducing personnel-related costs and streamlining business processes.

• As a percentage of net operating income, our general and administrative expenses for the

trailing twelve months ended June 30, 2025 were 6.3%, representing the lowest level in the

past ten years, compared to 9.2% for the trailing twelve months ended June 30, 2024.

**<u>Strong and flexible balance sheet</u>**

*<u>Key metrics as of or for the three months ended</u> <u>June 30, 2025</u>*

• $25.7 billion in total market capitalization.

• $12.4 billion in total equity capitalization.

---

| | | | |
|:---|:---|:---|:---|
|  | 2Q25 | 2Q25 | Target |
|  | Quarter<br>Annualized | Trailing<br>12 Months | 4Q25<br>Annualized |
| Net debt and preferred stock to <br>Adjusted EBITDA<br>| 5.9x | 5.8x | Less than or equal to 5.2x |
| Fixed-charge coverage ratio | 4.1x | 4.3x | 4.0x to 4.5x |

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>3</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Second Quarter Ended June 30, 2025 Financial and Operating Results (continued)**  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**<u>Strong and flexible balance sheet (continued)</u>**

*<u>Key capital events</u>*

• Upon maturity on April 30, 2025, we repaid $600.0 million of our 3.45% unsecured senior

notes payable with proceeds from our February 2025 unsecured senior notes payable

offering.

• Under our common stock repurchase program authorized in December 2024, we may

repurchase up to $500.0 million of our common stock through December 31, 2025. During

2Q25, we did not repurchase any shares. As of July 21, 2025, the approximate value of

shares authorized and remaining under this program was$241.8 million.

• In August 2025, we expect to repay a secured construction loan held by our consolidated real

estate joint venture for 99 Coolidge Avenue, a development project where we have a76.9%

interest. The project is currently76% leased/negotiating and is expected to deliver in2026.

We expect to repay the loan aggregating $153.5 million which matures in 2026 and bears an

interest rate of 7.16% as of June 30, 2025. As a result, we expect to recognize a loss on early

extinguishment of debt of$99 thousand for the write-off of unamortized deferred financing

costs in 3Q25.

*<u>Investments</u>*

• As of June 30, 2025:

• Our non-real estate investments aggregated $1.5 billion.

• Unrealized gains presented in our consolidated balance sheet were $7.7 million,

comprising gross unrealized gains and losses aggregating $180.2 million and

$172.5 million, respectively.

• Investment loss of $30.6 million for 2Q25 presented in our consolidated statement of

operations consisted of $30.5 million of realized gains, $21.9 million of unrealized losses, and

$39.2 million of impairment charges.

**<u>Other key highlights</u>**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* | *<u>Key items included in net income attributable to Alexandria's common stockholders:</u>* |
|  | 2Q25 | 2Q24 | 2Q25 | 2Q24 | 1H25 | 1H24 | 1H25 | 1H24 |
| *(in millions, except per share* <br>*amounts)*<br>| Amount | Amount | Per Share – <br>Diluted | Per Share – <br>Diluted | Amount | Amount | Per Share – <br>Diluted | Per Share – <br>Diluted |
| Unrealized losses on non-<br>real estate investments<br>| $(21.9) | $(64.2) | $(0.13) | $(0.37) | $(90.1) | $(35.1) | $(0.53) | $(0.20) |
| Gain on sales of real estate |  |  |  |  | 13.2 | 0.4 | 0.08 |  |
| Impairment of non-real <br>estate investments<br>| (39.2) | (12.8) | (0.23) | (0.08) | (50.4) | (27.5) | (0.30) | (0.16) |
| Impairment of real estate<sup>(1)</sup> | (129.6) | (30.8) | (0.76) | (0.18) | (161.8) | (30.8) | (0.95) | (0.18) |
| Increase in provision for <br>expected credit losses on <br>financial instruments<br>|  |  |  |  | (0.3) |  |  |  |
| Total | $(190.7) | $(107.8) | $(1.12) | $(0.63) | $(289.4) | $(93.0) | $(1.70) | $(0.54) |
| (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. | (1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for<br>additional details. |

---

**<u>Subsequent event</u>**

• In July 2025, we executed the largest life science lease in company history with a long-

standing multinational pharmaceutical tenant for a 16-year expansion build-to-suit lease,

aggregating 466,598 RSF, located on the Campus Point by Alexandria Megacampus in our

University Town Center submarket.

• The tenant currently occupies two buildings within the Megacampus, one building

aggregating 52,620 RSF and another building aggregating52,853 RSF. At the end of 2025,

the tenant will vacate the52,620 RSF building to allow for the demolition and development

of the new purpose-built life science building at this site. Upon delivery of the new build-to-

suit property anticipated to occur in 2028, the tenant will vacate the52,853 RSF building to

allow for the construction of an amenity which will service the entire Megacampus.

**<u>Industry and corporate responsibility leadership: catalyzing and leading the way for</u>**

**<u>positive change to benefit human health and society</u>**

• 8 Davis Drive on the Alexandria Center<sup>®</sup> for Advanced Technologies – Research Triangle

Megacampus won the prestigious 2025 BOMA (Building Owners and Managers Association)

International TOBY (The Outstanding Building of the Year) Award in the Life Science

category. The TOBY Awards are the commercial real estate industry's highest recognition

honoring excellence in building management and operations. The award represents the

company's first win in the International TOBY Awards. Of the four regional winners in the Life

Science category that progressed as international TOBY nominees, three were Alexandria-

owned, -operated, and -developed facilities. The two additional Alexandria facilities were:

• 201 Haskins Way on the Alexandria Center<sup>®</sup> for Life Science – South San Francisco

campus in the San Francisco Bay Area and

• 188 East Blaine Street on the Alexandria Center<sup>®</sup> for Life Science – Eastlake Megacampus

in Seattle.

• We released our 2024 Corporate Responsibility Report, which underscores our

groundbreaking sustainability approach and the continued execution of our impactful

corporate responsibility platform. Notable highlights in the report include:

• The continued advancement of our innovative strategy to reduce operational greenhouse

gas (GHG) emissions in our asset base through energy efficiency, electrification and

alternative energy, and renewable electricity. We reduced operational GHG emissions

intensity by 18% from 2022 to 2024, representing ongoing progress toward our 30%

reduction target by 2030 relative to a 2022 baseline.

• Our steadfast work to catalyze the health and vitality of our local communities and make a

tangible positive impact through action-oriented solutions addressing some of the nation's

most pressing issues, including mental health and education.

• 15 Necco Street, a state-of-the-art R&D facility totaling 345,996 RSF in our Seaport

Innovation District submarket in Greater Boston, earned LEED Platinum certification, the

highest certification level under the U.S. Green Building Council's Core and Shell rating

system. Home to the Lilly Seaport Innovation Center, the facility serves as the central hub for

Lilly's genetic medicines efforts.

• We deepened our commitment to driving educational opportunities for students and

supporting STEM education with the opening of the Alexandria Real Estate Equities, Inc.

Learning Lab at the Fred Hutch Cancer Center in Seattle. Designed and built by Alexandria in

close collaboration with Fred Hutch's Science Education and Facilities teams, the innovative

laboratory environment is dedicated to inspiring and training future scientists.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>4</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Second Quarter Ended June 30, 2025 Financial and Operating Results (continued)**  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**<u>Industry and corporate responsibility leadership (continued)</u>**

• Alexandria was named a recipient of the 2025 Charles A. Sanders, MD, Partnership Award by

the Foundation for the National Institutes of Health (FNIH) in recognition of our key role in

catalyzing a public-private partnership focused on the development of biomarkers for major

depressive disorder to address the urgent need for new medicines for neuropsychology.

• Lawrence J. Diamond, co-chief operating officer and regional market director of Maryland,

was honored with the Beacon of Service Award at the Maryland Tech Council's 2025 ICON

Awards. The award recognizes Mr. Diamond's leadership, service, and profound impact on

Maryland's innovation ecosystem and broader community.

**<u>About Alexandria Real Estate Equities, Inc.</u>**

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500<sup>®</sup> company, is a best-in-class,

mission-driven life science REIT making a positive and lasting impact on the world. With our

founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the

preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus™

ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San

Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of

June 30, 2025, Alexandria has a total market capitalization of $25.7 billion and an asset base in

North America that includes 39.7 million RSF of operating properties and4.4 million RSF of Class

A/A+ properties undergoing construction and one 100% pre-leasedcommitted near-term project

expected to commence construction in the next year.Alexandria has a long-standing and proven

track record of developing Class A/A+ properties clustered in highly dynamic and collaborative

Megacampus environments that enhance our tenants' ability to successfully recruit and retain

world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also

provides strategic capital to transformative life science companies through our venture capital

platform. We believe our unique business model and diligent underwriting ensure a high-quality

and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental

income, higher returns, and greater long-term asset value. For more information on Alexandria,

please visit www.are.com.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>5</sub>

---

| | |
|:---|:---|
| **Guidance** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in millions, except per share amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Guidance for 2025 has been updated to reflect our current view of existing market conditions and assumptions for the year ending December 31, 2025. There can be no assurance that actual amounts will

not be materially higher or lower than these expectations. Our guidance for 2025 is subject to a number of variables and uncertainties, including actions and changes in policy by the current U.S. administration

related to the regulatory environment, life science funding, the U.S. Food and Drug Administration and National Institutes of Health, trade, and other areas. For additional discussion relating to risks and uncertainties

that could cause actual results to differ materially from those anticipated, refer to our discussion of "forward-looking statements" on page [7](#i97e12a746f8347daae03a6c076b22350_115) of the Earnings Press Release as well as our SEC filings, including our

most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025 Guidance Midpoint** | **2025 Guidance Midpoint** | **2025 Guidance Midpoint** | **2025 Guidance Midpoint** |
| <br>**Summary of Key Changes in Guidance** | **As of 7/21/25** | **As of 4/28/25** | **As of 7/21/25** | **As of 4/28/25** |
| EPS, FFO per share, and FFO per share, as adjusted | See updates below | See updates below<br> Repayment of secured note payable<sup>(5)</sup> | $154 | $— |

---

---

| | | |
|:---|:---|:---|
| **Projected 2025 Earnings per Share and Funds From Operations per Share Attributable to** <br>**Alexandria's Common Stockholders – Diluted** | **Projected 2025 Earnings per Share and Funds From Operations per Share Attributable to** <br>**Alexandria's Common Stockholders – Diluted** | **Projected 2025 Earnings per Share and Funds From Operations per Share Attributable to** <br>**Alexandria's Common Stockholders – Diluted** |
|  | **As of 7/21/25** | **As of 4/28/25** |
| Earnings per share<sup>(1)</sup> | $0.40 to $0.60 | $1.36 to $1.56 |
| Depreciation and amortization of real estate assets | 7.05 | 7.05 |
| Gain on sales of real estate | (0.08) | (0.08) |
| Impairment of real estate – rental properties and land<sup>(2)</sup> | 0.77 | 0.21 |
| Allocation to unvested restricted stock awards | (0.03) | (0.03) |
| Funds from operations per share and funds from operations <br>per share, as adjusted<sup>(3)</sup><br>| $8.11 to $8.31 | $8.51 to $8.71 |
| Unrealized losses on non-real estate investments | 0.53 | 0.40 |
| Impairment of non-real estate investments<sup>(2)</sup> | 0.30 | 0.07 |
| Impairment of real estate | 0.23 | 0.19 |
| Allocation to unvested restricted stock awards | (0.01) | (0.01) |
| Funds from operations per share, as adjusted<sup>(3)</sup> | $9.16 to $9.36 | $9.16 to $9.36 |
| Midpoint | $9.26 | $9.26 |

---

---

| | | |
|:---|:---|:---|
| **Key Assumptions** | **Low** | **High** |
| Occupancy percentage in North America as of December 31, 2025 | 90.9% | 92.5% |
| Lease renewals and re-leasing of space: |  |  |
| Rental rate changes | 9.0% | 17.0% |
| Rental rate changes (cash basis) | 0.5% | 8.5% |
| Same property performance: |  |  |
| Net operating income | (3.7)% | (1.7)% |
| Net operating income (cash basis) | (1.2)% | 0.8% |
| Straight-line rent revenue | $96 | $116 |
| General and administrative expenses | $112 | $127 |
| Capitalization of interest | $320 | $350 |
| Interest expense | $185 | $215 |
| Realized gains on non-real estate investments<sup>(4)</sup> | $100 | $130 |

---

---

| | |
|:---|:---|
| **Key Credit Metric Targets**<sup>(3)</sup> | |
| Net debt and preferred stock to Adjusted EBITDA – 4Q25 annualized | Less than or equal to 5.2x |
| Fixed-charge coverage ratio – 4Q25 annualized | 4.0x to 4.5x |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Key Sources and Uses of Capital** | **Range** | **Range** | **Midpoint** | **Certain** <br>**Completed** <br>**Items** |
| *Sources of capital:* |  |  |  |  |
| Reduction in debt | $(290) | $(290) | $(290) | See below |
| Net cash provided by operating activities after <br>dividends<br>| 425 | 525 | 475 |  |
| Dispositions and sales of partial interests (refer to <br>page [6](#i97e12a746f8347daae03a6c076b22350_109)) <br>| 1450 | 2450 | 1950 | <sup>(6)</sup> |
| Total sources of capital | $1585 | $2685 | $2135 |  |
| *Uses of capital:* |  |  |  |  |
| Construction | $1450 | $2050 | $1750 |  |
| Acquisitions and other opportunistic uses of <br>capital<sup>(7)</sup><br>|  | 500 | 250 | $208<br><sup>(7)</sup> |
| Ground lease prepayment | 135 | 135 | 135 | $135 |
| Total uses of capital | $1585 | $2685 | $2135 |  |
| *Reduction in debt (included above):* |  |  |  |  |
| Issuance of unsecured senior notes payable | $550 | $550 | $550 | $550 |
| Repayment of unsecured notes payable | (600) | (600) | (600) | $(600) |
| Repayment of secured note payable<sup>(5)</sup> | (154) | (154) | (154) |  |
| Unsecured senior line of credit, commercial paper, <br>and other<br>| (86) | (86) | (86) |  |
| Net reduction in debt | $(290) | $(290) | $(290) |  |

---

(1)Excludes unrealized gains or losses on non-real estate investments after June 30, 2025that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.

(2)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release for additional details.

(3)Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

(4)Represents realized gains and losses included in funds from operations per share – diluted, as adjusted, and excludes significant impairments realized on non-real estate investments, if any. Refer to "Investments" in the Supplemental

Information for additional details.

(5)In August 2025, we expect to repay a secured construction loan held by our consolidated real estate joint venture for 99 Coolidge Avenue, a development project where we have a 76.9% interest. Refer to "Key capital events" in the

Earnings Press release for additional details.

(6)As of July 21, 2025, completed dispositions aggregated $260.6 million and our share of pending transactions subject to non-refundable deposits, signed letters of intent, or purchase and sale agreement negotiations aggregated

$524.7 million. We expect to achieve a weighted-average capitalization rate on our projected 2025 dispositions and partial interest sales (excluding land and including stabilized and non-stabilized operating properties) in the 7.5% – 8.5%

range. We expect dispositions of land to represent 20%–30% of our total dispositions and sales of partial interest sales for the year ending December 31, 2025. Refer to "Dispositions and sales of partial interests" in the Earnings Press

Release for additional details.

(7)Under our common stock repurchase program authorized in December 2024, we may repurchase up to $500.0 million of our common stock through December 31, 2025. During 2Q25, we did not repurchase any shares of common stock.

As of July 21, 2025, the approximate value of shares authorized and remaining under this program was $241.8 million. Subject to market conditions, we may consider repurchasing additional shares of our common stock.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>6</sub>

---

| | |
|:---|:---|
| **Dispositions and Sales of Partial Interests** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Square Footage** | **Square Footage** | | **Gain on** <br>**Sales of** <br>**Real Estate** |
| <br>**Property** | <br>**Submarket/Market** | <br>**Date of** <br>**Sale**<br>| <br>**Interest** <br>**Sold** | **Operating** | **Future** <br>**Development** <br>| <br>**Sales Price** | **Gain on** <br>**Sales of** <br>**Real Estate** |
| Completed in 1Q25 |  |  |  |  |  | $176352 | $13165 |
| Completed in 2Q25: |  |  |  |  |  |  |  |
| *Properties with vacancies* |  |  |  |  |  |  |  |
| 2425 Garcia Avenue and 2400/2450 Bayshore Parkway | Greater Stanford/San Francisco Bay Area | 6/30/25 | 100% | 95901 |  | 11000 |  |
| *Land* |  |  |  |  |  |  |  |
| Land parcel | Texas | 5/7/25 | 100% |  | 1350000 | 73287 |  |
|  |  |  |  |  |  | 84287 |  |
| Dispositions completed in 1H25 |  |  |  |  |  | 260639 | $13165 |
| Our share of pending dispositions and sales of partial interests subject to <br>non-refundable deposits, signed letters of intent, and/or purchase and <br>sale agreement negotiations<br>|  |  |  |  |  | 524745 |  |
| Our share of completed and pending 2025 dispositions and sales of <br>partial interests<br>|  |  |  |  |  | $785384 |  |
| 2025 guidance range for dispositions and sales of partial interests |  |  |  |  | $1450000 – $2450000 | $1450000 – $2450000 |  |
| 2025 guidance midpoint for dispositions and sales of partial interests |  |  |  |  |  | $1950000 |  |

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>7</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Earnings Call Information and About the Company** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

We will host a conference call on Tuesday, July 22, 2025, at 2:00 p.m. Eastern Time ("ET")/11:00 a.m. Pacific Time ("PT"), which is open to the general public, to discuss our financial and operating results

for the second quarter ended June 30, 2025. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 2:00 p.m. ET/11:00 a.m. PT and ask the operator to join the call for Alexandria

Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the "For Investors" section. A replay of the call will be available for a limited time from 4:00 p.m. ET/1:00 p.m. PT on Tuesday,

July 22, 2025. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 1006663.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the second quarter ended June 30, 2025 is available in the "For Investors" section of our website at www.are.com or

by following this link: https://www.are.com/fs/2025q2.pdf.

For any questions, please contact corporateinformation@are.com; Joel S. Marcus, executive chairman and founder; Peter M. Moglia, chief executive officer and chief investment officer; Marc E. Binda,

chief financial officer and treasurer; or Paula Schwartz, managing director of Rx Communications Group, at (917) 633-7790.

**About the Company**

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500<sup>®</sup> company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994,

Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus™ ecosystems in AAA life science innovation

cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a total market capitalization of

$25.7 billionand an asset base in North America that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction and one100% pre-leased committed

near-term project expected to commence construction in the next year. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative

Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to

transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher

occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For more information on Alexandria, please visit www.are.com.

**Forward-Looking Statements**

This document includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Such forward-looking statements include, without limitation, statements regarding our projected 2025 earnings per share, projected 2025 funds from operations per share, projected 2025 funds from operations per

share, as adjusted, projected net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as "forecast,"

"guidance," "goals," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," "targets," or "will," or the negative of those words or similar words. These forward-looking

statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a

number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties,

assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without

limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, lower than expected yields, increased interest rates and operating costs, adverse economic or real

estate developments in our markets, our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or

redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace

expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, failure to

obtain LEED and other healthy building certifications and efficiencies, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission ("SEC"). Accordingly, you are cautioned

not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated,

we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For

more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our

SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

This document is not an offer to sell or a solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy our securities shall be made only by means of a

prospectus approved for that purpose. Unless otherwise indicated, the "Company," "Alexandria," "ARE," "we," "us," and "our" refer to Alexandria Real Estate Equities, Inc. and our consolidated subsidiaries.

Alexandria<sup>®</sup>, Lighthouse Design<sup>®</sup> logo, Building the Future of Life-Changing Innovation<sup>®</sup>, That's What's in Our DNA<sup>®</sup>, Megacampus™, At the Vanguard and Heart of the Life Science Ecosystem™, Alexandria

Center<sup>®</sup>, Alexandria Technology Square<sup>®</sup>, Alexandria Technology Center<sup>®</sup>, and Alexandria Innovation Center<sup>®</sup> are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names,

trademarks, and logos referenced herein are the property of their respective owners.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>8</sub>

---

| | |
|:---|:---|
| **Consolidated Statements of Operations** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands, except per share amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** | **6/30/25** | **6/30/24** |
| Revenues: |  |  |  |  |  |  |  |
| Income from rentals | $737279 | $743175 | $763249 | $775744 | $755162 | $1480454 | $1510713 |
| Other income | 24761 | 14983 | 25696 | 15863 | 11572 | 39744 | 25129 |
| Total revenues | 762040 | 758158 | 788945 | 791607 | 766734 | 1520198 | 1535842 |
| Expenses: |  |  |  |  |  |  |  |
| Rental operations | 224433 | 226395 | 240432 | 233265 | 217254 | 450828 | 435568 |
| General and administrative | 29128 | 30675 | 32730 | 43945 | 44629 | 59803 | 91684 |
| Interest | 55296 | 50876 | 55659 | 43550 | 45789 | 106172 | 86629 |
| Depreciation and amortization | 346123 | 342062 | 330108 | 293998 | 290720 | 688185 | 578274 |
| Impairment of real estate | 129606 | 32154 | 186564 | 5741 | 30763 | 161760 | 30763 |
| Total expenses | 784586 | 682162 | 845493 | 620499 | 629155 | 1466748 | 1222918 |
| Equity in (losses) earnings of unconsolidated real estate joint ventures | (9021)<br><sup>(1)</sup> | (507) | 6635 | 139 | 130 | (9528) | 285 |
| Investment (loss) income | (30622) | (49992) | (67988) | 15242 | (43660) | (80614) | (376) |
| Gain on sales of real estate |  | 13165 | 101806 | 27114 |  | 13165 | 392 |
| Net (loss) income | (62189) | 38662 | (16095) | 213603 | 94049 | (23527) | 313225 |
| Net income attributable to noncontrolling interests | (44813) | (47601) | (46150) | (45656) | (47347) | (92414) | (95978) |
| Net (loss) income attributable to Alexandria Real Estate Equities, Inc.'s <br>stockholders<br>| (107002) | (8939) | (62245) | 167947 | 46702 | (115941) | 217247 |
| Net income attributable to unvested restricted stock awards | (2609) | (2660) | (2677) | (3273) | (3785) | (5269) | (7444) |
| Net (loss) income attributable to Alexandria Real Estate Equities, Inc.'s <br>common stockholders<br>| $(109611) | $(11599) | $(64922) | $164674 | $42917 | $(121210) | $209803 |
| Net (loss) income per share attributable to Alexandria Real Estate Equities, <br>Inc.'s common stockholders:<br>|  |  |  |  |  |  |  |
| Basic | $(0.64) | $(0.07) | $(0.38) | $0.96 | $0.25 | $(0.71) | $1.22 |
| Diluted | $(0.64) | $(0.07) | $(0.38) | $0.96 | $0.25 | $(0.71) | $1.22 |
| Weighted-average shares of common stock outstanding: |  |  |  |  |  |  |  |
| Basic | 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Diluted | 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Dividends declared per share of common stock | $1.32 | $1.32 | $1.32 | $1.30 | $1.30 | $2.64 | $2.57 |

---

(1)Refer to footnote 1 in "Funds from operations and funds from operations per share" in the Earnings Press Release for additional details.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>9</sub>

---

| | |
|:---|:---|
| **Consolidated Balance Sheets** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(In thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Assets |  |  |  |  |  |
| Investments in real estate | $32160600 | $32121712 | $32110039 | $32951777 | $32673839 |
| Investments in unconsolidated real estate joint ventures | 40234 | 50086 | 39873 | 40170 | 40535 |
| Cash and cash equivalents | 520545 | 476430 | 552146 | 562606 | 561021 |
| Restricted cash | 7403 | 7324 | 7701 | 17031 | 4832 |
| Tenant receivables | 6267 | 6875 | 6409 | 6980 | 6822 |
| Deferred rent | 1232719 | 1210584 | 1187031 | 1216176 | 1190336 |
| Deferred leasing costs | 491074 | 489287 | 485959 | 516872 | 519629 |
| Investments | 1476696 | 1479688 | 1476985 | 1519327 | 1494348 |
| Other assets  | 1688091 | 1758442 | 1661306 | 1657189 | 1356503 |
| Total assets | $37623629 | $37600428 | $37527449 | $38488128 | $37847865 |
| Liabilities, Noncontrolling Interests, and Equity |  |  |  |  |  |
| Secured notes payable | $153500 | $150807 | $149909 | $145000 | $134942 |
| Unsecured senior notes payable | 12042607 | 12640144 | 12094465 | 12092012 | 12089561 |
| Unsecured senior line of credit and commercial paper | 1097993 | 299883 |  | 454589 | 199552 |
| Accounts payable, accrued expenses, and other liabilities | 2360840 | 2281414 | 2654351 | 2865886 | 2529535 |
| Dividends payable | 229686 | 228622 | 230263 | 227191 | 227408 |
| Total liabilities | 15884626 | 15600870 | 15128988 | 15784678 | 15180998 |
| Commitments and contingencies |  |  |  |  |  |
| Redeemable noncontrolling interests | 9612 | 9612 | 19972 | 16510 | 16440 |
| Alexandria Real Estate Equities, Inc.'s stockholders' equity: |  |  |  |  |  |
| Common stock | 1701 | 1701 | 1722 | 1722 | 1720 |
| Additional paid-in capital | 17200949 | 17509148 | 17933572 | 18238438 | 18284611 |
| Accumulated other comprehensive loss | (27415) | (46202) | (46252) | (22529) | (27710) |
| Alexandria Real Estate Equities, Inc.'s stockholders' equity | 17175235 | 17464647 | 17889042 | 18217631 | 18258621 |
| Noncontrolling interests | 4554156 | 4525299 | 4489447 | 4469309 | 4391806 |
| Total equity | 21729391 | 21989946 | 22378489 | 22686940 | 22650427 |
| Total liabilities, noncontrolling interests, and equity | $37623629 | $37600428 | $37527449 | $38488128 | $37847865 |

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>10</sub>

---

| | |
|:---|:---|
| **Funds From Operations and Funds From Operations per Share** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(In thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

The following table presents a reconciliation of net income (loss) attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in

accordance with U.S. generally accepted accounting principles ("GAAP"), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations

attributable to Alexandria's common stockholders – diluted, and funds from operations attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** | **6/30/25** | **6/30/24** |
| **Net (loss) income attributable to Alexandria's common stockholders – basic** <br>**and diluted**<br>| **$(109611)** | **$(11599)** | **$(64922)** | **$164674** | **$42917** | **$(121210)** | **$209803** |
| Depreciation and amortization of real estate assets | 343729 | 339381 | 327198 | 291258 | 288118 | 683110 | 573068 |
| Noncontrolling share of depreciation and amortization from consolidated real estate <br>JVs<br>| (36047) | (33411) | (34986) | (32457) | (31364) | (69458) | (62268) |
| Our share of depreciation and amortization from unconsolidated real estate JVs | 942 | 1054 | 1061 | 1075 | 1068 | 1996 | 2102 |
| Gain on sales of real estate |  | (13165) | (100109) | (27114) |  | (13165) | (392) |
| Impairment of real estate – rental properties and land | 131090<br><sup>(1)</sup> |  | 184532 | 5741 | 2182 | 131090 | 2182 |
| Allocation to unvested restricted stock awards  | (1222) | (686) | (1182) | (2908) | (1305) | (1916) | (4736) |
| **Funds from operations attributable to Alexandria's common stockholders –** <br>**diluted**<sup>(2)</sup><br>| **328881** | **281574** | **311592** | **400269** | **301616** | **610447** | **719759** |
| Unrealized losses (gains) on non-real estate investments | 21938 | 68145 | 79776 | (2610) | 64238 | 90083 | 35080 |
| Impairment of non-real estate investments | 39216<br><sup>(3)</sup> | 11180 | 20266 | 10338 | 12788 | 50396 | 27486 |
| Impairment of real estate | 7189 | 32154 | 2032 |  | 28581 | 39343 | 28581 |
| Increase (decrease) in provision for expected credit losses on financial instruments |  | 285 | (434) |  |  | 285 |  |
| Allocation to unvested restricted stock awards | (794) | (1329) | (1407) | (125) | (1738) | (2116) | (1528) |
| **Funds from operations attributable to Alexandria's common stockholders –** <br>**diluted, as adjusted**<br>| **$396430** | **$392009** | **$411825** | **$407872** | **$405485** | **$788438** | **$809378** |

---

Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

(1)Primarily represents impairment charges to reduce the carrying amount of our investments in real estate assets to their respective estimated fair values less costs to sell upon their classification as held for sale in 2Q25, including

(i)$47.5 million related to land parcels in our non-cluster market, (ii) $35.4 million related to an office property located in Carlsbad, San Diego, and (iii) $8.7 million related to an unconsolidated real estate joint venture, which is

classified in equity in earnings of unconsolidated real estate joint ventures in our consolidated statement of operations.

(2)Calculated in accordance with standards established by the Nareit Board of Governors.

(3)Primarily related toone non-real estate investment in a privately held entity that does not report NAV.

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>11</sub>

---

| | |
|:---|:---|
| **Funds From Operations and Funds From Operations per Share (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(In thousands, except per share amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

The following table presents a reconciliation of net income (loss) per share attributable to Alexandria's common stockholders, the most directly comparable financial measure presented in

accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria's common

stockholders – diluted, and funds from operations per share attributable to Alexandria's common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to

rounding.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** | **6/30/25** | **6/30/24** |
| **Net (loss) income per share attributable to Alexandria's common stockholders –** <br>**diluted**<br>| **$(0.64)** | **$(0.07)** | **$(0.38)** | **$0.96** | **$0.25** | **$(0.71)** | **$1.22** |
| Depreciation and amortization of real estate assets | 1.81 | 1.80 | 1.70 | 1.51 | 1.50 | 3.61 | 2.98 |
| Gain on sales of real estate |  | (0.08) | (0.58) | (0.16) |  | (0.08) |  |
| Impairment of real estate – rental properties and land | 0.77 |  | 1.07 | 0.03 | 0.01 | 0.77 | 0.01 |
| Allocation to unvested restricted stock awards | (0.01) |  |  | (0.01) | (0.01) | (0.01) | (0.02) |
| **Funds from operations per share attributable to Alexandria's common** <br>**stockholders – diluted**<br>| **1.93** | **1.65** | **1.81** | **2.33** | **1.75** | **3.58** | **4.19** |
| Unrealized losses (gains) on non-real estate investments | 0.13 | 0.40 | 0.46 | (0.02) | 0.37 | 0.53 | 0.20 |
| Impairment of non-real estate investments | 0.23 | 0.07 | 0.12 | 0.06 | 0.08 | 0.30 | 0.16 |
| Impairment of real estate | 0.04 | 0.19 | 0.01 |  | 0.17 | 0.23 | 0.17 |
| Allocation to unvested restricted stock awards |  | (0.01) | (0.01) |  | (0.01) | (0.01) | (0.01) |
| **Funds from operations per share attributable to Alexandria's common** <br>**stockholders – diluted, as adjusted**<br>| **$2.33** | **$2.30** | **$2.39** | **$2.37** | **$2.36** | **$4.63** | **$4.71** |
| Weighted-average shares of common stock outstanding – diluted |  |  |  |  |  |  |  |
| Earnings per share – diluted | 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Funds from operations – diluted, per share | 170192 | 170599 | 172262 | 172058 | 172013 | 170390 | 171981 |
| Funds from operations – diluted, as adjusted, per share | 170192 | 170599 | 172262 | 172058 | 172013 | 170390 | 171981 |

---

Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

**SUPPLEMENTAL**

**INFORMATION**

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>13</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Company Profile** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500<sup>®</sup> company, is a

best-in-class, mission-driven life science REIT making a positive and lasting impact on the

world. With our founding in 1994, Alexandria pioneered the life science real estate niche.

Alexandria is the preeminent and longest-tenured owner, operator, and developer of

collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations,

including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland,

Research Triangle, and New York City. As of June 30, 2025, Alexandria has a total market

capitalization of$25.7 billion and an asset base in North America that includes 39.7 million

RSF of operating properties and4.4 million RSF of Class A/A+ properties undergoing

construction and one 100% pre-leasedcommitted near-term project expected to

commence construction in the next year.Alexandria has a long-standing and proven track

record of developing Class A/A+ properties clustered in highly dynamic and collaborative

Megacampus environments that enhance our tenants' ability to successfully recruit and

retain world-class talent and inspire productivity, efficiency, creativity, and success.

Alexandria also provides strategic capital to transformative life science companies through

our venture capital platform. We believe our unique business model and diligent

underwriting ensure a high-quality and diverse tenant base that results in higher

occupancy levels, longer lease terms, higher rental income, higher returns, and greater

long-term asset value. For more information on Alexandria, please visit www.are.com.

**Tenant base**

Alexandria is known for our high-quality and diverse tenant base, with 53% of our

annual rental revenue being generated from tenants that are investment-grade rated or

publicly traded large cap companies. The quality, diversity, breadth, and depth of our

significant relationships with our tenants provide Alexandria with high-quality and stable

cash flows. Alexandria's underwriting team and long-term industry relationships positively

distinguish us from all other publicly traded REITs and real estate companies.

**Executive and senior management team**

Alexandria's executive and senior management team has unique experience and

expertise in creating, owning, and operating highly dynamic and collaborative

Megacampus real estate in key life science cluster locations to catalyze innovation. From

design to development to the management of our high-quality, sustainable real estate, as

well as our ongoing cultivation of collaborative environments with unique amenities and

events, the Alexandria team has a best-in-class reputation of excellence in life science real

estate. Alexandria's highly experienced management team includes regional market

directors with leading reputations and long-standing relationships within the life science

communities in their respective innovation clusters. We believe that our experience,

expertise, reputation, and key relationships in the real estate and life science industries

provide Alexandria significant competitive advantages in attracting new business

opportunities.

Alexandria's executive and senior management team consists of

62 individuals, averaging 24 years of real estate experience,

including 13 years with Alexandria. Our executive management

team alone averages 19 years with Alexandria.

---

| | |
|:---|:---|
| **EXECUTIVE MANAGEMENT TEAM** | **EXECUTIVE MANAGEMENT TEAM** |
| Joel S. Marcus | Peter M. Moglia |
| Executive Chairman & <br>Founder<br>| Chief Executive Officer & <br>Chief Investment Officer<br>|
| Daniel J. Ryan | Hunter L. Kass |
| Co-President & Regional Market <br>Director – San Diego<br>| Co-President & Regional Market <br>Director – Greater Boston<br>|
| Marc E. Binda | Lawrence J. Diamond |
| Chief Financial Officer & <br>Treasurer<br>| Co-Chief Operating Officer & Regional <br>Market Director – Maryland<br>|
| Joseph Hakman | Hart Cole |
| Co-Chief Operating Officer & <br>Chief Strategic Transactions Officer<br>| Executive Vice President – Capital <br>Markets/Strategic Operations & <br>Co-Regional Market Director – Seattle<br>|
| Jackie B. Clem | Gary D. Dean |
| General Counsel & Secretary | Executive Vice President – <br>Real Estate Legal Affairs<br>|
| Andres R. Gavinet | Onn C. Lee |
| Chief Accounting Officer | Executive Vice President –<br>Accounting<br>|
| Kristina A. Fukuzaki-Carlson | Madeleine T. Alsbrook |
| Executive Vice President – <br>Business Operations<br>| Executive Vice President –<br>Talent Management<br>|

---

[Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025<sub>14</sub>

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Investor Information** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Corporate Headquarters** | **New York Stock Exchange Trading Symbol** | **Information Requests** | **Information Requests** |
| 26 North Euclid Avenue | Common stock: ARE | Phone: | (626) 578-0777 |
| Pasadena, California 91101 |  | Email: | corporateinformation@are.com |
| www.are.com |  | Website: | investor.are.com |

---

**Equity Research Coverage**<br>

Alexandria is currently covered by the following research analysts. This list may be incomplete and is subject to change as firms initiate or discontinue coverage of our company.<br>Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, estimates, or<br>forecasts of Alexandria or our management. Alexandria does not by our reference or distribution of the information below imply our endorsement of or concurrence with any opinions,<br>estimates, or forecasts of these analysts. Interested persons may obtain copies of analysts' reports on their own as we do not distribute these reports. Several of these firms may, from time to<br>time, own our stock and/or hold other long or short positions in our stock and may provide compensated services to us.<br>

---

| | | | |
|:---|:---|:---|:---|
| **BNP Paribas Exane** | **Citigroup Global Markets Inc.** | **Green Street** | **RBC Capital Markets** |
| Nate Crossett / Monir Koummal | Nicholas Joseph / Seth Bergey | Dylan Burzinski | Michael Carroll |
| (646) 342-1588 / (646) 342-1554 | (212) 816-1909 / (212) 816-2066 | (949) 640-8780 | (440) 715-2649 |
| **BofA Securities** | **Citizens** | **J.P. Morgan Securities LLC** | **Robert W. Baird & Co. Incorporated** |
| Jeff Spector / Farrell Granath | Aaron Hecht / Linda Fu | Anthony Paolone / Ray Zhong | Wesley Golladay / Nicholas Thillman |
| (646) 855-1363 / (646) 855-1351 | (415) 835-3963 / (415) 869-4411 | (212) 622-6682 / (212) 622-5411 | (216) 737-7510 / (414) 298-5053 |
| **BTIG, LLC** | **Deutsche Bank AG** | **Jefferies** |  |
| Tom Catherwood / Michael Tompkins | Tayo Okusanya / Samuel Ohiomah | Peter Abramowitz / Katie Elders |  |
| (212) 738-6140 / (212) 527-3566 | (212) 250-9284 / (212) 250-0057 | (212) 336-7241 / (917) 421-1968 |  |
| **CFRA** | **Evercore ISI** | **Mizuho Securities USA LLC** |  |
| Nathan Schmidt | Steve Sakwa / James Kammert | Vikram Malhotra / Georgi Dinkov |  |
| (646) 517-1144 | (212) 446-9462 / (312) 705-4233 | (212) 282-3827 / (617) 352-1721 |  |
| **Fixed Income Research Coverage** | **Fixed Income Research Coverage** | **Rating Agencies** | **Rating Agencies** |
| **Barclays Capital Inc.** | **J.P. Morgan Securities LLC** | **Moody's Ratings** | **S&P Global Ratings** |
| Srinjoy Banerjee / Japheth Otieno | Mark Streeter | (212) 553-0376 | Alan Zigman |
| (212) 526-3521 / (212) 526-6961 | (212) 834-5086 |  | (416) 507-2556 |
| **Mizuho Securities USA LLC** |  |  |  |
| Thierry Perrein |  |  |  |
| (212) 205-7665 |  |  |  |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 15 |

---

---

| | |
|:---|:---|
| **Financial and Asset Base Highlights** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands, except per share amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** |
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| *Selected financial data from consolidated financial statements and related information* |  |  |  |  |  |
| Rental revenues | $553377 | $552112 | $566535 | $579569 | $576835 |
| Tenant recoveries | $183902 | $191063 | $196714 | $196175 | $178327 |
| General and administrative expenses | $29128 | $30675 | $32730 | $43945 | $44629 |
| General and administrative expenses as a percentage of net operating income – <br>trailing 12 months<br>| 6.3% | 6.9% | 7.6% | 8.9% | 9.2% |
| Operating margin | 71% | 70% | 70% | 71% | 72% |
| Adjusted EBITDA margin | 71% | 71% | 72% | 70% | 72% |
| Adjusted EBITDA – quarter annualized | $2174160 | $2165632 | $2273480 | $2219632 | $2216144 |
| Adjusted EBITDA – trailing 12 months | $2208226 | $2218722 | $2228921 | $2184298 | $2122250 |
| Net debt at end of period  | $12844726 | $12687856 | $11762176 | $12191574 | $11940144 |
| Net debt and preferred stock to Adjusted EBITDA – quarter annualized | 5.9x | 5.9x | 5.2x | 5.5x | 5.4x |
| Net debt and preferred stock to Adjusted EBITDA – trailing 12 months | 5.8x | 5.7x | 5.3x | 5.6x | 5.6x |
| Total debt and preferred stock at end of period | $13294100 | $13090834 | $12244374 | $12691601 | $12424055 |
| Gross assets at end of period | $43770007 | $43486989 | $43152628 | $44112770 | $43305279 |
| Total debt and preferred stock to gross assets at end of period | 30% | 30% | 28% | 29% | 29% |
| Fixed-charge coverage ratio – quarter annualized | 4.1x | 4.3x | 4.3x | 4.4x | 4.5x |
| Fixed-charge coverage ratio – trailing 12 months | 4.3x | 4.4x | 4.5x | 4.5x | 4.6x |
| Unencumbered net operating income as a percentage of total net operating income | 99.7% | 99.8% | 99.9% | 99.1% | 99.1% |
| Closing stock price at end of period | $72.63 | $92.51 | $97.55 | $118.75 | $116.97 |
| Common shares outstanding (in thousands) at end of period  | 170146 | 170130 | 172203 | 172244 | 172018 |
| Total equity capitalization at end of period | $12357709 | $15738715 | $16798446 | $20454023 | $20120907 |
| Total market capitalization at end of period | $25651809 | $28829549 | $29042820 | $33145624 | $32544962 |
| Dividend per share – quarter/annualized | $1.32/$5.28 | $1.32/$5.28 | $1.32/$5.28 | $1.30/$5.20 | $1.30/$5.20 |
| Dividend payout ratio for the quarter | 57% | 57% | 55% | 55% | 55% |
| Dividend yield – annualized | 7.3% | 5.7% | 5.4% | 4.4% | 4.4% |
| Amounts related to operating leases: |  |  |  |  |  |
| Operating lease liabilities at end of period | $363419 | $371412 | $507127 | $648338 | $379223 |
| Rent expense | $12139 | $11666 | $10685 | $10180 | $9412 |
| Capitalized interest | $82423<br><sup>(1)</sup> | $80065 | $81586 | $86496 | $81039 |
| Average real estate basis capitalized during the period | $8107180 | $8026566 | $8118010 | $8281318 | $7936612 |
| Weighted-average interest rate for capitalization of interest during the period | 4.07% | 3.99% | 4.02% | 3.98% | 3.96% |
| Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. | Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. | Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. | Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. | Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. | Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.<br>(1) Increase in capitalized interest driven primarily by an increase in the weighted-average interest rate from 3.99% at 1Q25 to 4.07% at 2Q25. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 16 |

---

---

| | |
|:---|:---|
| **Financial and Asset Base Highlights (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands, except annual rental revenue per occupied RSF amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** | **Three Months Ended (unless stated otherwise)** |
|  | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| *Amounts included in funds from operations and non-revenue-enhancing capital expenditures* |  |  |  |  |  |
| Straight-line rent revenue | $18536 | $22023 | $17653 | $29087 | $48338 |
| Amortization of acquired below-market leases | $10196 | $15222 | $15512 | $17312 | $22515 |
| Amortization of deferred revenue related to tenant-funded and - built landlord improvements | $2401 | $1651 | $1214 | $329 | $— |
| Straight-line rent expense on ground leases | $87 | $149 | $1021 | $789 | $341 |
| Cash payment for ground lease extension | $— | $(135000) | $(135000) | $— | $— |
| Stock compensation expense | $12530 | $10064 | $12477 | $15525 | $14507 |
| Amortization of loan fees  | $4615 | $4691 | $4620 | $4222 | $4146 |
| Amortization of debt discounts | $335 | $349 | $333 | $330 | $328 |
| Non-revenue-enhancing capital expenditures: |  |  |  |  |  |
| Building improvements  | $4622 | $3789 | $4313 | $4270 | $4210 |
| Tenant improvements and leasing commissions | $23971 | $73483 | $81918 | $55920 | $15724 |
| Funds from operations attributable to noncontrolling interests | $80860 | $81012 | $76111 | $78113 | $78711 |
| *Operating statistics and related information (at end of period)* |  |  |  |  |  |
| Number of properties – North America | 384 | 386 | 391 | 406 | 408 |
| RSF – North America (including development and redevelopment projects under construction) | 43699922 | 43687343 | 44124001 | 46748734 | 47085993 |
| Total square footage – North America | 67220337 | 68518184 | 69289411 | 73611815 | 74103404 |
| Annual rental revenue per occupied RSF – North America | $58.68 | $58.38 | $56.98 | $57.09 | $56.87 |
| Occupancy of operating properties – North America | 90.8%<br><sup>(1)</sup> | 91.7% | 94.6% | 94.7% | 94.6% |
| Occupancy of operating and redevelopment properties – North America | 86.2% | 86.9% | 89.7% | 89.7% | 89.9% |
| Weighted-average remaining lease term (in years)  | 7.4 | 7.6 | 7.5 | 7.5 | 7.4 |
| Total leasing activity – RSF | 769815<br><sup>(2)</sup> | 1030553 | 1310999 | 1486097 | 1114001 |
| Lease renewals and re-leasing of space – change in average new rental rates over expiring rates: |  |  |  |  |  |
| Rental rate changes | 5.5% | 18.5% | 18.1% | 5.1% | 7.4% |
| Rental rate changes (cash basis) | 6.1% | 7.5% | 3.3% | 1.5% | 3.7% |
| RSF (included in total leasing activity above) | 483409 | 884408 | 1024862 | 1278857 | 589650 |
| Top 20 tenants: |  |  |  |  |  |
| Annual rental revenue | $795244 | $754354 | $741965 | $796898 | $805751 |
| Annual rental revenue from investment-grade or publicly traded large cap tenants | 89% | 87% | 92% | 92% | 92% |
| Weighted-average remaining lease term (in years)  | 9.4 | 9.6 | 9.3 | 9.5 | 9.4 |
| Same property – percentage change over comparable quarter from prior year: |  |  |  |  |  |
| Net operating income changes | (5.4)%<br><sup>(3)</sup> | (3.1)% | 0.6% | 1.5% | 1.5% |
| Net operating income changes (cash basis) | 2.0%<br><sup>(3)</sup> | 5.1% | 6.3% | 6.5% | 3.9% |

---

Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

(1)Refer to page 2 in the Earnings Press Release and "Summary of properties and occupancy" in the Supplemental Information for additional details.

(2)In July 2025, we executed the largest life science lease in company history with a long-standing multinational pharmaceutical tenant for a 16-year expansion build-to-suit lease, aggregating466,598 RSF, located on the Campus

Point by Alexandria Megacampus in our University Town Center submarket. If this were included in the leasing volume for 2Q25, the total leased RSF would have increased to 1.2 million RSF for 2Q25 from 769,815 RSF.

(3)Refer to page 2 in the Earnings Press Release and "Same property performance" in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 17 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **High-Quality and Diverse Client Base** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | |
|:---|:---|
| **Stable Cash Flows From Our High-Quality and Diverse Mix of Approximately 750 Tenants** | **Stable Cash Flows From Our High-Quality and Diverse Mix of Approximately 750 Tenants** |
| | **Investment-Grade or Publicly Traded** <br>**Large Cap Tenants** |
|  | **89%** |
|  | **89%** |
|  | **89%** |
|  | of ARE's Top 20 Tenant <br>Annual Rental Revenue |
|  | **53%** |
|  | **53%** |
|  | **53%** |
| Percentage of ARE's Annual Rental Revenue | of ARE's Total<br>Annual Rental Revenue |

---

![chart-93a15c923e3b45bba49.gif](chart-93a15c923e3b45bba49.gif)

Life Science

Product,

Service, and

Device

Multinational

Pharmaceutical

Public

Biotechnology –

Approved or

Marketed

Product

Public Biotechnology –

Preclinical or Clinical

Stage

Private

Biotechnology

Other<sup>(3)</sup>

Biomedical

Institutions<sup>(1)</sup>

Government

Institutions

Advanced Technologies<sup>(2)</sup>

As of June 30, 2025. Annual rental revenue represents amounts in effect as of June 30, 2025. Refer to "Definitions and reconciliations" in the Supplemental Information for additional details, including our methodology of calculating annual rental

revenue from unconsolidated real estate joint ventures.

(1)79%of our annual rental revenue from biomedical institutions is from investment-grade or publicly traded large cap tenants.

(2)63% of our annual rental revenue from advanced technology tenants is from investment-grade or publicly traded large cap tenants.

(3)Represents the percentage of our annual rental revenue generated by professional services, finance, telecommunications, construction/real estate companies, and retail-related tenants.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 18 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **High-Quality and Diverse Client Base (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | |
|:---|:---|:---|
| **Strong, Broad, and Diverse Life Science Tenant Base Drives Solid**<br>**Leasing and Long-Term Remaining Lease Terms** | **Strong, Broad, and Diverse Life Science Tenant Base Drives Solid**<br>**Leasing and Long-Term Remaining Lease Terms** | **Strong, Broad, and Diverse Life Science Tenant Base Drives Solid**<br>**Leasing and Long-Term Remaining Lease Terms** |
| | **Long-Duration Life Science Lease Terms** | **Long-Duration Life Science Lease Terms** |
|  |  | Remaining Lease <br>Term (in years)<sup>(1)</sup><br>|
|  | Multinational Pharmaceutical | 7.1 |
|  | Life Science Product, Service, and <br>Device<br>| 6.6 |
|  | Government Institutions | 5.1 |
|  | Biomedical Institutions | 7.8 |
|  | Private Biotechnology | 7.2 |
|  | Public Biotechnology | 7.1 |
| Percentage of Life Science Leasing Activity by RSF<sup>(2)</sup> |  |  |

---

Multinational

Pharmaceutical

Public

Biotechnology

Life Science

Product,

Service, and

Device

Biomedical

Institutions

Private

Biotechnology

![chart-293fd959c25e42f5a9ca.gif](chart-293fd959c25e42f5a9ca.gif)

Other

Advanced

Technologies

(1)Average remaining lease term based on annual rental revenue in effect as of June 30, 2025.

(2)Represents the percentage of RSF for leases executed during the three months ended June 30, 2025 for each respective business type.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 19 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **High-Quality and Diverse Client Base (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Sustained Operational Excellence and Strength in Tenant Collections**

---

| | |
|:---|:---|
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> |  |
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> | **99.9%**<br>**2Q25**<br>|
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> |  |
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> | **99.4%**<br>**July 2025**<br>|
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> |  |
| **Tenant Rents And Receivables Collected**<sup>(1)</sup> | **99.8%**<br>**Average Tenant**<br>**Collections**<br>**1Q21–2Q25**<br>|

---

![chart-722408bfd13e4e39afca.gif](chart-722408bfd13e4e39afca.gif)

(1)Represents tenant collections for each quarter-end as of each respective earnings release date.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 20 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Key Operating Metrics** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Same Property**<br>**Net Operating Income Performance** | **Same Property**<br>**Net Operating Income Performance** | **Rental Rate Growth:** <br>**Renewed/Re-Leased Space** | **Rental Rate Growth:** <br>**Renewed/Re-Leased Space** |
| **Margins**<sup>(2)</sup> | **Margins**<sup>(2)</sup> | **Favorable Lease Structure**<sup>(3)</sup> | **Favorable Lease Structure**<sup>(3)</sup> |
| **Operating** | **Adjusted EBITDA** | **Strategic Lease Structure by Owner and** <br>**Operator of Collaborative Megacampus Ecosystems** | **Strategic Lease Structure by Owner and** <br>**Operator of Collaborative Megacampus Ecosystems** |
| 71% | 71% | *Increasing cash flows* |  |
| 71% | 71% | **Percentage of leases containing** <br>**annual rent escalations** | **97%** |
| 71% | 71% | *Stable cash flows* |  |
| **Long-Duration Lease Terms**<sup>(4)</sup> | **Long-Duration Lease Terms**<sup>(4)</sup> | **Percentage of triple net leases** | **91%** |
|  |  | **Percentage of triple net leases** |  |
| 9.4 Years | 7.4 Years | *Lower capex burden* |  |
| 9.4 Years | 7.4 Years | **Percentage of leases providing for the**<br>**recapture of capital expenditures**  | **92%** |
| Top 20 Tenants | All Tenants |  |  |

---

![chart-2d6184df01ad4ed99fb.gif](chart-2d6184df01ad4ed99fb.gif)

![chart-3930a7501b774816bd3.gif](chart-3930a7501b774816bd3.gif)

![chart-dd31d154c1b148ef830.gif](chart-dd31d154c1b148ef830.gif)

![chart-1db258f919df48d69e9.gif](chart-1db258f919df48d69e9.gif)

<sup>(1)</sup>

**(4.3)%**

---

| | |
|:---|:---|
| **2024** | **YTD** <br>**6/30/25**<br>|

---

Refer to "Same property performance" and "Definitions and reconciliations" in the Supplemental Information for additional details. "Definitions and reconciliations" contains the definition of "Net operating income" and its reconciliation

from the most directly comparable financial measure presented in accordance with GAAP.

(1)Refer to footnote 1 under "Same property performance" in the Supplemental Information for additional details.

(2)For the three months ended June 30, 2025.

(3)Percentages calculated based on our annual rental revenue in effectas of June 30, 2025.

(4)Represents the weighted-average remaining term based on annual rental revenue in effect as of June 30, 2025.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 21 |

---

---

| | |
|:---|:---|
| **Same Property Performance** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | | **June 30, 2025** | **June 30, 2025** |
| <br>**Same Property Financial Data** | **Three Months** <br>**Ended**<br>| **Six Months** <br>**Ended**<br>| <br>**Same Property Statistical Data** | **Three Months** <br>**Ended**<br>| **Six Months** <br>**Ended**<br>|
| Percentage change over comparable period from prior year: |  |  | Number of same properties | 330 | 329 |
| **Net operating income changes**<sup>(1)</sup> | **(5.4)%** | **(4.3)%** | Rentable square feet | 33904941 | 33709506 |
| **Net operating income changes (cash basis)**<sup>(1)(2)</sup> | **2.0%** | **3.4%** | Occupancy – current-period average | 91.3% | 92.5% |
| Operating margin | 68% | 68% | Occupancy – same-period prior-year average | 94.5% | 94.4% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** | **$ Change** | **% Change** |
| Income from rentals: |  |  |  |  |  |  |  |  |
| Same properties | $462622 | $480547 | $(17925) | (3.7)% | $925636 | $950433 | $(24797) | (2.6)% |
| Non-same properties | 90755 | 96288 | (5533) | (5.7) | 179853 | 207802 | (27949) | (13.4) |
| Rental revenues | 553377 | 576835 | (23458) | (4.1) | 1105489 | 1158235 | (52746) | (4.6) |
| Same properties | 166465 | 155157 | 11308 | 7.3 | 335349 | 308553 | 26796 | 8.7 |
| Non-same properties | 17437 | 23170 | (5733) | (24.7) | 39616 | 43925 | (4309) | (9.8) |
| Tenant recoveries | 183902 | 178327 | 5575 | 3.1 | 374965 | 352478 | 22487 | 6.4 |
| Income from rentals | 737279 | 755162 | (17883) | (2.4) | 1480454 | 1510713 | (30259) | (2.0) |
| Same properties | 429 | 379 | 50 | 13.2 | 774 | 719 | 55 | 7.6 |
| Non-same properties | 24332 | 11193 | 13139 | 117.4 | 38970 | 24410 | 14560 | 59.6 |
| Other income | 24761 | 11572 | 13189 | 114.0 | 39744 | 25129 | 14615 | 58.2 |
| Same properties | 629516 | 636083 | (6567) | (1.0) | 1261759 | 1259705 | 2054 | 0.2 |
| Non-same properties | 132524 | 130651 | 1873 | 1.4 | 258439 | 276137 | (17698) | (6.4) |
| **Total revenues** | **762040** | **766734** | **(4694)** | **(0.6)** | **1520198** | **1535842** | **(15644)** | **(1.0)** |
| Same properties | 201305 | 183582 | 17723 | 9.7 | 403337 | 362407 | 40930 | 11.3 |
| Non-same properties | 23128 | 33672 | (10544) | (31.3) | 47491 | 73161 | (25670) | (35.1) |
| Rental operations | 224433 | 217254 | 7179 | 3.3 | 450828 | 435568 | 15260 | 3.5 |
| Same properties | 428211 | 452501 | (24290) | (5.4) | 858422 | 897298 | (38876) | (4.3) |
| Non-same properties | 109396 | 96979 | 12417 | 12.8 | 210948 | 202976 | 7972 | 3.9 |
| Net operating income | $537607 | $549480 | $(11873) | (2.2)%<br><sup>(3)</sup> | $1069370 | $1100274 | $(30904) | (2.8)%<br><sup>(3)</sup> |
| **Net operating income – same properties** | **$428211** | **$452501** | **$(24290)** | **(5.4)%** | **$858422** | **$897298** | **$(38876)** | **(4.3)%** |
| Straight-line rent revenue  | (8463) | (38585) | 30122 | (78.1) | (13930) | (76294) | 62364 | (81.7) |
| Amortization of acquired below-market leases | (9199) | (11349) | 2150 | (18.9) | (19097) | (22772) | 3675 | (16.1) |
| **Net operating income – same properties (cash basis)** | **$410549** | **$402567** | **$7982** | **2.0%** | **$825395** | **$798232** | **$27163** | **3.4%** |

---

Refer to "Same property comparisons" under "Definitions and reconciliations" in the Supplemental Information for additional details, including a reconciliation of same properties to total properties. "Definitions and reconciliations" also

contains definitions of "Tenant recoveries" and "Net operating income" and their respective reconciliations from the most directly comparable financial measures presented in accordance with GAAP.

(1)Includes 1Q25 lease expirations aggregating 768,080 RSF, that are vacant as of June 30, 2025, across six properties and four submarkets. Excluding the impact of the properties with these leases, same property net operating

income changes for the three and six months ended June 30, 2025 would have been (2.1)% and 6.5% (cash basis) and (1.1)% and 7.6% (cash basis), respectively. Refer to "Summary of properties and occupancy" in the

Supplemental Information for additional details.

(2)Includes the impact of initial free rent concessions that burned off after January 1, 2024 for development and redevelopment projects that were placed into service in 2023 and accordingly are part of our same property pool for the

three and six months ended June 30, 2025, including at 325 Binney Street in our Cambridge submarket, 15 Necco Street in our Seaport Innovation District submarket, and 751 Gateway Boulevard in our South San Francisco

submarket. Excluding the impact of these initial free rent concessions, same property net operating income changes (cash basis) for the three and six months ended June 30, 2025 would have been (1.8)% and (0.8)%, respectively.

(3)Decrease in total net operating income includes the impact of operating properties disposed of after January 1, 2024. Excluding these dispositions, net operating income for the three and six months ended June 30, 2025 would have

increased by 4.0% and 3.2%, respectively, over the corresponding periods in 2024.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 22 |

---

---

| | |
|:---|:---|
| **Leasing Activity** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars per RSF)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Year Ended** | **Year Ended** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Including** <br>**Straight-Line Rent** | **Cash Basis** | **Including** <br>**Straight-Line Rent** | **Cash Basis** | **Including** <br>**Straight-Line Rent** | **Cash Basis** |
| *Leasing activity:* |  |  |  |  |  |  |
| Renewed/re-leased space<sup>(1)</sup> |  |  |  |  |  |  |
| **Rental rate changes** | **5.5%** | **6.1%** | **13.2%** | **6.9%** | **16.9%** | **7.2%** |
| New rates | $64.78 | $68.27 | $60.11 | $59.72 | $65.48 | $64.18 |
| Expiring rates | $61.38 | $64.36 | $53.10 | $55.84 | $56.01 | $59.85 |
| RSF | 483409 |  | 1367817 |  | 3888139 |  |
| Tenant improvements/leasing commissions | $49.59 |  | $80.68<br><sup>(2)</sup> |  | $46.89 |  |
| Weighted-average lease term | 9.4 years |  | 9.8 years |  | 8.5 years |  |
| Developed/redeveloped/previously vacant space leased<sup>(3)</sup> |  |  |  |  |  |  |
| New rates | $58.12 | $58.73 | $55.31 | $55.61 | $59.44 | $57.34 |
| RSF | 286406 |  | 432551 |  | 1165815 |  |
| Weighted-average lease term | 12.3 years |  | 11.5 years |  | 10.0 years |  |
| *Leasing activity summary (totals):* |  |  |  |  |  |  |
| New rates | $62.30 | $64.72 | $58.96 | $58.73 | $64.16 | $62.68 |
| RSF | 769815<br><sup>(4)</sup> |  | 1800368 |  | 5053954 |  |
| Weighted-average lease term | 10.5 years |  | 10.2 years |  | 8.9 years |  |
| *Lease expirations*<sup>(1)</sup> |  |  |  |  |  |  |
| Expiring rates | $63.31 | $63.62 | $53.95 | $55.17 | $53.82 | $57.24 |
| RSF | 825583 |  | 2748631 |  | 5005638 |  |

---

Leasing activity includes 100% of results for properties in North America in which we have an investment.

(1)Excludes month-to-month leases aggregating 163,493RSF and 136,131RSF as of June 30, 2025and December 31, 2024, respectively. During the trailing twelve months ended June 30, 2025, we granted free rent

concessions averaging0.9 months per annum.

(2)Includes tenant improvements and leasing commissions for one 11.4-year lease, executed during the three months ended March 31, 2025, at the Alexandria Technology Square<sup>®</sup> Megacampus in our Cambridge submarket

aggregating 119,280 RSF. Excluding this lease, tenant improvements and leasing commissions per RSF for the six months ended June 30, 2025 was $47.01.

(3)Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" in the Supplemental Information for additional details, including total project costs.

(4)In July 2025, we executed the largest life science lease in company history with a long-standing multinational pharmaceutical tenant for a 16-year expansion build-to-suit lease, aggregating466,598 RSF, located on the

Campus Point by Alexandria Megacampus in our University Town Center submarket. If this were included in the leasing volume for2Q25, the total leased RSF would have increased to 1.2 million RSF for 2Q25 from

769,815 RSF.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 23 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Contractual Lease Expirations** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **RSF** | **Percentage of**<br>**Occupied RSF** | **Annual Rental Revenue** <br>**(per RSF)**<sup>(1)</sup> | **Percentage of** <br>**Annual Rental Revenue** |
| 2025<br><sup>(2)</sup> | 1320692 | 3.7% | $51.73 | 3.3% |
| 2026 | 3137647 | 8.9% | $57.29 | 8.8% |
| 2027 | 3393561 | 9.6% | $50.88 | 8.4% |
| 2028 | 4015759 | 11.4% | $50.83 | 10.0% |
| 2029 | 2286491 | 6.5% | $48.02 | 5.4% |
| 2030 | 3078313 | 8.7% | $43.50 | 6.5% |
| 2031 | 3585208 | 10.2% | $54.35 | 9.5% |
| 2032 | 993042 | 2.8% | $57.50 | 2.8% |
| 2033 | 2592303 | 7.3% | $47.59 | 6.0% |
| 2034 | 3063408 | 8.7% | $68.56 | 10.2% |
| Thereafter | 7838957 | 22.2% | $76.19 | 29.1% |

---

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market** | **2025 Contractual Lease Expirations (in RSF)** | **2025 Contractual Lease Expirations (in RSF)** | **2025 Contractual Lease Expirations (in RSF)** | **2025 Contractual Lease Expirations (in RSF)** | **2025 Contractual Lease Expirations (in RSF)** | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> | **2026 Contractual Lease Expirations (in RSF)** | **2026 Contractual Lease Expirations (in RSF)** | **2026 Contractual Lease Expirations (in RSF)** | **2026 Contractual Lease Expirations (in RSF)** | **2026 Contractual Lease Expirations (in RSF)** | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> |
| **Market** | **Leased** | **Negotiating/**<br>**Anticipating** | **Targeted for** <br>**Future** <br>**Development/**<br>**Redevelopment**<sup>(3)</sup> | **Remaining**<br>**Expiring**<br>**Leases**<sup>(4)</sup> | **Total**<sup>(2)</sup> | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> | **Leased** | **Negotiating/**<br>**Anticipating** | **Targeted for** <br>**Future**<br>**Development/**<br>**Redevelopment** | **Remaining**<br>**Expiring** <br>**Leases**<sup>(4)</sup> | **Total** | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> |
| **Market** | **Leased** | **Negotiating/**<br>**Anticipating** | **Targeted for** <br>**Future** <br>**Development/**<br>**Redevelopment**<sup>(3)</sup> | **Remaining**<br>**Expiring**<br>**Leases**<sup>(4)</sup> | **Total**<sup>(2)</sup> | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> | **Leased** | **Negotiating/**<br>**Anticipating** | **Targeted for** <br>**Future**<br>**Development/**<br>**Redevelopment** | **Remaining**<br>**Expiring** <br>**Leases**<sup>(4)</sup> | **Total** | **Annual** <br>**Rental** <br>**Revenue**<br>**(per RSF)**<sup>(1)</sup> |
| Greater Boston | 214399 |  |  | 145329 | 359728 | $35.89 | 60418 | 11897 |  | 514566 | 586881 | $89.16 |
| San Francisco Bay Area | 134423 | 10208 |  | 279182 | 423813 | 95.48 | 28454 |  |  | 686304 | 714758 | 72.57 |
| San Diego | 23327 |  |  | 68081 | 91408 | 55.21 |  |  |  | 846084 | 846084 | 48.90 |
| Seattle | 1868 |  |  | 54781 | 56649 | 32.64 | 29604 | 50552 |  | 111720 | 191876 | 30.42 |
| Maryland | 41283 |  |  | 23469 | 64752 | 22.61 |  |  |  | 255147 | 255147 | 18.85 |
| Research Triangle | 10478 | 8368 |  | 34461 | 53307 | 43.56 | 19753 |  |  | 159362 | 179115 | 39.19 |
| New York City |  |  |  | 30384 | 30384 | 96.62 |  |  |  | 73363 | 73363 | 103.16 |
| Texas |  |  | 198972 |  | 198972 | N/A |  |  |  |  |  |  |
| Canada |  |  |  | 40679 | 40679 | 10.65 |  | 247743 |  | 1755 | 249498 | 21.57 |
| Non-cluster/other markets |  |  |  | 1000 | 1000 | N/A |  | 9266 |  | 31659 | 40925 | 85.36 |
| Total | 425778 | 18576 | 198972 | 677366 | 1320692 | $51.73 | 138229 | 319458 |  | 2679960 | 3137647 | $57.29 |
| Percentage of expiring leases | 32% | 1% | 15% | 52% | 100% |  | 4% | 10% | 0% | 86% | 100% |  |

---

Contractual lease expirations for properties classified as held for sale as of June 30, 2025 are excluded from the information on this page.

(1)Represents amounts in effect as of June 30, 2025.

(2)Excludes month-to-month leases aggregating 163,493 RSFas of June 30, 2025.

(3)Primarily represents assets that were recently acquired for future development or redevelopment opportunities, for which we expect, subject to market conditions and leasing, to commence first-time conversion from non-laboratory space

to laboratory space, or to commence future ground-up development. As of June 30, 2025, the weighted-average annual rental revenue and expiration date of these leases expiring in 2025 is$895 thousandand July 1, 2025, respectively.

Refer to "Investments in real estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.

(4)Includes 12 properties primarily located in Greater Boston, the San Francisco Bay Area, and San Diego markets aggregating 868,289 RSF with a weighted-average lease expiration date of February 9, 2026 and annual rental revenue

aggregating $70 million and are expected to be re-leased to new tenants, including the following:

(i)Three properties aggregating 213,705 RSF in our Greater Stanford submarket that were recently acquired and we are evaluating options to reposition the campus for advanced technology use;

(ii)One property aggregating 118,225 RSF in our Torrey Pines submarket for which we are evaluating options to re-lease or reposition the space from single tenancy to multi-tenancy; and

(iii)One lease expiration aggregating 34,714 RSF at our Alexandria Technology Square Megacampus in our Cambridge submarket for which we are in the process of repositioning the building for multi-tenant use.

We continue to evaluate the business plans and re-leasing strategies for these projects.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 24 |

---

---

| | |
|:---|:---|
| **Top 20 Tenants** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands, except average market cap amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

89% of Top 20 Tenant Annual Rental Revenue Is From Investment-Grade

or Publicly Traded Large Cap Tenants<sup>(1)</sup>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Tenant** | **Remaining Lease** <br>**Term**<sup>(1)</sup>***(in years)*** | **Aggregate** <br>**RSF** | **Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Percentage of** <br>**Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Investment-Grade** <br>**Credit Ratings** | **Investment-Grade** <br>**Credit Ratings** | **Average** <br>**Market Cap**<br>***(in billions)*** |
| | **Tenant** | **Remaining Lease** <br>**Term**<sup>(1)</sup>***(in years)*** | **Aggregate** <br>**RSF** | **Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Percentage of** <br>**Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Investment-Grade** <br>**Credit Ratings** | **Investment-Grade** <br>**Credit Ratings** | **Average** <br>**Market Cap**<br>***(in billions)*** |
| | **Tenant** | **Remaining Lease** <br>**Term**<sup>(1)</sup>***(in years)*** | **Aggregate** <br>**RSF** | **Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Percentage of** <br>**Annual Rental** <br>**Revenue**<sup>(1)</sup> | **Moody's** | **S&P** | **Average** <br>**Market Cap**<br>***(in billions)*** |
| 1 | Bristol-Myers Squibb Company<sup>(2)</sup> | 5.8 | 1312184 | $113542 | 5.5% | A2 | A | $106.0 |
| 2 | Eli Lilly and Company | 9.3 | 1086165 | 91233 | 4.4 | Aa3 | A+ | $791.0 |
| 3 | Moderna, Inc. | 10.9 | 496814 | 88729 | 4.3 |  |  | $19.5 |
| 4 | Takeda Pharmaceutical Company Limited | 9.9 | 549759 | 47899 | 2.3 | Baa1 | BBB+ | $45.0 |
| 5 | AstraZeneca PLC | 6.4 | 450848 | 39637 | 1.9 | A1 | A+ | $227.0 |
| 6 | Eikon Therapeutics, Inc.<sup>(3)</sup> | 13.5 | 311806 | 38913 | 1.9 |  |  | $— |
| 7 | Roche | 7.7 | 647069 | 36373 | 1.7 | Aa2 | AA | $255.0 |
| 8 | Illumina, Inc. | 5.4 | 857967 | 35924 | 1.7 | Baa3 | BBB | $18.1 |
| 9 | Alphabet Inc. | 2.3 | 625015 | 34899 | 1.7 | Aa2 | AA+ | $2120.0 |
| 10 | United States Government | 5.1 | 429359 | 29502<br><sup>(4)</sup> | 1.4 | Aaa | AA+ | $— |
| 11 | Uber Technologies, Inc. | 57.3<br><sup>(5)</sup> | 1009188 | 27809 | 1.3 | Baa1 | BBB | $155.0 |
| 12 | Novartis AG | 3.1 | 387563 | 27709 | 1.3 | Aa3 | AA- | $238.0 |
| 13 | Cloud Software Group, Inc. | 1.0<br><sup>(6)</sup> | 292013 | 26446 | 1.3 |  |  | $— |
| 14 | Boston Children's Hospital | 11.7 | 309231 | 26294 | 1.3 | Aa2 | AA | $— |
| 15 | The Regents of the University of California | 9.9 | 363974 | 25309 | 1.2 | Aa2 | AA | $— |
| 16 | Sanofi | 5.5 | 267278 | 21851 | 1.0 | Aa3 | AA | $132.0 |
| 17 | New York University | 7.1 | 218983 | 21110 | 1.0 | Aa2 | AA- | $— |
| 18 | Merck & Co., Inc. | 8.2 | 333124 | 21001 | 1.0 | Aa3 | A+ | $250.0 |
| 19 | Charles River Laboratories, Inc. | 10.0 | 250905 | 20535 | 1.0 |  |  | $8.9 |
| 20 | Massachusetts Institute of Technology | 4.5 | 242428 | 20529 | 1.0 | Aaa | AAA | $— |
|  | Total/weighted-average | 9.4<br><sup>(5)</sup> | 10441673 | $795244 | 38.2% |  |  |  |

---

Annual rental revenue and RSF include 100% of each property managed by us in North America. Refer to "Annual rental revenue" and "Investment-grade or publicly traded large cap tenants" under "Definitions and reconciliations" in the

Supplemental Information for additional details, including our methodology of calculating annual rental revenue from unconsolidated real estate joint ventures and average market capitalization, respectively.

(1)Based on annual rental revenue in effect as of June 30, 2025.

(2)During the three months ended June 30, 2025, Bristol-Myers Squibb Company acquired 2seventy bio, Inc., which was a Top 20 tenant as of March 31, 2025.

(3)Eikon Therapeutics, Inc. is a private biotechnology company led by renowned biopharma executive Roger Perlmutter, formerly an executive vice president at Merck & Co., Inc. As of February 25, 2025, the company has raised over

$1.2 billion in private venture capital funding.

(4)Includes leases, which are not subject to annual appropriations, with governmental entities such as the National Institutes of Health and the General Services Administration. Approximately 3%of the annual rental revenue derived from our

leases with the United States Government is cancellable prior to the lease expiration date.

(5)Includes (i) ground leases for land at 1455 and 1515 Third Street (two buildings aggregating 422,980 RSF) and (ii) leases at 1655 and 1725 Third Street (two buildings aggregating 586,208 RSF) in our Mission Bay submarket owned by

our unconsolidated real estate joint venture in which we have an ownership interest of 10%. Annual rental revenue is presented using 100% of the annual rental revenue from our consolidated properties and our share of annual rental

revenue from our unconsolidated real estate joint ventures. Excluding these ground leases, the weighted-average remaining lease term for our top 20 tenants was 7.6 years as of June 30, 2025.

(6)Represents one lease encompassing four properties acquired in 2022 that we expect to reposition upon lease expiration. This lease with Cloud Software Group, Inc. (formerly known as TIBCO Software, Inc.) was in place when we

acquired the properties. Refer to footnote 4 in "Contractual lease expirations" in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 25 |

---

---

| | |
|:---|:---|
| **Summary of Properties and Occupancy** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands, except per RSF amounts)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Solid Historical Occupancy of95% Over Past 10 Years<sup>(1)</sup> From Historically

Strong Demand for Our Class A/A+ Properties in AAA Locations

**Summary of properties**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market** | **RSF** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual Rental Revenue** | **Annual Rental Revenue** | **Annual Rental Revenue** |
| **Market** | **Operating** | **Development** | **Redevelopment** | **Total** | **% of Total** | **Number of** <br>**Properties** | **Total** | **% of Total** | **Per RSF** |
| Greater Boston | 9270787 | 632850 | 1626322 | 11529959 | 26% | 65 | $731510 | 35% | $87.55 |
| San Francisco Bay Area | 7991106 | 212796 | 344934 | 8548836 | 20 | 64 | 459269 | 22 | 69.82 |
| San Diego | 6851449 | 784590 |  | 7636039 | 17 | 74 | 324236 | 16 | 49.91 |
| Seattle | 3178090 | 227577 |  | 3405667 | 8 | 45 | 130470 | 6 | 45.45 |
| Maryland | 3848923 |  |  | 3848923 | 9 | 50 | 155975 | 7 | 43.70 |
| Research Triangle | 3825870 |  |  | 3825870 | 9 | 38 | 107155 | 5 | 30.19 |
| New York City | 921800 |  |  | 921800 | 2 | 4 | 75006 | 4 | 91.48 |
| Texas | 1845159 |  | 73298 | 1918457 | 4 | 15 | 37761 | 2 | 24.93 |
| Canada | 979575 |  | 56314 | 1035889 | 2 | 11 | 20208 | 1 | 22.74 |
| Non-cluster/other markets | 349099 |  |  | 349099 | 1 | 10 | 14577 | 1 | 57.54 |
| Properties held for sale | 679383 |  |  | 679383 | 2 | 8 | 25063 | 1 | 43.66 |
| **North America** | **39741241** | **1857813** | **2100868** | **43699922** | **100%** | **384** | **$2081230** | **100%** | **$58.68** |
|  |  | **3958681** | **3958681** |  |  |  |  |  |  |

---

**Summary of occupancy**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Operating Properties** | **Operating Properties** | **Operating Properties** | **Operating and Redevelopment Properties** | **Operating and Redevelopment Properties** | **Operating and Redevelopment Properties** |
| <br>**Market** | **6/30/25** | **3/31/25** | **6/30/24** | **6/30/25** | **3/31/25** | **6/30/24** |
| Greater Boston | 90.1%<br><sup>(2)</sup> | 91.8% | 94.2% | 76.7% | 78.4% | 81.7% |
| San Francisco Bay Area | 88.9<br><sup>(2)</sup> | 90.3 | 94.0 | 85.2 | 86.3 | 90.7 |
| San Diego | 94.8 | 94.3 | 95.1 | 94.8 | 94.3 | 95.1 |
| Seattle | 90.3 | 91.5 | 94.7 | 90.3 | 91.5 | 93.7 |
| Maryland | 93.9 | 94.1 | 96.5 | 93.9 | 94.1 | 96.5 |
| Research Triangle | 92.8<br><sup>(2)</sup> | 93.4 | 97.4 | 92.8 | 93.4 | 97.4 |
| New York City | 88.9<br><sup>(3)</sup> | 87.6 | 85.1 | 88.9 | 87.6 | 85.1 |
| Texas | 82.1<br><sup>(2)</sup> | 82.1 | 95.5 | 78.9 | 78.9 | 91.8 |
| Subtotal | 91.0 | 91.8 | 94.7 | 86.3 | 87.1 | 90.2 |
| Canada | 90.7 | 94.6 | 94.9 | 85.8 | 82.4 | 82.5 |
| Non-cluster/other markets | 72.6 | 73.0 | 75.6 | 72.6 | 73.0 | 75.6 |
| **North America** | **90.8%**<br><sup>(2)(4)</sup> | **91.7%** | **94.6%** | **86.2%** | **86.9%** | **89.9%** |

---

(1)Represents the average occupancy percentage of operating properties as of each December 31 from 2016 through 2024 and as of June 30, 2025.

(2)Includes previously disclosed lease expirations that became vacant in 1Q25 aggregating 768,080 RSF across six properties and in four submarkets comprising the following: (i) 182,054 RSF at the Alexandria Technology

Square<sup>®</sup> Megacampus in our Cambridge submarket, (ii) 234,249 RSF at 409 Illinois Street in our Mission Bay submarket, (iii) one property aggregating 104,531 RSF in our Research Triangle market, and (iv) two properties

aggregating 247,246 RSF in our Austin submarket. As of June 30, 2025, 153,658 RSF was leased with a weighted-average lease commencement date of April 30, 2026, and we expect to favorably resolve the remaining

614,422 RSF over the next several quarters.

(3)The Alexandria Center<sup>®</sup> for Life Science – New York City Megacampus is 97.8% occupied as of June 30, 2025. Occupancy percentage in our New York City market reflects vacancy at the Alexandria Center<sup>®</sup> for Life

Science – Long Island City property, which was 52.2% occupied as of June 30, 2025.

(4)Includes temporary vacancies as of June 30, 2025 aggregating 668,795 RSF, or1.7%, primarily in the Greater Boston, San Francisco Bay Area, and San Diego markets, which are leased and expected to be occupied

upon completion of building and/or tenant improvements. The weighted-average expected delivery date is January 2, 2026.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 26 |

---

---

| | |
|:---|:---|
| **Property Listing** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Our Megacampus<sup>™</sup> Properties Account for75% of Our Annual Rental Revenue

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **Greater Boston** |  |  |  |  |  |  |  |  |
| *Cambridge/Inner Suburbs* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **at Kendall Square** | 2213867 |  |  | 2213867 | 8 | $211592 | 97.4% | 97.4% |
| *50*<sup>(1)</sup>*, 60*<sup>(1)</sup>*, 75/125*<sup>(1)</sup>*, 90, 100*<sup>(1)</sup>*, and 225*<sup>(1)</sup>*Binney Street, 140 First Street,* <br>*and 300 Third Street*<sup>(1)</sup><br>|  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **at One Kendall Square** | 1284337 |  | 104956 | 1389293 | 12 | 144417 | 94.2 | 87.1 |
| *One Kendall Square (Buildings 100, 200, 300, 400, 500, 600/700, 1400,* <br>*1800, and 2000), 325 and 399 Binney Street, and One Hampshire Street*<br>|  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Technology Square**<sup>®</sup> | 1190888 |  |  | 1190888 | 7 | 96651 | 79.5 | 79.5 |
| *100, 200, 300, 400, 500, 600, and 700 Technology Square*  |  |  |  |  |  |  |  |  |
| **Megacampus: The Arsenal on the Charles** | 751316 | 36444 | 333758 | 1121518 | 13 | 45819 | 79.6 | 55.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;*311, 321, and 343 Arsenal Street, 300, 400, and 500 North Beacon Street,* <br>*1, 2, 3, and 4 Kingsbury Avenue, and 100, 200, and 400 Talcott Avenue*<br>|  |  |  |  |  |  |  |  |
| **Megacampus: 480 Arsenal Way, 446, 458, 500, and 550 Arsenal Street,** <br>**and 99 Coolidge Avenue**<sup>(1)</sup><br>| 623056 | 204395 |  | 827451 | 6 | 27508 | 95.9 | 95.9 |
| *Cambridge/Inner Suburbs* | 6063464 | 240839 | 438714 | 6743017 | 46 | 525987 | 90.9 | 84.7 |
| *Fenway* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Fenway** | 1295745 | 392011 | 137675 | 1825431 | 3 | 99477 | 87.2 | 78.8 |
| *401 and 421 Park Drive and 201 Brookline Avenue* |  |  |  |  |  |  |  |  |
| *Seaport Innovation District* |  |  |  |  |  |  |  |  |
| 5 and 15<sup>(1)</sup> Necco Street | 459395 |  |  | 459395 | 2 | 47345 | 96.6 | 96.6 |
| *Seaport Innovation District* | 459395 |  |  | 459395 | 2 | 47345 | 96.6 | 96.6 |
| *Route 128* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Waltham** | 466094 |  | 596064 | 1062158 | 5 | 39741 | 100.0 | 43.9 |
| *40, 50, and 60 Sylvan Road, 35 Gatehouse Drive, and 840 Winter Street* |  |  |  |  |  |  |  |  |
| 19, 225, and 235 Presidential Way | 585226 |  |  | 585226 | 3 | 14194 | 97.0 | 97.0 |
| *Route 128* | 1051320 |  | 596064 | 1647384 | 8 | 53935 | 98.3 | 62.8 |
| *Other* | 400863 |  | 453869 | 854732 | 6 | 4766 | 59.7 | 28.0 |
| **Greater Boston** | **9270787** | **632850** | **1626322** | **11529959** | **65** | **$731510** | **90.1%** | **76.7%** |
| Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 27 |

---

---

| | |
|:---|:---|
| **Property Listing (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **San Francisco Bay Area** |  |  |  |  |  |  |  |  |
| *Mission Bay* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Science and Technology –** <br>**Mission Bay**<sup>(1)</sup><br>| 2023185 | 212796<br><sup>(3)</sup> |  | 2235981 | 10 | $78852 | 82.5% | 82.5% |
| *1455*<sup>(2)</sup>*, 1515*<sup>(2)</sup>*, 1655, and 1725 Third Street, 409 and 499 Illinois Street,* <br>*1450*<sup>(3)</sup>*, 1500, and 1700 Owens Street, and 455 Mission Bay Boulevard* <br>*South*<br>|  |  |  |  |  |  |  |  |
| *Mission Bay* | 2023185 | 212796 |  | 2235981 | 10 | 78852 | 82.5 | 82.5 |
| *South San Francisco* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Technology Center**<sup>®</sup> **– Gateway**<sup>(1)</sup> | 1431608 |  | 237684 | 1669292 | 12 | 76715 | 81.3 | 69.7 |
| *600*<sup>(2)</sup>*, 601, 611, 630*<sup>(2)</sup>*, 650*<sup>(2)</sup>*, 651, 681, 685, 701, 751, 901*<sup>(2)</sup>*, and 951*<sup>(2)</sup><br>*Gateway Boulevard*<br>|  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – South** <br>**San Francisco**<br>| 812453 |  | 107250 | 919703 | 5 | 52990 | 100.0 | 88.3 |
| *213*<sup>(1)</sup>*, 249, 259, 269, and 279 East Grand Avenue* |  |  |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Life Science – South San Francisco | 504235 |  |  | 504235 | 3 | 32001 | 88.0 | 88.0 |
| *201 Haskins Way and 400 and 450 East Jamie Court* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – Tanforan** | 445232 |  |  | 445232 | 2 | 2359 | 100.0 | 100.0 |
| *1122 and 1150 El Camino Real* |  |  |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Life Science – Millbrae<sup>(1)</sup> | 285346 |  |  | 285346 | 1 | 35828 | 100.0 | 100.0 |
| *230 Harriet Tubman Way* |  |  |  |  |  |  |  |  |
| 500 Forbes Boulevard<sup>(1)</sup> | 155685 |  |  | 155685 | 1 | 10908 | 100.0 | 100.0 |
| *South San Francisco* | 3634559 |  | 344934 | 3979493 | 24 | 210801 | 91.0 | 83.1 |
| *Greater Stanford* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – San Carlos** | 738038 |  |  | 738038 | 9 | 44886 | 88.1 | 88.1 |
| *825, 835, 960, and 1501-1599 Industrial Road* |  |  |  |  |  |  |  |  |
| Alexandria Stanford Life Science District | 704716 |  |  | 704716 | 9 | 72225 | 97.0 | 97.0 |
| *3160, 3165, 3170, and 3181 Porter Drive and 3301, 3303, 3305, 3307, and* <br>*3330 Hillview Avenue*<br>|  |  |  |  |  |  |  |  |
| 3412, 3420, 3440, 3450, and 3460 Hillview Avenue | 340103 |  |  | 340103 | 5 | 23597 | 82.9 | 82.9 |
| 3875 Fabian Way | 228000 |  |  | 228000 | 1 | 9642 | 100.0 | 100.0 |
| 2475 and 2625/2627/2631 Hanover Street and 1450 Page Mill Road | 198548 |  |  | 198548 | 3 | 12893 | 89.4 | 89.4 |
| 2100 and 2200 Geng Road | 62526 |  |  | 62526 | 2 | 2732 | 100.0 | 100.0 |
| 3350 West Bayshore Road | 61431 |  |  | 61431 | 1 | 3641 | 73.2 | 73.2 |
| *Greater Stanford* | 2333362 |  |  | 2333362 | 30 | 169616 | 91.2 | 91.2 |
| **San Francisco Bay Area** | **7991106** | **212796** | **344934** | **8548836** | **64** | **$459269** | **88.9%** | **85.2%** |
| Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property.<br>(3)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.  |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 28 |

---

---

| | |
|:---|:---|
| **Property Listing (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **San Diego** |  |  |  |  |  |  |  |
| *Torrey Pines* |  |  |  |  |  |  |  |
| **Megacampus: One Alexandria Square** | 968527 | 122302 |  | 1090829 | 10 | $62077 | 88.2% |
| *3115 and 3215*<sup>(1)</sup> *Merryfield Row, 3010, 3013, and 3033 Science Park Road,* <br>*10935, 10945, 10955, and 10970 Alexandria Way, 10996 Torreyana* <br>*Road, and 3545 Cray Court*<br>|  |  |  |  |  |  |  |
| ARE Torrey Ridge | 299138 |  |  | 299138 | 3 | 13263 | 79.7 |
| *10578, 10618, and 10628 Science Center Drive* |  |  |  |  |  |  |  |
| ARE Nautilus | 218459 |  |  | 218459 | 4 | 14656 | 97.7 |
| *3530 and 3550 John Hopkins Court and 3535 and 3565 General Atomics* <br>*Court*<br>|  |  |  |  |  |  |  |
| *Torrey Pines* | 1486124 | 122302 |  | 1608426 | 17 | 89996 | 87.9 |
| *University Town Center* |  |  |  |  |  |  |  |
| **Megacampus: Campus Point by Alexandria**<sup>(1)</sup> | 1310696 | 426927 |  | 1737623 | 8 | 81788 | 98.8 |
| *9880*<sup>(2)</sup>*, 10210, 10290, and 10300 Campus Point Drive and 4135, 4155,* <br>*4224, and 4242 Campus Point Court*<br>|  |  |  |  |  |  |  |
| **Megacampus: 5200 Illumina Way**<sup>(1)</sup> | 792687 |  |  | 792687 | 6 | 29978 | 100.0 |
| 9625 Towne Centre Drive<sup>(1)</sup> | 163648 |  |  | 163648 | 1 | 6520 | 100.0 |
| *University Town Center* | 2267031 | 426927 |  | 2693958 | 15 | 118286 | 99.3 |
| *Sorrento Mesa* |  |  |  |  |  |  |  |
| **Megacampus: SD Tech by Alexandria**<sup>(1)</sup> | 816048 | 235361 |  | 1051409 | 11 | 37003 | 96.0 |
| *9605, 9645, 9675, 9725, 9735, 9808, 9855, and 9868 Scranton Road, and* <br>*10055, 10065, and 10075 Barnes Canyon Road*<br>|  |  |  |  |  |  |  |
| **Megacampus: Sequence District by Alexandria** | 671039 |  |  | 671039 | 6 | 23458 | 100.0 |
| *6290, 6310, 6340, 6350, 6420, and 6450 Sequence Drive* |  |  |  |  |  |  |  |
| Pacific Technology Park<sup>(1)</sup> | 544352 |  |  | 544352 | 5 | 9352 | 92.8 |
| *9389, 9393, 9401, 9455, and 9477 Waples Street* |  |  |  |  |  |  |  |
| Summers Ridge Science Park<sup>(1)</sup> | 316531 |  |  | 316531 | 4 | 11521 | 100.0 |
| *9965, 9975, 9985, and 9995 Summers Ridge Road* |  |  |  |  |  |  |  |
| Scripps Science Park by Alexandria | 144113 |  |  | 144113 | 1 | 11379 | 100.0 |
| *10102 Hoyt Park Drive* |  |  |  |  |  |  |  |
| ARE Portola | 101857 |  |  | 101857 | 3 | 4222 | 100.0 |
| *6175, 6225, and 6275 Nancy Ridge Drive* |  |  |  |  |  |  |  |
| 5810/5820 Nancy Ridge Drive | 83354 |  |  | 83354 | 1 | 4621 | 100.0 |
| 9877 Waples Street | 63774 |  |  | 63774 | 1 | 2680 | 100.0 |
| 5871 Oberlin Drive | 33842 |  |  | 33842 | 1 | 2103 | 100.0 |
| *Sorrento Mesa* | 2774910 | 235361 |  | 3010271 | 33 | 106339 | 97.4 |
| *Sorrento Valley* |  |  |  |  |  |  |  |
| 3911, 3931, 3985, 4025, 4031, and 4045 Sorrento Valley Boulevard | 151406 |  |  | 151406 | 6 | 2866 | 42.7 |
| 11045 and 11055 Roselle Street | 43233 |  |  | 43233 | 2 | 2191 | 96.3 |
| *Sorrento Valley* | 194639 |  |  | 194639 | 8 | 5057 | 54.6 |
| *Other* | 128745 |  |  | 128745 | 1 | 4558 | 100.0 |
| **San Diego** | **6851449** | **784590** | **—** | **7636039** | **74** | **$324236** | **94.8%** |
| Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.<br>(2)We own 100% of this property. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 29 |

---

---

| | |
|:---|:---|
| **Property Listing (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **Seattle** |  |  |  |  |  |  |  |
| *Lake Union* |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Eastlake** | 1151672 |  |  | 1151672 | 9 | $73275 | 93.8% |
| *1150, 1201*<sup>(1)</sup>*, 1208*<sup>(1)</sup>*, 1551, 1600, and 1616 Eastlake Avenue East, 188 and* <br>*199*<sup>(1)</sup> *East Blaine Street, and 1600 Fairview Avenue East*<br>|  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – South** <br>**Lake Union**<br>| 381380 | 227577 |  | 608957 | 3 | 21811 | 99.6 |
| *400*<sup>(1)</sup> *and 701Dexter Avenue North and 428 Westlake Avenue North* |  |  |  |  |  |  |  |
| 219 Terry Avenue North | 31797 |  |  | 31797 | 1 | 1368 | 56.9 |
| *Lake Union* | 1564849 | 227577 |  | 1792426 | 13 | 96454 | 94.5 |
| *Elliott Bay* |  |  |  |  |  |  |  |
| 410 West Harrison Street and 410 Elliott Avenue West | 20101 |  |  | 20101 | 2 | 710 | 100.0 |
| *Bothell* |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – Canyon** <br>**Park**<br>| 1065194 |  |  | 1065194 | 22 | 21113 | 86.3 |
| *22121 and 22125 17th Avenue Southeast, 22021, 22025, 22026, 22030,* <br>*22118, and 22122 20th Avenue Southeast, 22333, 22422, 22515, 22522,* <br>*22722, and 22745 29th Drive Southeast, 21540, 22213 and 22309 30th* <br>*Drive Southeast, and 1629, 1631, 1725, 1916, and 1930 220th Street* <br>*Southeast*<br>|  |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Advanced Technologies – Monte Villa Parkway | 464889 |  |  | 464889 | 6 | 11527 | 83.9 |
| *3301, 3303, 3305, 3307, 3555, and 3755 Monte Villa Parkway* |  |  |  |  |  |  |  |
| *Bothell* | 1530083 |  |  | 1530083 | 28 | 32640 | 85.6 |
| *Other* | 63057 |  |  | 63057 | 2 | 666 | 100.0 |
| **Seattle** | **3178090** | **227577** | **—** | **3405667** | **45** | **130470** | **90.3** |
| **Maryland** |  |  |  |  |  |  |  |
| *Rockville* |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Shady Grove** | 1691960 |  |  | 1691960 | 20 | 92343 | 94.4 |
| *9601, 9603, 9605, 9704, 9708, 9712, 9714, 9800, 9804, 9808, 9900, and* <br>*9950 Medical Center Drive, 14920 and 15010 Broschart Road, 9920* <br>*Belward Campus Drive, and 9810 and 9820 Darnestown Road*<br>|  |  |  |  |  |  |  |
| 1330 Piccard Drive | 131508 |  |  | 131508 | 1 | 4324 | 100.0 |
| 1405 and 1450<sup>(1)</sup> Research Boulevard | 114182 |  |  | 114182 | 2 | 2958 | 72.8 |
| 1500 and 1550 East Gude Drive | 91359 |  |  | 91359 | 2 | 1844 | 100.0 |
| 5 Research Place | 63852 |  |  | 63852 | 1 | 3108 | 100.0 |
| 5 Research Court | 51520 |  |  | 51520 | 1 | 1976 | 100.0 |
| 12301 Parklawn Drive | 49185 |  |  | 49185 | 1 | 1598 | 100.0 |
| *Rockville* | 2193566 |  |  | 2193566 | 28 | $108151 | 94.3% |
| Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 30 |

---

---

| | |
|:---|:---|
| **Property Listing (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating and** <br>**Redevelopment** |
| **Maryland (continued)** |  |  |  |  |  |  |  |
| *Gaithersburg* |  |  |  |  |  |  |  |
| Alexandria Technology Center<sup>®</sup> – Gaithersburg I | 619061 |  |  | 619061 | 9 | $19642 | 93.6% |
| *9, 25, 35, 45, 50, and 55 West Watkins Mill Road and 910, 930, and 940* <br>*Clopper Road*<br>|  |  |  |  |  |  |  |
| Alexandria Technology Center<sup>®</sup> – Gaithersburg II | 486300 |  |  | 486300 | 7 | 17692 | 95.1 |
| *700, 704, and 708 Quince Orchard Road and 19, 20, 21, and 22 Firstfield* <br>*Road*<br>|  |  |  |  |  |  |  |
| 20400 Century Boulevard | 81006 |  |  | 81006 | 1 | 1858 | 100.0 |
| 401 Professional Drive | 63207 |  |  | 63207 | 1 | 1434 | 82.7 |
| 950 Wind River Lane | 50000 |  |  | 50000 | 1 | 1234 | 100.0 |
| 620 Professional Drive | 27950 |  |  | 27950 | 1 | 1207 | 100.0 |
| *Gaithersburg* | 1327524 |  |  | 1327524 | 20 | 43067 | 94.4 |
| *Beltsville* |  |  |  |  |  |  |  |
| 8000/9000/10000 Virginia Manor Road  | 191884 |  |  | 191884 | 1 | 3050 | 100.0 |
| 101 West Dickman Street<sup>(1)</sup> | 135949 |  |  | 135949 | 1 | 1707 | 75.0 |
| *Beltsville* | 327833 |  |  | 327833 | 2 | 4757 | 89.6 |
| **Maryland** | **3848923** | **—** | **—** | **3848923** | **50** | **155975** | **93.9** |
| **Research Triangle** |  |  |  |  |  |  |  |
| *Research Triangle* |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Durham** | 2214887 |  |  | 2214887 | 16 | 54090 | 97.6 |
| *6, 8, 10, 12, 14, 40, 41, 42, and 65 Moore Drive, 21, 25, 27, 29, and 31*<br>*Alexandria Way, 2400 Ellis Road, and 14 TW Alexander Drive*<br>|  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies and** <br>**AgTech – Research Triangle**<br>| 711490 |  |  | 711490 | 6 | 29518 | 93.2 |
| *6, 8, 10, and 12 Davis Drive and 5 and 9 Laboratory Drive* |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Sustainable Technologies** | 364493 |  |  | 364493 | 7 | 7283 | 60.7 |
| *104, 108, 110, 112, and 114 TW Alexander Drive and 5 and 7 Triangle Drive* |  |  |  |  |  |  |  |
| Alexandria Technology Center<sup>®</sup> – Alston | 155731 |  |  | 155731 | 3 | 2755 | 82.2 |
| *100, 800, and 801 Capitola Drive* |  |  |  |  |  |  |  |
| Alexandria Innovation Center<sup>®</sup> – Research Triangle | 136722 |  |  | 136722 | 3 | 4222 | 98.3 |
| *7010, 7020, and 7030 Kit Creek Road* |  |  |  |  |  |  |  |
| 2525 East NC Highway 54 | 82996 |  |  | 82996 | 1 | 3651 | 100.0 |
| 407 Davis Drive | 81956 |  |  | 81956 | 1 | 3323 | 100.0 |
| 601 Keystone Park Drive | 77595 |  |  | 77595 | 1 | 2313 | 100.0 |
| **Research Triangle** | **3825870** | **—** | **—** | **3825870** | **38** | **$107155** | **92.8%** |
| Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. | Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We own a partial interest in this property through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 31 |

---

---

| | |
|:---|:---|
| **Property Listing (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Occupancy Percentage** | **Occupancy Percentage** |
| **Market / *Submarket* / Address** | **RSF** | **RSF** | **RSF** | **RSF** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **Market / *Submarket* / Address** | **Operating** | **Development** | **Redevelopment** | **Total** | **Number of** <br>**Properties** | **Annual** <br>**Rental** <br>**Revenue** | **Operating** | **Operating and** <br>**Redevelopment** |
| **New York City** |  |  |  |  |  |  |  |  |
| *New York City* |  |  |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – New York City** | 742700 |  |  | 742700 | 3 | $69318 | 97.8% | 97.8% |
| *430 and 450 East 29th Street* |  |  |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Life Science – Long Island City | 179100 |  |  | 179100 | 1 | 5688 | 52.2 | 52.2 |
| *30-02 48th Avenue* |  |  |  |  |  |  |  |  |
| **New York City** | **921800** | **—** | **—** | **921800** | **4** | **75006** | **88.9** | **88.9** |
| **Texas** |  |  |  |  |  |  |  |  |
| *Austin* |  |  |  |  |  |  |  |  |
| **Megacampus: Intersection Campus** | 1525359 |  |  | 1525359 | 12 | 33694 | 83.0 | 83.0 |
| *507 East Howard Lane, 13011 McCallen Pass, 13813 and 13929 Center* <br>*Lake Drive, and 12535, 12545, 12555, and 12565 Riata Vista Circle*<br>|  |  |  |  |  |  |  |  |
| 1001 Trinity Street and 1020 Red River Street | 198972 |  |  | 198972 | 2 | 895 | 100.0 | 100.0 |
| *Austin* | 1724331 |  |  | 1724331 | 14 | 34589 | 84.9 | 84.9 |
| *Greater Houston* |  |  |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Advanced Technologies at The Woodlands  | 120828 |  | 73298 | 194126 | 1 | 3172 | 41.5 | 25.8 |
| *8800 Technology Forest Place* |  |  |  |  |  |  |  |  |
| **Texas** | **1845159** | **—** | **73298** | **1918457** | **15** | **37761** | **82.1** | **78.9** |
| **Canada** | 979575 |  | 56314 | 1035889 | 11 | 20208 | 90.7 | 85.8 |
| **Non-cluster/other markets** | 349099 |  |  | 349099 | 10 | 14577 | 72.6 | 72.6 |
| **North America, excluding properties held for sale** | **39061858** | **1857813** | **2100868** | **43020539** | **376** | **2056167** | **90.8%** | **86.2%** |
| **Properties held for sale**  | 679383 |  |  | 679383 | 8 | 25063 | 84.5% | 84.5% |
| **Total – North America** | **39741241** | **1857813** | **2100868** | **43699922** | **384** | **$2081230** |  |  |

---

Refer to "New Class A/A+ development and redevelopment properties: summary of pipeline" and "Definitions and reconciliations" in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 32 |

---

---

| | | |
|:---|:---|:---|
| **Investments in Real Estate** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Investments in Real Estate** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

![pipelinepagev2.jpg](pipelinepagev2.jpg)

**ALEXANDRIA'S DEVELOPMENT AND REDEVELOPMENT** 

**DELIVERIES ARE EXPECTED TO PROVIDE INCREMENTAL** 

**GROWTH IN ANNUAL NET OPERATING INCOME**

---

| | | |
|:---|:---|:---|
| **Placed Into**<br>**Service** | **Near-Term** <br>**Deliveries** | **Intermediate-Term** <br>**Deliveries** |
| **1H25** | **3Q25–4Q26** | **2027–2028** |
| **$52M** | **$139M** | **$261M** |
| **$52M** | **$139M** | **$261M** |
| **96%**<br>**Occupied** | **84%**<br>**Leased/Negotiating** | **28%**<br>**Leased/Negotiating** |
| **527,268 RSF** | **1.2 million RSF** | **3.3 million RSF** |

---

**(4)** **(2)** **(5)** **(1)** **(3)** Refer to "Net operating income" under "Definitions and reconciliations" in the Supplemental Information for additional details, including its reconciliation from the most directly comparable financial measure presented in accordance with GAAP.

(1)Excludes incremental annual net operating income from recently delivered spaces aggregating 22,005 RSF that are vacant and/or unleased as of June 30, 2025.

(2)Includesexpected partial deliveries through 4Q26 from projects expected to stabilize in 2027 and beyond, including speculative future leasing that is not yet fully committed. Our share of incremental annual net operating income from

development and redevelopment projects expected to be placed into service primarily commencing from3Q25 through 4Q26 is projected to be $103 million. Refer to the initial and stabilized occupancy years under "New Class A/A+

development and redevelopment properties: current projects" in the Supplemental Information for additional details.

(3)Our share of incremental annual net operating income from development and redevelopment projects expected to be placed into service primarily commencing from2027 through 2028 is projected to be $236 million.

(4)Represents the leased/negotiating percentage of development and redevelopment projects that are expected to stabilize during 2H25 and 2026.

(5)Represents the RSF related to projects expected to stabilize by 4Q26. Does not include RSF for partial deliveries through 4Q26 from projects expected to stabilize in 2027 and beyond.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 33 |

---

---

| | |
|:---|:---|
| **Investments in Real Estate (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Investments in real estate**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
|  | | **Under Construction** | **Under Construction** | **100% Pre-leased** <br>**Committed** <br>**Near Term**<sup>(1)</sup> | | | |
|  | <br>**Operating** | **2025 and**<br>**2026** <br>| **2027 and** <br>**Beyond**<br>| **100% Pre-leased** <br>**Committed** <br>**Near Term**<sup>(1)</sup> | <br>**Future** | <br>**Subtotal** | <br>**Total** |
| **Square footage** |  |  |  |  |  |  |  |
| Operating | 39061858 |  |  |  |  |  | 39061858 |
| Future Class A/A+ development and redevelopment properties |  | 1155041 | 2803640 | 466598 | 24754090 | 29179369 | 29179369 |
| Future development and redevelopment square feet currently <br>included in rental properties<sup>(2)</sup><br>|  |  |  | (52620) | (2525858) | (2578478) | (2578478) |
| Total square footage, excluding properties held for sale | 39061858 | 1155041 | 2803640 | 413978 | 22228232 | 26600891 | 65662749 |
| Properties held for sale | 679383 |  |  |  | 878205 | 878205 | 1557588 |
| Total square footage | 39741241 | 1155041 | 2803640 | 413978 | 23106437 | 27479096 | 67220337 |
| **Investments in real estate** |  |  |  |  |  |  |  |
| Gross book value as of June 30, 2025<sup>(3)</sup> | $29681626 | $1128865 | $2657516 | $19965 | $4819006 | $8625352 | $38306978 |

---

(1)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that

currently occupies two buildings within the Megacampus, one building aggregating52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the

demolition and development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the

construction of an amenity which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital

would be contributed pro-rata with our joint venture partner.

(2)Refer to "Investments in real estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including future development and redevelopment square feet currently included in rental properties.

(3)Balances exclude accumulated depreciation and our share of the cost basis associated with our properties held by our unconsolidated real estate joint ventures, which is classified as investments in unconsolidated real estate joint

ventures in our consolidated balance sheet. Refer to "Investments in real estate" under "Definitions and reconciliations"in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 34 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Recent Deliveries** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Incremental Annual Net Operating Income Generated From 1H25 Deliveries

Aggregated $52 Million, Including $15 Million<sup>(1)</sup> in 2Q25

---

| | | |
|:---|:---|:---|
| **230 Harriet Tubman Way** | **10935, 10945, and 10955** <br>**Alexandria Way**<sup>(2)</sup><br>| **10075 Barnes Canyon Road** |
| San Francisco Bay Area/<br>South San Francisco<br>| San Diego/Torrey Pines | San Diego/Sorrento Mesa |
| 285,346 RSF | 212,694 RSF | 17,718 RSF |
| 100% Occupancy | 100% Occupancy | 100% Occupancy |
| ![harriettubman.jpg](harriettubman.jpg) | ![alexandriawayoas.jpg](alexandriawayoas.jpg) | ![barnescanyon10075v2.jpg](barnescanyon10075v2.jpg) |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property/Market/Submarket** |  | **Our** <br>**Ownership** <br>**Interest** | **RSF Placed in Service** | **RSF Placed in Service** | **RSF Placed in Service** | **RSF Placed in Service** | **Occupancy** <br>**Percentage**<sup>(4)</sup> | **Total Project** | **Total Project** | **Unlevered Yields** | **Unlevered Yields** |
| **Property/Market/Submarket** | **2Q25**<br>**Delivery** <br>**Date**<sup>(3)</sup> | **Our** <br>**Ownership** <br>**Interest** | **Prior to** <br>**1/1/25** | **1Q25** | **2Q25** | **Total** | **Occupancy** <br>**Percentage**<sup>(4)</sup> | **Total Project** | **Total Project** | **Initial** <br>**Stabilized** | **Initial** <br>**Stabilized** <br>**(Cash Basis)** |
| **Property/Market/Submarket** | **2Q25**<br>**Delivery** <br>**Date**<sup>(3)</sup> | **Our** <br>**Ownership** <br>**Interest** | **Prior to** <br>**1/1/25** | **1Q25** | **2Q25** | **Total** | **Occupancy** <br>**Percentage**<sup>(4)</sup> | **RSF** | **Investment** | **Initial** <br>**Stabilized** | **Initial** <br>**Stabilized** <br>**(Cash Basis)** |
| **Development projects** |  |  |  |  |  |  |  |  |  |  |  |
| 230 Harriet Tubman Way/San Francisco Bay Area/South <br>San Francisco<br>| N/A | 48.5% |  | 285346 |  | 285346 | 100% | 285346 | 476000 | 7.5% | 6.2% |
| 10935, 10945, and 10955 Alexandria Way/San Diego/<br>Torrey Pines<br>| 5/11/25 | 100% | 93492 |  | 119202 | 212694 | 100% | 334996 | 480000<br><sup>(5)</sup> | 7.2<br><sup>(5)</sup> | 6.9<br><sup>(5)</sup> |
| 10075 Barnes Canyon Road/San Diego/Sorrento Mesa | N/A | 50.0% |  | 17718 |  | 17718 | 100% | 253079 | 321000 | 5.5 | 5.7 |
| **Redevelopment projects** |  |  |  |  |  |  |  |  |  |  |  |
| 651 Gateway Boulevard/San Francisco Bay Area/South <br>San Francisco<br>| N/A<sup>(6)</sup> | 50.0% | 67017 |  | 22005<br><sup>(6)</sup> | 89022 | 75%<br><sup>(6)</sup> | 326706 | 487000 | 5.0 | 5.1 |
| Canada | 5/29/25 | 100% | 78487 | 6430 | 76567 | 161484 | 100% | 250790 | 115000 | 6.0 | 6.0 |
| Weighted average/total | 5/14/25 |  | 238996 | 309494 | 217774 | 766264 |  | 1450917 | $1879000 | 6.3% | 6.0% |

---

Refer to "New Class A/A+ development and redevelopment properties: current projects" in the Supplemental Information for additional details on the square footage in service and under construction, if applicable.

(1)Excludes incremental annual net operating income from recently delivered spaces aggregating 22,005 RSF that are vacant and/or unleased as of June 30, 2025. Refer to footnote 6 below.

(2)Image represents 10955 Alexandria Way on the One Alexandria Square Megacampus.

(3)Represents the average delivery date for deliveries that occurred during the current quarter, weighted by annual rental revenue.

(4)Occupancy relates to total operating RSF placed in service as of the most recent delivery.

(5)Improvements of 100 bps and 110 bps in initial stabilized yield and initial stabilized yield (cash basis), respectively, were primarily driven by leasing space at higher rental rates than previously underwritten and a$23 million reduction in total

investment due to construction cost savings from overall project efficiencies.

(6)Represents a turnkey space delivered vacant and unleased that did not generate incremental annual net operating income as of June 30, 2025.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 35 |

---

---

| | | |
|:---|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties:**<br>**2025 and 2026 Stabilization ("Near-Term Deliveries")** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **New Class A/A+ Development and Redevelopment Properties:**<br>**2025 and 2026 Stabilization ("Near-Term Deliveries")** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

---

| | | |
|:---|:---|:---|
| **99 Coolidge Avenue** | **500 North Beacon Street and** <br>**4 Kingsbury Avenue**<sup>(1)</sup><br>| **10935, 10945, and 10955** <br>**Alexandria Way**<sup>(2)</sup><br>|
| Greater Boston/<br>Cambridge/Inner Suburbs<br>| Greater Boston/<br>Cambridge/Inner Suburbs<br>| San Diego/Torrey Pines |
| 204,395 RSF | 36,444 RSF | 122,302 RSF |
| 76% Leased/Negotiating | 92% Leased/Negotiating | 100% Leased |
| ![a99coolidge.jpg](a99coolidge.jpg) | ![arsenalphaseiiv2.jpg](arsenalphaseiiv2.jpg) | ![alexandriawayoas.jpg](alexandriawayoas.jpg) |

---

---

| | | |
|:---|:---|:---|
| **4135 Campus Point Court** | **10075 Barnes Canyon Road** | **8800 Technology Forest Place** |
| San Diego/<br>University Town Center<br>| San Diego/Sorrento Mesa | Texas/Greater Houston |
| 426,927 RSF | 235,361 RSF | 73,298 RSF |
| 100% Leased | 68% Leased/Negotiating | 41% Leased/Negotiating |
| ![campuspoint4135.jpg](campuspoint4135.jpg) | ![barnescanyon10075v2.jpg](barnescanyon10075v2.jpg) | ![techforest8800.jpg](techforest8800.jpg) |

---

(1)Image represents 500 North Beacon Street on The Arsenal on the Charles Megacampus.

(2)Image represents 10955 Alexandria Way on the One Alexandria Square Megacampus.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 36 |

---

---

| | | |
|:---|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties:**<br>**2027 and Beyond Stabilization ("Intermediate-Term Deliveries")** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **New Class A/A+ Development and Redevelopment Properties:**<br>**2027 and Beyond Stabilization ("Intermediate-Term Deliveries")** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

---

| | | | |
|:---|:---|:---|:---|
| **311 Arsenal Street** | **421 Park Drive** | **401 Park Drive** | **40, 50, and 60 Sylvan Road**<sup>(1)</sup> |
| Greater Boston/<br>Cambridge/Inner Suburbs<br>| Greater Boston/Fenway | Greater Boston/Fenway | Greater Boston/Route 128 |
| 333,758 RSF | 392,011 RSF | 137,675 RSF | 596,064 RSF |
| ![arsenal311.jpg](arsenal311.jpg) | ![parkdrive421.jpg](parkdrive421.jpg) | ![parkdrive401v2.jpg](parkdrive401v2.jpg) | ![a60sylvan.jpg](a60sylvan.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **1450 Owens Street** | **651 Gateway Boulevard** | **269 East Grand Avenue** | **701 Dexter Avenue North** |
| San Francisco Bay Area/<br>Mission Bay<br>| San Francisco Bay Area/<br>South San Francisco<br>| San Francisco Bay Area/<br>South San Francisco<br>| Seattle/Lake Union |
| 212,796 RSF<sup>(2)</sup> | 237,684 RSF | 107,250 RSF | 227,577 RSF |
| ![owens1450.jpg](owens1450.jpg) | ![gateway651.jpg](gateway651.jpg) | ![a269egrand.jpg](a269egrand.jpg) | ![a701dexter.jpg](a701dexter.jpg) |

---

(1)Image represents 60 Sylvan Road on the Alexandria Center<sup>®</sup> for Life Science – Waltham Megacampus. The project is expected to capture demand in our Route 128 submarket.

(2)Image represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we

executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the

institution decided to pursue a long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF to our presentation of the development project.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 37 |

---

---

| | | |
|:---|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Current Projects** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **New Class A/A+ Development and Redevelopment Properties: Current Projects** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property/Market/Submarket** | | **Square Footage** | **Square Footage** | **Square Footage** | **Percentage** | **Percentage** | **Occupancy**<sup>(1)</sup> | **Occupancy**<sup>(1)</sup> |
| **Property/Market/Submarket** | <br>**Dev/Redev** | **In Service** | **CIP** | **Total** | **Leased** | **Leased/**<br>**Negotiating** | **Initial** | **Stabilized** |
| **Under construction** |  |  |  |  |  |  |  |  |
| **<u>2025 and 2026 stabilization</u>** |  |  |  |  |  |  |  |  |
| 99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | Dev | 116414 | 204395 | 320809 | 52% | 76% | 4Q23 | 2026 |
| 500 North Beacon Street and 4 Kingsbury Avenue/Greater Boston/<br>Cambridge/Inner Suburbs<br>| Dev | 211574 | 36444 | 248018 | 92 | 92 | 1Q24 | 2025 |
| 10935, 10945, and 10955 Alexandria Way/San Diego/Torrey Pines | Dev | 212694 | 122302 | 334996 | 100 | 100 | 4Q24 | 2025 |
| 4135 Campus Point Court/San Diego/University Town Center | Dev |  | 426927 | 426927 | 100 | 100 | 2026 | 2026 |
| 10075 Barnes Canyon Road/San Diego/Sorrento Mesa | Dev | 17718 | 235361 | 253079 | 68 | 68 | 1Q25 | 2026 |
| 8800 Technology Forest Place/Texas/Greater Houston | Redev | 50094 | 73298 | 123392 | 41 | 41 | 2Q23 | 2026 |
| Canada | Redev | 194476 | 56314 | 250790 | 78 | 80 | 3Q23 | 2025 |
|  |  | 802970 | 1155041 | 1958011 | 80 | 84 |  |  |
| **<u>2027 and beyond stabilization</u>** |  |  |  |  |  |  |  |  |
| One Hampshire Street/Greater Boston/Cambridge | Redev |  | 104956 | 104956 |  |  | 2027 | 2028 |
| 311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | Redev | 56904 | 333758 | 390662 | 7 | 7 | 2027 | 2027 |
| 421 Park Drive/Greater Boston/Fenway | Dev |  | 392011 | 392011 | 13 | 13 | 2027 | 2028 |
| 401 Park Drive/Greater Boston/Fenway | Redev |  | 137675 | 137675 |  |  | 2026 | 2027 |
| 40, 50, and 60 Sylvan Road/Greater Boston/Route 128 | Redev |  | 596064 | 596064 | 33 | 33 | 2026 | 2027 |
| Other/Greater Boston | Redev |  | 453869 | 453869 |  |  | 2027 | 2027 |
| 1450 Owens Street/San Francisco Bay Area/Mission Bay<sup>(2)</sup> | Dev |  | 212796 | 212796 |  | 49<br><sup>(2)</sup> | 2026 | 2027 |
| 651 Gateway Boulevard/San Francisco Bay Area/South San Francisco<sup>(3)</sup> | Redev | 89022 | 237684 | 326706 | 21 | 21 | 1Q24 | 2027 |
| 269 East Grand Avenue/San Francisco Bay Area/South San Francisco | Redev |  | 107250 | 107250 |  |  | 2026 | 2027 |
| 701 Dexter Avenue North/Seattle/Lake Union | Dev |  | 227577 | 227577 | 23 | 23 | 2026 | 2027 |
|  |  | 145926 | 2803640 | 2949566 |  |  |  |  |
| **<u>100%</u> <u>Pre-leased committed near-term project expected to commence construction in the next year</u>** | **<u>100%</u> <u>Pre-leased committed near-term project expected to commence construction in the next year</u>** |  |  |  |  |  |  |  |
| Campus Point by Alexandria/San Diego/University Town Center<sup>(4)</sup> | Dev |  | 466598 | 466598 | 100 | 100 | 2028 | 2028 |
| Total 2027 and beyond stabilization and committed near-term project |  | 145926 | 3270238 | 3416164 | 25 | 28 |  |  |
|  |  | 948896 | 4425279 | 5374175 | 45% | 49% |  |  |
| (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. | (1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. <br>(2)Represents a multi-tenant project expanding the Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay Megacampus, where we have a 25% interest. During the three months ended December 31, 2024, we executed a letter of <br>intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the three months ended June 30, 2025, the institution decided to pursue a <br>long-term lease at the project instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development project. <br>(3)We continue to build out this project on a floor-by-floor basis. As of 2Q25, the remaining cost to complete is $138 million, or 28% of the total cost at completion. <br>(4)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we currently have a 55% interest. The project is fully leased to a longtime multinational pharmaceutical tenant that currently <br>occupies two buildings within the Megacampus, one building aggregating 52,620 RSF and another building aggregating 52,853 RSF. At the end of 2025, the tenant will vacate the 52,620 RSF building to allow for the demolition and <br>development of the new, build-to-suit life science building at this site. Upon delivery of the new purpose-built property anticipated to occur in 2028, the tenant will vacate the 52,853 RSF building to allow for the construction of an amenity <br>which will service the entire Megacampus. We expect to fund the majority of future construction costs at the Megacampus until our ownership interest increases from 55% to 75%, after which future capital would be contributed pro-rata <br>with our joint venture partner. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 38 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Current Projects (continued)** |  |
| **New Class A/A+ Development and Redevelopment Properties: Current Projects (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Our** <br>**Ownership** <br>**Interest** | **At 100%** | **At 100%** | **At 100%** | **At 100%** | **Unlevered Yields** | **Unlevered Yields** |
| **Property/Market/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **In Service** | **CIP** | **Cost to** <br>**Complete** | **Total at**<br>**Completion** | **Initial** <br>**Stabilized** | **Initial Stabilized** <br>**(Cash Basis)** |
| **Property/Market/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **In Service** | **CIP** | **Cost to** <br>**Complete** | **Total at**<br>**Completion** | **Initial** <br>**Stabilized** | **Initial Stabilized** <br>**(Cash Basis)** |
| **Under construction** |  |  |  |  |  |  |  |
| **<u>2025 and 2026 stabilization with</u> <u>84%</u> <u>leased/negotiating</u>** |  |  |  |  |  |  |  |
| 99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | 76.9% | $136692 | $217195 | $90113 | $444000 | 6.0% | 6.8% |
| 500 North Beacon Street and 4 Kingsbury Avenue/Greater Boston/<br>Cambridge/Inner Suburbs<br>| 100% | 376928 | 45565 | 4507 | 427000 | 6.2% | 5.5% |
| 10935, 10945, and 10955 Alexandria Way/San Diego/Torrey Pines | 100% | 258106 | 218712 | 3182 | 480000 | 7.2% | 6.9% |
| 4135 Campus Point Court/San Diego/University Town Center | 55.0% |  | 380816 | 143184 | 524000 | 7.3% | 6.2% |
| 10075 Barnes Canyon Road/San Diego/Sorrento Mesa | 50.0% | 16646 | 205116 | 99238 | 321000 | 5.5% | 5.7% |
| 8800 Technology Forest Place/Texas/Greater Houston | 100% | 60360 | 46373 | 5267 | 112000 | 6.3% | 6.0% |
| Canada | 100% | 96895 | 15088 | 3017 | 115000 | 6.0% | 6.0% |
|  |  | 945627 | 1128865 |  |  |  |  |
| **<u>2027 and beyond stabilization</u>**<sup>(1)</sup> |  |  |  |  |  |  |  |
| One Hampshire Street/Greater Boston/Cambridge | 100% |  | 170821 | TBD | TBD | TBD | TBD |
| 311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | 100% | 21613 | 291434 | TBD | TBD | TBD | TBD |
| 421 Park Drive/Greater Boston/Fenway | 100% |  | 533157 | TBD | TBD | TBD | TBD |
| 401 Park Drive/Greater Boston/Fenway | 100% |  | 170697 | TBD | TBD | TBD | TBD |
| 40, 50, and 60 Sylvan Road/Greater Boston/Route 128 | 100% |  | 480940 | TBD | TBD | TBD | TBD |
| Other/Greater Boston | 100% |  | 157989 | TBD | TBD | TBD | TBD |
| 1450 Owens Street/San Francisco Bay Area/Mission Bay | 25.0% |  | 242946 | TBD | TBD | TBD | TBD |
| 651 Gateway Boulevard/San Francisco Bay Area/South San Francisco | 50.0% | 116544 | 232366 | 138090 | 487000 | 5.0% | 5.1% |
| 269 East Grand Avenue/San Francisco Bay Area/South San Francisco | 100% |  | 93905 | TBD | TBD | TBD | TBD |
| 701 Dexter Avenue North/Seattle/Lake Union | 100% |  | 283261 | TBD | TBD | TBD | TBD |
|  |  | 138157 | 2657516 |  |  |  |  |
|  |  | 1083784 | 3786381 |  |  |  |  |
| **<u>100%</u> <u>Pre-leased committed near-term project expected to commence construction in the next year</u>** | **<u>100%</u> <u>Pre-leased committed near-term project expected to commence construction in the next year</u>** | **<u>100%</u> <u>Pre-leased committed near-term project expected to commence construction in the next year</u>** |  |  |  |  |  |
| Campus Point by Alexandria/San Diego/University Town Center | 55.0% |  | 19965 | 640035 | 660000 | 7.3% | 6.5% |
| Total |  | $1083784 | $3806346 | $2880000<br><sup>(2)</sup> | $7780000<br><sup>(2)</sup> |  |  |
| Our share of investment<sup>(2)(3)</sup> |  | $990000 | $3180000 | $2440000 | $6610000 |  |  |
| Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. | Refer to "Initial stabilized yield (unlevered)" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2027 and beyond over the next several quarters. <br>(2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. Total cost to complete for our development and redevelopment projects under construction have not <br>been adjusted for the potential impact related to higher materials costs associated with potential tariffs. We are still evaluating the potential impact on costs and returns that can be significantly impacted by tariffs, the amount of foreign <br>materials required, and/or the higher cost of domestic materials. <br>(3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 39 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Summary of Pipeline** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

74% of Our Total Development and Redevelopment Pipeline RSF

Is Within Our Megacampus<sup>™</sup> Ecosystems

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Square Footage** | **Square Footage** | **Square Footage** | **Square Footage** |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Under** <br>**Construction**<br>| **Committed** <br>**Near Term**<br>| **Future** | <br>**Total**<sup>(1)</sup> |
| Greater Boston |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **at One Kendall Square/Cambridge** | 100% | $170821 | 104956 |  |  | 104956 |
| *One Hampshire Street* |  |  |  |  |  |  |
| **Megacampus: The Arsenal on the Charles/Cambridge/Inner Suburbs** | 100% | 348966 | 370202 |  | 34157 | 404359 |
| *311 Arsenal Street, 500 North Beacon Street, and 4 Kingsbury Avenue* |  |  |  |  |  |  |
| **Megacampus: 480 Arsenal Way and 446, 458, 500, and 550 Arsenal Street, and 99** <br>**Coolidge Avenue/Cambridge/Inner Suburbs**<br>| <sup>(2)</sup> | 308792 | 204395 |  | 902000 | 1106395 |
| *446, 458, 500, and 550 Arsenal Street, and 99 Coolidge Avenue* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Fenway/Fenway** | 100% | 703854 | 529686 |  |  | 529686 |
| *401 and 421 Park Drive* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Waltham/Route 128** | 100% | 544558 | 596064 |  | 515000 | 1111064 |
| *40, 50, and 60 Sylvan Road, and 35 Gatehouse Drive* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **at Kendall Square/Cambridge** | 100% | 209528 |  |  | 174500 | 174500 |
| *100 Edwin H. Land Boulevard* |  |  |  |  |  |  |
| **Megacampus: Alexandria Technology Square**<sup>®</sup>**/Cambridge** | 100% | 8239 |  |  | 100000 | 100000 |
| **Megacampus: 285, 299, 307, and 345 Dorchester Avenue/Seaport Innovation** <br>**District**<br>| 60.0% | 293055 |  |  | 1040000 | 1040000 |
| 10 Necco Street/Seaport Innovation District | 100% | 105734 |  |  | 175000 | 175000 |
| 215 Presidential Way/Route 128 | 100% | 6816 |  |  | 112000 | 112000 |
| Other development and redevelopment projects | 100% | 373732 | 453869 |  | 1348541 | 1802410 |
|  |  | **$3074095** | **2259172** | **—** | **4401198** | **6660370** |
| Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 76.9% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 40 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Summary of Pipeline (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Square Footage** | **Square Footage** | **Square Footage** | **Square Footage** |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Under** <br>**Construction**<br>| **Committed** <br>**Near Term**<br>| **Future** | <br>**Total**<sup>(1)</sup> |
| San Francisco Bay Area |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Science and Technology – Mission Bay/**<br>**Mission Bay**<br>| 25.0% | $242946<br><sup>(2)</sup> | 212796<br><sup>(2)</sup> |  |  | 212796 |
| *1450 Owens Street* |  |  |  |  |  |  |
| **Megacampus: Alexandria Technology Center**<sup>®</sup> **– Gateway/**<br>**South San Francisco**<br>| 50.0% | 258932 | 237684 |  | 291000 | 528684 |
| *651 Gateway Boulevard* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – South San** <br>**Francisco/South San Francisco**<br>| 100% | 100560 | 107250 |  | 90000 | 197250 |
| *211*<sup>(3)</sup> *and 269 East Grand Avenue* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – Tanforan/South** <br>**San Francisco**<br>| 100% | 420858 |  |  | 1930000 | 1930000 |
| *1122, 1150, and 1178 El Camino Real* |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Life Science – Millbrae/South San Francisco | 48.5% | 157008 |  |  | 348401 | 348401 |
| *201 and 231 Adrian Road and 30 Rollins Road* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup>**for Life Science – San Carlos/Greater Stanford** | 100% | 471861 |  |  | 1497830 | 1497830 |
| *960 Industrial Road, 987 and 1075 Commercial Street, and 888 Bransten Road* |  |  |  |  |  |  |
| 3825 and 3875 Fabian Way/Greater Stanford | 100% | 161492 |  |  | 478000 | 478000 |
| 2100, 2200, 2300, and 2400 Geng Road/Greater Stanford | 100% | 38761 |  |  | 240000 | 240000 |
| **Megacampus: 88 Bluxome Street/SoMa** | 100% | 408649 |  |  | 1070925 | 1070925 |
|  |  | **$2261067** | **557730** | **—** | **5946156** | **6503886** |
| Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project. During the <br>three months ended June 30, 2025, the institution decided to pursue a long-term lease instead of a condominium sale. As a result, we added back the 103,361 RSF and the related book basis to our presentation of the development <br>project. <br>(3)Includes a property in which we own a partial interest through a real estate joint venture. Refer to "Joint venture financial information" in the Supplemental Information for additional details.  |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 41 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Summary of Pipeline (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Square Footage** | **Square Footage** | **Square Footage** | **Square Footage** |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Under** <br>**Construction**<br>| **Committed** <br>**Near Term**<br>| **Future** | <br>**Total**<sup>(1)</sup> |
| San Diego |  |  |  |  |  |  |
| **Megacampus: One Alexandria Square/Torrey Pines** | 100% | $281632 | 122302 |  | 125280 | 247582 |
| *10945 Alexandria Way and 10975 and 10995 Torreyana Road* |  |  |  |  |  |  |
| **Megacampus: Campus Point by Alexandria/University Town Center** | 55.0%<br><sup>(3)</sup> | 540207 | 426927 | 466598 | 500859 | 1394384 |
| *10010*<sup>(2)</sup>*, 10140*<sup>(2)</sup>*, 10210, and 10260 Campus Point Drive and 4135, 4161, 4165,* <br>*and 4224 Campus Point Court*<br>|  |  |  |  |  |  |
| **Megacampus: SD Tech by Alexandria/Sorrento Mesa** | 50.0% | 391642 | 235361 |  | 493845 | 729206 |
| *9805 Scranton Road and 10075 Barnes Canyon Road* |  |  |  |  |  |  |
| 11255 and 11355 North Torrey Pines Road/Torrey Pines | 100% | 156121 |  |  | 215000 | 215000 |
| **Megacampus: 5200 Illumina Way/University Town Center** | 51.0% | 17458 |  |  | 451832 | 451832 |
| 9625 Towne Centre Drive/University Town Center | 30.0% | 837 |  |  | 100000 | 100000 |
| **Megacampus: Sequence District by Alexandria/Sorrento Mesa** | 100% | 47565 |  |  | 1661915 | 1661915 |
| *6290, 6310, 6340, 6350, and 6450 Sequence Drive* |  |  |  |  |  |  |
| Scripps Science Park by Alexandria/Sorrento Mesa | 100% | 42700 |  |  | 154308 | 154308 |
| *10256 and 10260 Meanley Drive* |  |  |  |  |  |  |
| 4075 Sorrento Valley Boulevard/Sorrento Valley | 100% | 28174 |  |  | 144000 | 144000 |
| Other development and redevelopment projects | <sup>(4)</sup> | 78002 |  |  | 475000 | 475000 |
|  |  | **$1584338** | **784590** | **466598** | **4322039** | **5573227** |
| Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in this property.<br>(3)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%, after <br>which future capital would be contributed pro-rata with our partner.<br>(4)Includes a property in which we own a partial interest through a real estate joint venture.  |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 42 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Summary of Pipeline (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Square Footage** | **Square Footage** | **Square Footage** | **Square Footage** |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Under** <br>**Construction**<br>| **Committed** <br>**Near Term**<br>| **Future** | <br>**Total**<sup>(1)</sup> |
| Seattle |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – South Lake Union/**<br>**Lake Union**<br>| <sup>(2)</sup> | $571319 | 227577 |  | 1057400 | 1284977 |
| *601 and 701 Dexter Avenue North and 800 Mercer Street* |  |  |  |  |  |  |
| 1010 4th Avenue South/SoDo | 100% | 61490 |  |  | 544825 | 544825 |
| 410 West Harrison Street/Elliott Bay | 100% |  |  |  | 91000 | 91000 |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies – Canyon Park/**<br>**Bothell**<br>| 100% | 19248 |  |  | 230000 | 230000 |
| *21660 20th Avenue Southeast* |  |  |  |  |  |  |
| Other development and redevelopment projects | 100% | 149289 |  |  | 706087 | 706087 |
|  |  | **801346** | **227577** | **—** | **2629312** | **2856889** |
| Maryland |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Shady Grove/Rockville** | 100% | 24020 |  |  | 296000 | 296000 |
| *9830 Darnestown Road* |  |  |  |  |  |  |
|  |  | **24020** | **—** | **—** | **296000** | **296000** |
| Research Triangle |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – Durham/Research Triangle** | 100% | 162011 |  |  | 2060000 | 2060000 |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Advanced Technologies and AgTech –** <br>**Research Triangle/Research Triangle**<br>| 100% | 109661 |  |  | 1170000 | 1170000 |
| *4 and 12 Davis Drive* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for NextGen Medicines/**<br>**Research Triangle**<br>| 100% | 112142 |  |  | 1055000 | 1055000 |
| *3029 East Cornwallis Road* |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Sustainable Technologies/Research Triangle** | 100% | 55122 |  |  | 750000 | 750000 |
| *120 TW Alexander Drive, 2752 East NC Highway 54, and 10 South Triangle Drive* |  |  |  |  |  |  |
| 100 Capitola Drive/Research Triangle | 100% |  |  |  | 65965 | 65965 |
| Other development and redevelopment projects | 100% | 4185 |  |  | 76262 | 76262 |
|  |  | **$443121** | **—** | **—** | **5177227** | **5177227** |
| Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. | Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.<br>(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have <br>future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to "Investments in real <br>estate" under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.<br>(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 43 |

---

---

| | |
|:---|:---|
| **New Class A/A+ Development and Redevelopment Properties: Summary of Pipeline (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Square Footage** | **Square Footage** | **Square Footage** | **Square Footage** |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Development and Redevelopment** | **Development and Redevelopment** | **Development and Redevelopment** | |
| **Market**<br>**Property/Submarket** | **Our** <br>**Ownership** <br>**Interest** | **Book Value** | **Under** <br>**Construction**<br>| **Committed** <br>**Near Term**<br>| **Future** | <br>**Total**<sup>(1)</sup> |
| New York City |  |  |  |  |  |  |
| **Megacampus: Alexandria Center**<sup>®</sup> **for Life Science – New York City/New York City** | 100% | $173815 |  |  | 550000<br><sup>(2)</sup> | 550000 |
|  |  | **173815** | **—** | **—** | **550000** | **550000** |
| Texas |  |  |  |  |  |  |
| Alexandria Center<sup>®</sup> for Advanced Technologies at The Woodlands/Greater Houston | 100% | 49280 | 73298 |  | 116405 | 189703 |
| *8800 Technology Forest Place* |  |  |  |  |  |  |
| 1001 Trinity Street and 1020 Red River Street/Austin | 100% | 10858 |  |  | 250010 | 250010 |
| Other development and redevelopment projects | 100% | 58577 |  |  | 344000 | 344000 |
|  |  | **118715** | **73298** | **—** | **710415** | **783713** |
| Canada | 100% | 15088 | 56314 |  | 371743 | 428057 |
| Other development and redevelopment projects | 100% | 47478 |  |  | 350000 | 350000 |
| Total pipeline as of June 30, 2025, excluding properties held for sale |  | **8543083** | **3958681** | **466598** | **24754090** | **29179369** |
| Properties held for sale |  | 82269 |  |  | 878205 | 878205 |
| Total pipeline as of June 30, 2025 |  | **$8625352**<br><sup>(3)</sup> | **3958681** | **466598** | **25632295** | **30057574** |

---

Refer to "Megacampus" under "Definitions and reconciliations" in the Supplemental Information for additional details.

(1)Total square footage includes 2,578,478 RSF of buildings currently in operation that we expect to demolish or redevelop and commence future construction subject to market conditions and leasing. Refer to "Investments in real estate"

under "Definitions and reconciliations" in the Supplemental Information for additional details, including development and redevelopment square feet currently included in rental properties.

(2)During the three months ended September 30, 2024, we filed a lawsuit against the New York City Health + Hospitals Corporation and the New York City Economic Development Corporation for fraud and breach of contract concerning our

option to ground lease a land parcel to develop a future world-class life science building within the Alexandria Center<sup>®</sup> for Life Science – New York City Megacampus. Refer to our quarterly report on Form 10-Q for the three months ended

June 30, 2025filed with the Securities and Exchange Commission on July 21, 2025 for additional details.

(3)Includes$3.8 billion of projects that are currently under construction and one 100% pre-leased committed near-term project expected to commence construction in the next year.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 44 |

---

---

| | |
|:---|:---|
| **Construction Spending** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Construction spending** | **Six Months Ended** <br>**June 30, 2025** | **Projected Guidance** <br>**Midpoint for Year Ending** <br>**December 31, 2025** | **Year Ended** <br>**December 31, 2024** |
|  | **Six Months Ended** <br>**June 30, 2025** | **Projected Guidance** <br>**Midpoint for Year Ending** <br>**December 31, 2025** | **Year Ended** <br>**December 31, 2024** |
| Construction of Class A/A+ properties: |  |  |  |
| Active construction projects |  |  |  |
| Under construction | $612341 | $1240000 | $1791097 |
| Future pipeline pre-construction |  |  |  |
| Primarily Megacampus expansion pre-construction work (entitlement, design, and site work) | 226587 | 500000 | 426948 |
| Revenue- and non-revenue-enhancing capital expenditures | 127772 | 415000<br><sup>(1)</sup> | 273377 |
| Construction spending (before contributions from noncontrolling interests or tenants): | 966700 | 2155000 | 2491422 |
| Contributions from noncontrolling interests (consolidated real estate joint ventures) | (113268) | (230000)<br><sup>(2)</sup> | (343798) |
| Tenant-funded and - built landlord improvements | (171153) | (175000) | (129152) |
| Total construction spending | $682279 | $1750000 | $2018472 |
| 2025 guidance range for construction spending |  | $1450000 – $2050000 |  |

---

---

| | |
|:---|:---|
| **Projected capital contributions from partners in consolidated real estate joint ventures to fund construction** | **Projected capital contributions from partners in consolidated real estate joint ventures to fund construction** |
| **Timing** | **Amount**<sup>(2)</sup> |
| 3Q25 through 2026 | $203691 |
| 2027 and beyond | 93585 |
| Total | $297276 |

---

Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

(1)Represents revenue-enhancing and non-revenue-enhancing capital expenditures before contributions from noncontrolling interests and tenant-funded and tenant-built landlord improvements for the year ending December 31, 2025. Our

share of the 2025 revenue-enhancing and non-revenue-enhancing capital expenditures is projected to be $340 million at the midpoint of our guidance for 2025 construction spending.

(2)Represents contractual capital commitments from existing real estate joint venture partners to fund construction.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 45 |

---

---

| | |
|:---|:---|
| **Capitalization of Interest** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Alexandria Has Been Curating and Growing Highly Desirable and Well-Amenitized Megacampus

Ecosystems In The Top Life Science Clusters For Nearly Two Decades

---

| | | | |
|:---|:---|:---|:---|
| |  | **Average Real Estate** <br>**Basis Capitalized** <br>**During 1H25** | **Percentage of Total** <br>**Average Real Estate** <br>**Basis Capitalized** |
| | **Leased/**<br>**Negotiating** | **Average Real Estate** <br>**Basis Capitalized** <br>**During 1H25** | **Percentage of Total** <br>**Average Real Estate** <br>**Basis Capitalized** |
| <br>**Key Categories of Real Estate Basis Capitalized** | **Leased/**<br>**Negotiating** | **Average Real Estate** <br>**Basis Capitalized** <br>**During 1H25** | **Percentage of Total** <br>**Average Real Estate** <br>**Basis Capitalized** |
| Construction of Class A/A+ properties: |  |  |  |
| Development and redevelopment of projects under construction and one 100% pre-leased committed near-term project <br>expected to commence construction in the next year<br>|  |  |  |
| 2025 and 2026 stabilization | 84% | $767453 | 10% |
| 2027 and beyond stabilization | 28% | 2102723 | 26 |
| Smaller redevelopments and repositioning capital projects |  | 1007166<br><sup>(1)</sup> | 12 |
| Key future Megacampus expansion pre-construction work |  | 1209540<br><sup>(2)</sup> | 15 |
| Future pipeline projects with key pre-construction milestones during 2H25 and 2026 |  | 2979991<br><sup>(3)</sup> | 37 |
| Total average real estate basis capitalized |  | $8066873 | 100% |

---

![chart-0d65eed92a6c40b48cf.gif](chart-0d65eed92a6c40b48cf.gif)

Under construction – 2025 and 2026 stabilization

**(84% leased/negotiating)**

Future pipeline – Key milestones in

2H25 and 2026<sup>(3)</sup>

Under construction and committed near-

term project – 2027 and beyond

**(28% leased/negotiating)**

Smaller redevelopments and

repositioning capital projects<sup>(1)</sup>

Future pipeline – Key

Megacampus projects<sup>(2)</sup>

Percentage of Total Average Real Estate Basis Capitalized During 1H25

(1)Includes 668,795 RSF that is leased, but not yet delivered. The weighted-average expected delivery date is January 2, 2026.

(2)Refer to the four projects on the following pages for additional details.

(3)Includes future pipeline projects that are expected to reach anticipated pre-construction milestones, including various phases of entitlement, design, site work and other activities necessary to begin aboveground vertical

construction, onApril 3, 2026, on a weighted-average real estate investment basis. We will evaluate whether to proceed with future pre-construction and/or construction activities based on leasing demand and market conditions.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 46 |

---

---

| | | |
|:---|:---|:---|
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

**Key Future Megacampus**<sup>™</sup> **Development Project**

![keyactivetanforanv5.jpg](keyactivetanforanv5.jpg)

## 1.9M RSF
**FUTURE** 

## 0.4M RSF
**OPERATING**

Refer to "Megacampus™" under "Definitions and reconciliations" in the Supplemental Information for additional details.

Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future

development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing properties subject to market conditions and leasing.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 47 |

---

---

| | | |
|:---|:---|:---|
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

**Key Future Megacampus**<sup>™</sup> **Development Project**

![keyactivesancarlosv7.jpg](keyactivesancarlosv7.jpg)

**0.7M RSF**

**OPERATING**

## 1.5M RSF
**FUTURE** 

Refer to "Megacampus™" under "Definitions and reconciliations" in the Supplemental Information for additional details.

Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future

development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing properties subject to market conditions and leasing.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 48 |

---

---

| | | |
|:---|:---|:---|
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

**Key Active, Committed Near-Term, and Future Megacampus**<sup>™</sup> **Development Project**

![keyactiveuniversitytowncen.jpg](keyactiveuniversitytowncen.jpg)

**1.3M RSF**

**OPERATING**

**1.4M RSF**

**ACTIVE/FUTURE** 

**100% Pre-leased** 

**Committed Near-**

**Term Development**

Refer to "Megacampus™" under "Definitions and reconciliations" in the Supplemental Information for additional details.

Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future

development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing properties subject to market conditions and leasing.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 49 |

---

---

| | | |
|:---|:---|:---|
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Capitalization of Interest (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

**Key Active and Future Megacampus**<sup>™</sup> **Development Project**

![keyactiveseattlev4.jpg](keyactiveseattlev4.jpg)

**1.3M RSF**

**ACTIVE/FUTURE** 

**0.4M RSF**

**OPERATING**

Refer to "Megacampus™" under "Definitions and reconciliations" in the Supplemental Information for additional details.

Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future

development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing properties subject to market conditions and leasing.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 50 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Joint Venture Financial Information** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Consolidated Real Estate Joint Ventures** | **Consolidated Real Estate Joint Ventures** | **Consolidated Real Estate Joint Ventures** | **Consolidated Real Estate Joint Ventures** | **Consolidated Real Estate Joint Ventures** |
| **Property** | **Market** | **Submarket** | **Noncontrolling** <br>**Interest Share** | **Operating RSF** <br>**at 100%** |
| 50 and 60 Binney Street | Greater Boston | Cambridge/Inner Suburbs | 66.0% | 532395 |
| 75/125 Binney Street | Greater Boston | Cambridge/Inner Suburbs | 60.0% | 388270 |
| 100 and 225 Binney Street and 300 Third Street | Greater Boston | Cambridge/Inner Suburbs | 70.0% | 870641 |
| 99 Coolidge Avenue<sup>(1)</sup> | Greater Boston | Cambridge/Inner Suburbs | 23.1% | 116414 |
| 15 Necco Street | Greater Boston | Seaport Innovation District | 43.3% | 345996 |
| 285, 299, 307, and 345 Dorchester Avenue | Greater Boston | Seaport Innovation District | 40.0% | —<br><sup>(1)</sup> |
| Alexandria Center<sup>®</sup> for Science and Technology – Mission Bay<sup>(2)</sup> | San Francisco Bay Area | Mission Bay | 75.0% | 1013997 |
| 601, 611, 651<sup>(1)</sup>, 681, 685, and 701 Gateway Boulevard | San Francisco Bay Area | South San Francisco | 50.0% | 874234 |
| 751 Gateway Boulevard | San Francisco Bay Area | South San Francisco | 49.0% | 230592 |
| 211 and 213 East Grand Avenue | San Francisco Bay Area | South San Francisco | 70.0% | 300930 |
| 500 Forbes Boulevard | San Francisco Bay Area | South San Francisco | 90.0% | 155685 |
| Alexandria Center<sup>®</sup> for Life Science – Millbrae | San Francisco Bay Area | South San Francisco | 51.5% | 285346 |
| 3215 Merryfield Row | San Diego | Torrey Pines | 70.0% | 170523 |
| Campus Point by Alexandria<sup>(1)(3)</sup> | San Diego | University Town Center | 45.0%<br><sup>(4)</sup> | 1212414 |
| 5200 Illumina Way | San Diego | University Town Center | 49.0% | 792687 |
| 9625 Towne Centre Drive | San Diego | University Town Center | 70.0% | 163648 |
| SD Tech by Alexandria<sup>(1)(5)</sup> | San Diego | Sorrento Mesa | 50.0% | 816048 |
| Pacific Technology Park | San Diego | Sorrento Mesa | 50.0% | 544352 |
| Summers Ridge Science Park<sup>(6)</sup> | San Diego | Sorrento Mesa | 70.0% | 316531 |
| 1201 and 1208 Eastlake Avenue East | Seattle | Lake Union | 70.0% | 206134 |
| 199 East Blaine Street  | Seattle | Lake Union | 70.0% | 115084 |
| 400 Dexter Avenue North | Seattle | Lake Union | 70.0% | 290754 |
| 800 Mercer Street | Seattle | Lake Union | 40.0% | —<br><sup>(1)</sup> |
| **Unconsolidated Real Estate Joint Ventures** | **Unconsolidated Real Estate Joint Ventures** | **Unconsolidated Real Estate Joint Ventures** | **Unconsolidated Real Estate Joint Ventures** | **Unconsolidated Real Estate Joint Ventures** |
| **Property** | **Market** | **Submarket** | **Our Ownership** <br>**Share**<sup>(7)</sup> | **Operating RSF** <br>**at 100%** |
| 1655 and 1725 Third Street | San Francisco Bay Area | Mission Bay | 10.0% | 586208 |
| 1450 Research Boulevard | Maryland | Rockville | 73.2%<br><sup>(8)</sup> | 42012 |
| 101 West Dickman Street | Maryland | Beltsville | 58.4%<br><sup>(8)</sup> | 135949 |

---

Refer to "Joint venture financial information" under "Definitions and reconciliations" in the Supplemental Information for additional details.

(1)Represents a property currently under construction or in our future development and redevelopment pipeline. Refer to the sections under "New Class A/A+ development and redevelopment properties" in the Supplemental

Information for additional details.

(2)Includes 409 and 499 Illinois Street, 1450, 1500, and 1700 Owens Street, and 455 Mission Bay Boulevard South.

(3)Includes 10210, 10260, 10290, and 10300 Campus Point Drive and 4110, 4135, 4155, 4161, 4165, 4224, and 4242 Campus Point Court.

(4)The noncontrolling interest share of our joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases from 55% to 75%,

after which future capital would be contributed pro-rata with our partner. Refer to "New Class A/A+ development and redevelopment properties: current projects" in the Supplemental Information for additional details.

(5)Includes 9605, 9645, 9675, 9725, 9735, 9805, 9808, 9855, and 9868 Scranton Road and 10055, 10065, and 10075 Barnes Canyon Road.

(6)Includes 9965, 9975, 9985, and 9995 Summers Ridge Road.

(7)In addition to the real estate joint ventures listed, we hold an interest in one insignificant unconsolidated real estate joint venture.

(8)Represents a joint venture with a local real estate operator in which our joint venture partner manages the day-to-day activities that significantly affect the economic performance of the joint venture.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 51 |

---

---

| | |
|:---|:---|
| **Joint Venture Financial Information (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(In thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | |
|:---|:---|:---|
|  | **As of June 30, 2025** | **As of June 30, 2025** |
|  | **Noncontrolling Interest** <br>**Share of Consolidated** <br>**Real Estate JVs** | **Our Share of** <br>**Unconsolidated** <br>**Real Estate JVs** |
| Investments in real estate | $4250023 | $99775 |
| Cash, cash equivalents, and restricted cash | 144770 | 2917 |
| Other assets | 457402 | 10156 |
| Secured notes payable | (35448) | (67378) |
| Other liabilities | (252979) | (5236) |
| Redeemable noncontrolling interests | (9612) |  |
|  | $4554156 | $40234 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Noncontrolling Interest Share of** <br>**Consolidated Real Estate JVs** | **Noncontrolling Interest Share of** <br>**Consolidated Real Estate JVs** | **Our Share of Unconsolidated** <br>**Real Estate JVs** | **Our Share of Unconsolidated** <br>**Real Estate JVs** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|  | **Three Months Ended** | **Six Months Ended** | **Three Months Ended** | **Six Months Ended** |
| Total revenues | $117958 | $234595 | $2688 | $5263 |
| Rental operations | (36039) | (70808) | (935) | (1983) |
|  | 81919 | 163787 | 1753 | 3280 |
| General and administrative | (930) | (1563) | (62) | (81) |
| Interest | (330) | (754) | (1097) | (2058) |
| Depreciation and amortization of real estate assets | (36047) | (69458) | (942) | (1996) |
| Impairment of real estate |  |  | (8673) | (8673) |
| Fixed returns allocated to redeemable noncontrolling interests<sup>(1)</sup> | 201 | 402 |  |  |
|  | $44813 | $92414 | $(9021) | $(9528) |
| Straight-line rent and below-market lease revenue  | $6542 | $10194 | $176 | $334 |
| Funds from operations<sup>(1)</sup> | $80860 | $161872 | $594 | $1141 |

---

Refer to "Joint venture financial information" under "Definitions and reconciliations" in the Supplemental Information for additional details.

(1)Refer to "Funds from operations and funds from operations per share" in the Earnings Press Release and "Definitions and reconciliations" in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 52 |

---

---

| | |
|:---|:---|
| **Investments** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. The tables below summarize components of our investment income

(loss) and non-real estate investments. Refer to "Investments" under "Definitions and reconciliations" in the Supplemental Information for additional details.

---

| | | | |
|:---|:---|:---|:---|
|  | **June 30, 2025** | **June 30, 2025** | **Year Ended** <br>**December 31, 2024** |
|  | **Three Months Ended** | **Six Months Ended** | **Year Ended** <br>**December 31, 2024** |
| Realized (losses) gains | $(8684)<br><sup>(1)</sup> | $9469<br><sup>(1)</sup> | $59124<br><sup>(2)</sup> |
| Unrealized losses | (21938)<br><sup>(3)</sup> | (90083)<br><sup>(4)</sup> | $(112246)<br><sup>(5)</sup> |
| Investment loss | $(30622) | $(80614) | $(53122) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** |
| <br>**Investments** | **Cost** | **Unrealized Gains** | **Unrealized Losses** | **Carrying Amount** | **Carrying Amount** |
| Publicly traded companies | $183859 | $18365 | $(120299) | $81925 | $105667 |
| Entities that report NAV | 497975 | 97201 | (43013) | 552163 | 609866 |
| Entities that do not report NAV: |  |  |  |  |  |
| Entities with observable price changes | 78105 | 64585 | (9156) | 133534 | 174737 |
| Entities without observable price changes | 432299 |  |  | 432299 | 400487 |
| Investments accounted for under the equity method | &nbsp;&nbsp;&nbsp;&nbsp;N/A | N/A | N/A | 276775 | 186228 |
| June 30, 2025 | $1192238<br><sup>(6)</sup> | $180151 | $(172468) | $1476696 | $1476985 |
| December 31, 2024 | $1207146 | $228100 | $(144489) | $1476985 |  |

---

---

| | |
|:---|:---|
| **Public/Private Mix (Cost)** | **Tenant/Non-Tenant Mix (Cost)** |

---

![chart-1bf2807853bf4ada9dc.gif](chart-1bf2807853bf4ada9dc.gif)

![chart-c2c07de07bdf4996aba.gif](chart-c2c07de07bdf4996aba.gif)

**12%**

**Public**

**22%**

**Tenant**

**88%**

**Private**

**78%**

**Non-Tenant**

(1)Consists of realized gains of $30.5 millionand $59.9 million, partially offset by impairment charges of$39.2 million and $50.4 million during the three and six months ended June 30, 2025, respectively.

(2)Consists of realized gains of $117.2 million, partially offset by impairment charges aggregating $58.1 million during the year ended December 31, 2024.

(3)Consists of unrealized gainsof $12.5 millionprimarily resulting from the increase in fair values of our investments in publicly traded entities and investments in privately held entities that report NAV and $34.4 million resulting from

accounting reclassifications of unrealized gains recognized in prior periods into realized gains upon our realization of investments during the three months ended June 30, 2025.

(4)Primarily relates to the accounting reclassifications of unrealized gains recognized in prior periods into realized gains upon our realization of investments during the six months ended June 30, 2025.

(5)Primarily relates to the accounting reclassifications of unrealized gains recognized in prior periods into realized gains upon our realization of investments during the year ended December 31, 2024.

(6)Represents 2.7% of gross assets as of June 30, 2025. Refer to "Gross assets" under "Definitions and reconciliations" in the Supplemental Information for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 53 |

---

---

| | | |
|:---|:---|:---|
| **Balance Sheet** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Balance Sheet** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

![balancesheeta.jpg](balancesheeta.jpg)

---

| | |
|:---|:---|
| **PERCENTAGE OF DEBT** <br>**MATURING THROUGH 2027**<br>| **PERCENTAGE OF FIXED-RATE** <br>**DEBT SINCE 2021**<sup>(2)</sup><br>|
| **9%** | **97.2%** |
| **One of the Lowest Debt Maturities**<br>**for 2025–2027 Among S&P 500 REITs**<sup>(</sup><sup>3)</sup><br>|  |
| **REMAINING DEBT TERM**<br>**(IN YEARS)**<br>| **DEBT INTEREST** <br>**RATE**<br>|
| **12.0** | **4.01%** |

---

**WEIGHTED AVERAGE**

**TOP** 

**10%**

**Baa1**

Stable

**BBB+**

Stable

**CREDIT RATING** 

**RANKING AMONG ALL** 

**PUBLICLY TRADED**

**U.S. REITS**<sup>(1</sup><sup>)</sup>

**ALEXANDRIA CONTINUES TO HAVE A STRONG AND FLEXIBLE** 

**BALANCE SHEET WITH SIGNIFICANT LIQUIDITY**

As of June 30, 2025. Refer to "Definitions and reconciliations" in the Supplemental Information for additional details.

(1)Top 10% ranking represents credit rating levels from S&P Global Ratings and Moody's Ratings for publicly traded U.S. REITs, from Bloomberg Professional Services and Nareit, as of June 30, 2025.

(2)Represents the quarterly average percentage fixed-rate debt as of each quarter end from January 1, 2021 through June 30, 2025.

(3)Sources: J.P. Morgan, "REIT Detailed Debt Maturities as of March 31, 2025" or company filings as of March 31, 2025, except ARE, which is as of June 30, 2025.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 54 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Key Credit Metrics** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | |
|:---|:---|:---|
| **Liquidity** | **Liquidity** | **Minimal Outstanding Borrowings and Significant Availability** <br>**on Unsecured Senior Line of Credit** |
|  |  | *(in millions)* |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| $4.6B | $4.6B | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
|  |  | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| *(in millions)* |  | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| Availability under our unsecured senior line of credit, net of amounts <br>outstanding under our commercial paper program<br>| $3900 | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| Cash, cash equivalents, and restricted cash | 528 | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| Availability under our secured construction loan | 42 | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| Investments in publicly traded companies | 82 | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| Liquidity as of June 30, 2025 | $4552 | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
|  |  | ![q225lineofcreditv2a.jpg](q225lineofcreditv2a.jpg) |
| **Net Debt and Preferred Stock to Adjusted EBITDA**<sup>(1)</sup> | **Net Debt and Preferred Stock to Adjusted EBITDA**<sup>(1)</sup> | **Fixed-Charge Coverage Ratio**<sup>(1)</sup> |

---

![chart-f25ae6f8704b44f4adf.gif](chart-f25ae6f8704b44f4adf.gif)

![chart-f823b631995e4c018e1.gif](chart-f823b631995e4c018e1.gif)

**4.0x to 4.5x**

Refer to "Definitions and reconciliations"in the Supplemental Information for additional details.

(1)Quarter annualized.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 55 |

---

---

| | |
|:---|:---|
| **Summary of Debt** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in millions)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

Weighted-Average Remaining Term of12.0 Years

![q225debtmaturitiesv3a.jpg](q225debtmaturitiesv3a.jpg)

(1)We expect to have limited borrowings outstanding on our unsecured senior line of credit and commercial paper program by the end of 2025. We expect to reduce the outstanding balance with proceeds from our 2025

dispositions.

(2)Refer to footnotes 2 through 4 on page [57](#i97e12a746f8347daae03a6c076b22350_214) under "Fixed-rate and variable-rate debt" for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 56 |

---

---

| | | |
|:---|:---|:---|
| **Summary of Debt (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |  |
| **Summary of Debt (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) | June 30, 2025 |
| | ![footerlogov2a.jpg](footerlogov2a.jpg) | |

---

**ALEXANDRIA HAS THE LONGEST WEIGHTED-AVERAGE REMAINING DEBT TERM** 

**AMONG S&P 500 REITS AT 2X THE AVERAGE DEBT TERM FOR THESE REITS**

![debttermbackground.jpg](debttermbackground.jpg)

![chart-a79a2d395cff49b9bcca.gif](chart-a79a2d395cff49b9bcca.gif)

**WEIGHTED-AVERAGE REMAINING DEBT TERM (IN YEARS)**

![debttermbox.jpg](debttermbox.jpg)

**5.9 Years**

Average Debt Term

of S&P 500 REITs

as of March 31, 2025

![arelogo2.jpg](arelogo2.jpg)

Sources: S&P Global Market Intelligence, Bloomberg, or company filings (data not disclosed for PSA) as of March 31, 2025, except for ARE, which is as of June 30, 2025.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 57 |

---

---

| | |
|:---|:---|
| **Summary of Debt (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fixed-rate and variable-rate debt** | **Fixed-Rate**<br>**Debt** | **Variable-Rate** <br>**Debt** | **Total** | **Percentage** | **Weighted-Average** | **Weighted-Average** |
|  | **Fixed-Rate**<br>**Debt** | **Variable-Rate** <br>**Debt** | **Total** | **Percentage** | **Interest Rate**<sup>(1)</sup> | **Remaining Term**<br>**(in years)** |
|  | **Fixed-Rate**<br>**Debt** | **Variable-Rate** <br>**Debt** | **Total** | **Percentage** | **Interest Rate**<sup>(1)</sup> | **Remaining Term**<br>**(in years)** |
| Secured note payable | $— | $153500 | $153500 | 1.2% | 7.16% | 1.4 |
| Unsecured senior notes payable | 12042607 |  | 12042607 | 90.5 | 3.90 | 12.8 |
| Unsecured senior line of credit<sup>(2)</sup> and commercial <br>paper program<sup>(3)</sup><br>|  | 1097993 | 1097993 | 8.3 | 4.71 | 4.6<br><sup>(4)</sup> |
| Total/weighted average | $12042607 | $1251493 | $13294100 | 100.0% | 4.01% | 12.0<br><sup>(4)</sup> |
| Percentage of total debt | 90.6% | 9.4% | 100.0% |  |  |  |

---

(1)Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to the amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

(2)As of June 30, 2025, we had no outstanding balance on our unsecured senior line of credit.

(3)The commercial paper program provides us with the ability to issue up to $2.5 billion of commercial paper notes that bear interest at short-term fixed rates and can generally be issued with a maturity of 30 days or less and with a

maximum maturity of 397 days from the date of issuance. Borrowings under the program are used to fund short-term capital needs and are backed by our unsecured senior line of credit. In the event we are unable to issue

commercial paper notes or refinance outstanding borrowings under terms equal to or more favorable than those under our unsecured senior line of credit, we expect to borrow under the unsecured senior line of credit at

SOFR+0.855%. As of June 30, 2025, we had$1.1 billion of commercial paper notes outstanding.

(4)We calculate the weighted-average remaining term of our commercial paper notes by using the maturity date of our unsecured senior line of credit. Using the maturity date of our outstanding commercial paper notes, the

consolidated weighted-average maturity of our debt is11.6 years. The commercial paper notes sold during the six months ended June 30, 2025 were issued at a weighted-average yield to maturity of4.67%and had a weighted-

average maturity term of 16 days.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Average Debt Outstanding** | **Average Debt Outstanding** | **Weighted-Average Interest Rate** | **Weighted-Average Interest Rate** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
|  | **Three Months Ended** | **Six Months Ended** | **Three Months Ended** | **Six Months Ended** |
| Long-term fixed-rate debt | $12314715 | $12374695 | 3.88% | 3.85% |
| Short-term variable-rate unsecured senior line of credit and commercial paper <br>programdebt<br>| 926720 | 651302 | 4.70 | 4.65 |
| Blended-average interest rate | 13241435 | 13025997 | 3.94 | 3.89 |
| Loan fee amortization and annual facility fee related to unsecured senior line of credit | N/A | N/A | 0.13 | 0.14 |
| Total/weighted average | $13241435 | $13025997 | 4.07% | 4.03% |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 58 |

---

---

| | |
|:---|:---|
| **Summary of Debt (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Unsecured Senior Notes Payable** | **Unsecured Senior Notes Payable** | **Unsecured Senior Line of Credit** | **Unsecured Senior Line of Credit** |
| **Debt covenants**<br>**Debt Covenant Ratios**<sup>(1)</sup> | **Requirement** | **June 30, 2025** | **Requirement** | **June 30, 2025** |
| Total Debt to Total Assets | ≤ 60% | 31% | ≤ 60.0% | 32.2% |
| Secured Debt to Total Assets | ≤ 40% | 0.4% | ≤ 45.0% | 0.3% |
| Consolidated EBITDA to Interest Expense | ≥ 1.5x | 10.6x | ≥ 1.50x | 3.71x |
| Unencumbered Total Asset Value to Unsecured Debt | ≥ 150% | 309% | N/A | N/A |
| Unsecured Interest Coverage Ratio | N/A | N/A | ≥ 1.75x | 9.30x |

---

(1)All covenant ratio titles utilize terms as defined in the respective debt and credit agreements. The calculation of consolidated EBITDA is based on the definitions contained in our loan agreements and is not directly comparable to

the computation of EBITDA as described in Exchange Act Release No. 47226.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **At 100%** | **At 100%** | |
| **Unconsolidated real estate joint ventures' debt**<br>**Unconsolidated Joint Venture** | <br>**Maturity Date** | <br>**Stated Rate** | <br>**Interest Rate**<sup>(1)</sup> | **Aggregate** <br>**Commitment**<br>| **Debt Balance**<sup>(2)</sup> | <br>**Our Share** |
| 101 West Dickman Street | 11/10/26 | SOFR+1.95%<br><sup>(3)</sup> | 6.34% | $26750 | $19081 | 58.4% |
| 1450 Research Boulevard | 12/10/26 | SOFR+1.95%<br><sup>(3)</sup> | 6.40% | 13000 | 8965 | 73.2% |
| 1655 and 1725 Third Street | 2/10/35 | 6.37% | 6.44% | 500000 | 496709 | 10.0% |
|  |  |  |  | $539750 | $524755 |  |

---

(1)Includes interest expense and amortization of loan fees.

(2)Represents outstanding principal, net of unamortized deferred financing costs, as of June 30, 2025.

(3)This loan is subject to a fixed SOFR floor of 0.75%.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 59 |

---

---

| | |
|:---|:---|
| **Summary of Debt (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| *(Dollars in thousands)* | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Debt** | **Stated** <br>**Rate** | **Interest** <br>**Rate**<sup>(1)</sup> | **Maturity** <br>**Date**<sup>(2)</sup> | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal Payments Remaining for the Periods Ending December 31,** | **Principal** | **Unamortized** <br>**(Deferred** <br>**Financing** <br>**Cost),** <br>**(Discount)/**<br>**Premium** | **Total** |
| **Debt** | **Stated** <br>**Rate** | **Interest** <br>**Rate**<sup>(1)</sup> | **Maturity** <br>**Date**<sup>(2)</sup> | **2025** | **2026** | **2027** | **2028** | **2029** | **Thereafter** | **Principal** | **Unamortized** <br>**(Deferred** <br>**Financing** <br>**Cost),** <br>**(Discount)/**<br>**Premium** | **Total** |
| Secured note payable |  |  |  |  |  |  |  |  |  |  |  |  |
| Greater Boston<sup>(3)</sup> | SOFR+2.70% | 7.16% | 11/19/26<br><sup>(3)</sup> | $— | $153624 | $— | $— | $— | $— | $153624 | $(124) | $153500 |
| Unsecured senior line of credit and commercial <br>paper program<sup>(4)</sup><br>| <sup>(4)</sup> | 4.71<br><sup>(4)</sup> | 1/22/30<br><sup>(4)</sup> |  |  |  |  |  | 1100000 | 1100000 | (2007) | 1097993 |
| Unsecured senior notes payable | 4.30% | 4.50 | 1/15/26 |  | 300000 |  |  |  |  | 300000 | (284) | 299716 |
| Unsecured senior notes payable | 3.80% | 3.96 | 4/15/26 |  | 350000 |  |  |  |  | 350000 | (408) | 349592 |
| Unsecured senior notes payable | 3.95% | 4.13 | 1/15/27 |  |  | 350000 |  |  |  | 350000 | (812) | 349188 |
| Unsecured senior notes payable | 3.95% | 4.07 | 1/15/28 |  |  |  | 425000 |  |  | 425000 | (1100) | 423900 |
| Unsecured senior notes payable | 4.50% | 4.60 | 7/30/29 |  |  |  |  | 300000 |  | 300000 | (916) | 299084 |
| Unsecured senior notes payable | 2.75% | 2.87 | 12/15/29 |  |  |  |  | 400000 |  | 400000 | (1860) | 398140 |
| Unsecured senior notes payable | 4.70% | 4.81 | 7/1/30 |  |  |  |  |  | 450000 | 450000 | (1872) | 448128 |
| Unsecured senior notes payable | 4.90% | 5.05 | 12/15/30 |  |  |  |  |  | 700000 | 700000 | (4339) | 695661 |
| Unsecured senior notes payable | 3.375% | 3.48 | 8/15/31 |  |  |  |  |  | 750000 | 750000 | (4027) | 745973 |
| Unsecured senior notes payable | 2.00% | 2.12 | 5/18/32 |  |  |  |  |  | 900000 | 900000 | (6506) | 893494 |
| Unsecured senior notes payable | 1.875% | 1.97 | 2/1/33 |  |  |  |  |  | 1000000 | 1000000 | (6675) | 993325 |
| Unsecured senior notes payable | 2.95% | 3.07 | 3/15/34 |  |  |  |  |  | 800000 | 800000 | (6857) | 793143 |
| Unsecured senior notes payable | 4.75% | 4.88 | 4/15/35 |  |  |  |  |  | 500000 | 500000 | (4730) | 495270 |
| Unsecured senior notes payable | 5.50% | 5.66 | 10/1/35 |  |  |  |  |  | 550000 | 550000 | (6624) | 543376 |
| Unsecured senior notes payable | 5.25% | 5.38 | 5/15/36 |  |  |  |  |  | 400000 | 400000 | (3939) | 396061 |
| Unsecured senior notes payable | 4.85% | 4.93 | 4/15/49 |  |  |  |  |  | 300000 | 300000 | (2814) | 297186 |
| Unsecured senior notes payable | 4.00% | 3.91 | 2/1/50 |  |  |  |  |  | 700000 | 700000 | 9916 | 709916 |
| Unsecured senior notes payable | 3.00% | 3.08 | 5/18/51 |  |  |  |  |  | 850000 | 850000 | (11034) | 838966 |
| Unsecured senior notes payable | 3.55% | 3.63 | 3/15/52 |  |  |  |  |  | 1000000 | 1000000 | (13450) | 986550 |
| Unsecured senior notes payable | 5.15% | 5.26 | 4/15/53 |  |  |  |  |  | 500000 | 500000 | (7482) | 492518 |
| Unsecured senior notes payable | 5.625% | 5.71 | 5/15/54 |  |  |  |  |  | 600000 | 600000 | (6580) | 593420 |
| Unsecured debt weighted-average interest rate/<br>subtotal<br>|  | 3.97 |  |  | 650000 | 350000 | 425000 | 700000 | 11100000 | 13225000 | (84400) | 13140600 |
| Weighted-average interest rate/total  |  | 4.01% |  | $— | $803624 | $350000 | $425000 | $700000 | $11100000 | $13378624 | $(84524) | $13294100 |
| Balloon payments |  |  |  | $— | $803624 | $350000 | $425000 | $700000 | $11100000 | $13378624 | $— | $13378624 |
| Principal amortization |  |  |  |  |  |  |  |  |  |  | (84524) | (84524) |
| Total debt |  |  |  | $— | $803624 | $350000 | $425000 | $700000 | $11100000 | $13378624 | $(84524) | $13294100 |
| Fixed-rate debt |  |  |  | $— | $650000 | $350000 | $425000 | $700000 | $10000000 | $12125000 | $(82393) | $12042607 |
| Variable-rate debt |  |  |  |  | 153624 |  |  |  | 1100000 | 1253624 | (2131) | 1251493 |
| Total debt |  |  |  | $— | $803624 | $350000 | $425000 | $700000 | $11100000 | $13378624 | $(84524) | $13294100 |
| Weighted-average stated rate on maturing debt | Weighted-average stated rate on maturing debt |  |  | N/A | 3.78% | 3.95% | 3.95% | 3.50% | 3.88% |  |  |  |

---

(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

(2)Reflects any extension options that we control.

(3)Represents a secured construction loan held by our consolidated real estate joint venture for 99 Coolidge Avenue, where we have a 76.9%interest. As of June 30, 2025, this joint venture has $41.7 millionavailable under existing lender

commitments. We expect to repay the entire $153.5 million balance in August 2025.

(4)Refer to footnotes 2 through 4 under "Fixed-rate and variable-rate debt" in "Summary of debt" for additional details.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 60 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

This section contains additional details for sections throughout the Supplemental Information and the accompanying Earnings Press Release, as well as explanations and reconciliations of certain non-

GAAP financial measures and the reasons why we use these supplemental measures of performance and believe they provide useful information to investors. Additional detail can be found in our most recent

annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.

**Adjusted EBITDA and Adjusted EBITDA margin**

The following table reconciles net income (loss), the most directly comparable financial

measure calculated and presented in accordance with GAAP, to Adjusted EBITDA and calculates the

Adjusted EBITDA margin:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| *(Dollars in thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Net (loss) income | $(62189) | $38662 | $(16095) | $213603 | $94049 |
| Interest expense | 55296 | 50876 | 55659 | 43550 | 45789 |
| Income taxes | 1020 | 1145 | 1855 | 1877 | 1182 |
| Depreciation and amortization | 346123 | 342062 | 330108 | 293998 | 290720 |
| Stock compensation expense | 12530 | 10064 | 12477 | 15525 | 14507 |
| Gain on sales of real estate |  | (13165) | (101806) | (27114) |  |
| Unrealized losses (gains) on non-real estate <br>investments<br>| 21938 | 68145 | 79776 | (2610) | 64238 |
| Impairment of real estate | 129606 | 32154 | 186564 | 5741 | 30763 |
| Impairment of non-real estate investments | 39216 | 11180 | 20266 | 10338 | 12788 |
| Increase (decrease) in provision for expected <br>credit losses on financial instruments<br>|  | 285 | (434) |  |  |
| Adjusted EBITDA | $543540 | $541408 | $568370 | $554908 | $554036 |
| Total revenues | $762040 | $758158 | $788945 | $791607 | $766734 |
| Adjusted EBITDA margin | 71% | 71% | 72% | 70% | 72% |

---

We use Adjusted EBITDA as a supplemental performance measure of our operations, for

financial and operational decision-making, and as a supplemental means of evaluating period-to-period

comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes,

depreciation, and amortization ("EBITDA"), excluding stock compensation expense, gains or losses on

early extinguishment of debt, gains or losses on sales of real estate, impairments of real estate, changes

in provision for expected credit losses on financial instruments, and significant termination fees. Adjusted

EBITDA also excludes unrealized gains or losses and significant realized gains or losses and

impairments that result from our non-real estate investments. These non-real estate investment amounts

are classified in our consolidated statements of operations outside of total revenues.

We believe Adjusted EBITDA provides investors with relevant and useful information as it

allows investors to evaluate the operating performance of our business activities without having to

account for differences recognized because of investing and financing decisions related to our real

estate and non-real estate investments, our capital structure, capital market transactions, and variances

resulting from the volatility of market conditions outside of our control. For example, we exclude gains or

losses on the early extinguishment of debt to allow investors to measure our performance independent

of our indebtedness and capital structure. We believe that adjusting for the effects of impairments and

gains or losses on sales of real estate, significant impairments and realized gains or losses on non-real

estate investments, changes in provision for expected credit losses on financial instruments, and

significant termination fees allows investors to evaluate performance from period to period on a

consistent basis without having to account for differences recognized because of investing and financing

decisions related to our real estate and non-real estate investments or other corporate activities that

may not be representative of the operating performance of our properties.

In addition, we believe that excluding charges related to stock compensation and unrealized

gains or losses facilitates for investors a comparison of our business activities across periods without the

volatility resulting from market forces outside of our control. Adjusted EBITDA has limitations as a

measure of our performance. Adjusted EBITDA does not reflect our historical expenditures or future

requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant

measure of performance, it does not represent net income (loss) or cash flows from operations

calculated and presented in accordance with GAAP, and it should not be considered as an alternative to

those indicators in evaluating performance or liquidity.

In order to calculate the Adjusted EBITDA margin, we divide Adjusted EBITDA by total

revenues as presented in our consolidated statements of operations. We believe that this supplemental

performance measure provides investors with additional useful information regarding the profitability of

our operating activities.

We are not able to forecast the net income of future periods without unreasonable effort and

therefore do not provide a reconciliation for Adjusted EBITDA on a forward-looking basis. This is due to

the inherent difficulty of forecasting the timing and/or amount of items that depend on market conditions

outside of our control, including the timing of dispositions, capital events, and financing decisions, as

well as quarterly components such as gain on sales of real estate, unrealized gains or losses on non-

real estate investments, impairments of real estate, impairments of non-real estate investments, and

changes in provision for expected credit losses on financial instruments. Our attempt to predict these

amounts may produce significant but inaccurate estimates, which would be potentially misleading for our

investors.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 61 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Annual rental revenue**

Annual rental revenue represents the annualized fixed base rental obligations, calculated in

accordance with GAAP, including the amortization of deferred revenue related to tenant-funded and

tenant-built landlord improvements, for leases in effect as of the end of the period, related to our

operating RSF. Annual rental revenue is presented using 100% of the annual rental revenue from our

consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint

ventures. Annual rental revenue per RSF is computed by dividing annual rental revenue by the sum of

100% of the RSF of our consolidated properties and our share of the RSF of properties held in

unconsolidated real estate joint ventures. As of June 30, 2025, approximately91% of our leases (on an

annual rental revenue basis) were triple net leases, which require tenants to pay substantially all real

estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other operating

expenses (including increases thereto) in addition to base rent. Annual rental revenue excludes these

operating expenses recovered from our tenants. Amounts recovered from our tenants related to these

operating expenses, along with base rent, are classified in income from rentals in our consolidated

statements of operations.

**Capitalization rates**

Capitalization rates are calculated based on net operating income and net operating income

(cash basis) annualized, excluding lease termination fees, on stabilized operating assets for the quarter

preceding the date on which the property is sold, or near-term prospective net operating income.

**Capitalized interest**

We capitalize interest cost as a cost of a project during periods for which activities necessary

to develop, redevelop, or reposition a project for its intended use are ongoing, provided that

expenditures for the asset have been made and interest cost has been incurred. Activities necessary to

develop, redevelop, or reposition a project include pre-construction activities such as entitlements,

permitting, design, site work, and other activities preceding commencement of construction of

aboveground building improvements. The advancement of pre-construction efforts is focused on

reducing the time required to deliver projects to prospective tenants. These critical activities add

significant value for future ground-up development and are required for the vertical construction of

buildings. If we cease activities necessary to prepare a project for its intended use, interest costs related

to such project are expensed as incurred.

**Cash interest**

Cash interest is equal to interest expense calculated in accordance with GAAP plus

capitalized interest, less amortization of loan fees and debt premiums (discounts). Refer to the definition

of fixed-charge coverage ratio for a reconciliation of interest expense, the most directly comparable

financial measure calculated and presented in accordance with GAAP, to cash interest.

**Class A/A+ properties and AAA locations**

Class A/A+ properties are properties clustered in AAA locations that provide innovative

tenants with highly dynamic and collaborative environments that enhance their ability to successfully

recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. These

properties are typically well-located, professionally managed, and well-maintained, offering a wide range

of amenities and featuring premium construction materials and finishes. Class A/A+ properties are

generally newer or have undergone substantial redevelopment and are generally expected to command

higher annual rental rates compared to other classes of similar properties. AAA locations are in close

proximity to concentrations of specialized skills, knowledge, institutions, and related businesses. It is

important to note that our definition of property classification may not be directly comparable to other

equity REITs.

**Credit ratings**

Represents the credit ratings assigned by S&P Global Ratings or Moody's Ratings as of

June 30, 2025. A credit rating is not a recommendation to buy, sell, or hold securities and may be

subject to revision or withdrawal at any time.

**Development, redevelopment, and pre-construction**

A key component of our business model is our disciplined allocation of capital to the

development and redevelopment of new Class A/A+ properties, as well as property enhancements

identified during the underwriting of certain acquired properties. These efforts are primarily concentrated

in collaborative Megacampus™ ecosystems within AAA life science innovation clusters, as well as other

strategic locations that support innovation and growth. These projects are generally focused on

providing high-quality, generic, and reusable spaces that meet the real estate requirements of a wide

range of tenants. Upon completion, each development or redevelopment project is expected to generate

increases in rental income, net operating income, and cash flows. Our development and redevelopment

projects are generally in locations that are highly desirable to high-quality entities, which we believe

results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater

long-term asset value.

Development projects generally consist of the ground-up development of generic and

reusable laboratory facilities. Redevelopment projects consist of the permanent change in use of

acquired office, warehouse, or shell space into laboratory space. We generally will not commence new

development projects for aboveground construction of new Class A/A+ laboratory space without first

securing significant pre-leasing for such space, except when there is solid market demand for high-

quality Class A/A+ properties.

Pre-construction activities include entitlements, permitting, design, site work, and other

activities preceding commencement of construction of aboveground building improvements. The

advancement of pre-construction efforts is focused on reducing the time required to deliver projects to

prospective tenants. These critical activities add significant value for future ground-up development and

are required for the vertical construction of buildings. Ultimately, these projects will provide high-quality

facilities and are expected to generate significant revenue and cash flows.

Development, redevelopment, and pre-construction spending also includes the following

costs: (i) amounts to bring certain acquired properties up to market standard and/or other costs identified

during the acquisition process (generally within two years of acquisition) and (ii) permanent conversion

of space for highly flexible, move-in-ready laboratory space to foster the growth of promising early- and

growth-stage life science companies.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 62 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Development, redevelopment, and pre-construction (continued)**

Revenue-enhancing and repositioning capital expenditures represent spending to reposition

or significantly change the use of a property, including through improvement in the asset quality from

Class B to Class A/A+.

Non-revenue-enhancing capital expenditures represent costs required to maintain the current

revenues of a stabilized property, including the associated costs for renewed and re-leased space.

**Dividend payout ratio (common stock)**

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends

on our common stock (shares of common stock outstanding on the respective record dates multiplied by

the related dividend per share) to funds from operations attributable to Alexandria's common

stockholders – diluted, as adjusted.

**Dividend yield**

Dividend yield for the quarter represents the annualized quarter dividend divided by the

closing common stock price at the end of the quarter.

Space Intentionally Blank

**Fixed-charge coverage ratio**

Fixed-charge coverage ratio is a non-GAAP financial measure representing the ratio of

Adjusted EBITDA to cash interest and fixed charges. We believe that this ratio is useful to investors as a

supplemental measure of our ability to satisfy fixed financing obligations and preferred stock dividends.

Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest,

less amortization of loan fees and debt premiums (discounts).

The following table reconciles interest expense, the most directly comparable financial

measure calculated and presented in accordance with GAAP, to cash interest and computes fixed-

charge coverage ratio:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| *(Dollars in thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Adjusted EBITDA | $543540 | $541408 | $568370 | $554908 | $554036 |
| Interest expense | $55296 | $50876 | $55659 | $43550 | $45789 |
| Capitalized interest | 82423 | 80065 | 81586 | 86496 | 81039 |
| Amortization of loan fees | (4615) | (4691) | (4620) | (4222) | (4146) |
| Amortization of debt discounts | (335) | (349) | (333) | (330) | (328) |
| Cash interest and fixed charges | $132769 | $125901 | $132292 | $125494 | $122354 |
| Fixed-charge coverage ratio: |  |  |  |  |  |
| – quarter annualized | 4.1x | 4.3x | 4.3x | 4.4x | 4.5x |
| – trailing 12 months | 4.3x | 4.4x | 4.5x | 4.5x | 4.6x |

---

We are not able to forecast the net income of future periods without unreasonable effort and

therefore do not provide a reconciliation for fixed-charge coverage ratio on a forward-looking basis. This

is due to the inherent difficulty of forecasting the timing and/or amount of items that depend on market

conditions outside of our control, including the timing of dispositions, capital events, and financing

decisions, as well as quarterly components such as gain on sales of real estate, unrealized gains or

losses on non-real estate investments, impairment of real estate, impairments of non-real estate

investments, and changes in provision for expected credit losses on financial instruments. Our attempt

to predict these amounts may produce significant but inaccurate estimates, which would be potentially

misleading for our investors.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 63 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Funds from operations and funds from operations, as adjusted, attributable to Alexandria's**

**common stockholders**

GAAP-basis accounting for real estate assets utilizes historical cost accounting and assumes

that real estate values diminish over time. In an effort to overcome the difference between real estate

values and historical cost accounting for real estate assets, the Nareit Board of Governors established

funds from operations as an improved measurement tool. Since its introduction, funds from operations

has become a widely used non-GAAP financial measure among equity REITs. We believe that funds

from operations is helpful to investors as an additional measure of the performance of an equity

REIT. Moreover, we believe that funds from operations, as adjusted, allows investors to compare our

performance to the performance of other real estate companies on a consistent basis, without having to

account for differences recognized because of real estate acquisition and disposition decisions,

financing decisions, capital structure, capital market transactions, variances resulting from the volatility

of market conditions outside of our control, or other corporate activities that may not be representative of

the operating performance of our properties.

The 2018 White Paper published by the Nareit Board of Governors (the "Nareit White Paper")

defines funds from operations as net income (computed in accordance with GAAP), excluding gains or

losses on sales of real estate, and impairments of real estate, plus depreciation and amortization of

operating real estate assets, and after adjustments for our share of consolidated and unconsolidated

partnerships and real estate joint ventures. Impairments represent the write-down of assets when fair

value over the recoverability period is less than the carrying value due to changes in general market

conditions and do not necessarily reflect the operating performance of the properties during the

corresponding period.

We compute funds from operations, as adjusted, as funds from operations calculated in

accordance with the Nareit White Paper, excluding significant gains, losses, and impairments realized

on non-real estate investments, unrealized gains or losses on non-real estate investments, impairments

of real estate primarily consisting of right-of-use assets and pre-acquisition costs related to projects that

we decided to no longer pursue, gains or losses on early extinguishment of debt, changes in the

provision for expected credit losses on financial instruments, significant termination fees, acceleration of

stock compensation expense due to the resignations of executive officers, deal costs, the income tax

effect related to such items, and the amount of such items that is allocable to our unvested restricted

stock awards. We compute the amount that is allocable to our unvested restricted stock awards with

nonforfeitable dividends using the two-class method. Under the two-class method, we allocate net

income (after amounts attributable to noncontrolling interests) to common stockholders and to unvested

restricted stock awards with nonforfeitable dividends by applying the respective weighted-average

shares outstanding during each quarter-to-date and year-to-date period. This may result in a difference

of the summation of the quarter-to-date and year-to-date amounts. Neither funds from operations nor

funds from operations, as adjusted, should be considered as alternatives to net income (determined in

accordance with GAAP) as indications of financial performance, or to cash flows from operating

activities (determined in accordance with GAAP) as measures of liquidity, nor are they indicative of the

availability of funds for our cash needs, including our ability to make distributions.

**Funds from operations and funds from operations, as adjusted, attributable to Alexandria's**

**common stockholders (continued)**

The following table reconciles net income (loss) to funds from operations for the share of

consolidated real estate joint ventures attributable to noncontrolling interests and our share of

unconsolidated real estate joint ventures:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Noncontrolling Interest Share of** <br>**Consolidated Real Estate JVs** | **Noncontrolling Interest Share of** <br>**Consolidated Real Estate JVs** | **Our Share of Unconsolidated** <br>**Real Estate JVs** | **Our Share of Unconsolidated** <br>**Real Estate JVs** |
|  | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| *(In thousands)* | **Three Months** <br>**Ended**<br>| **Six Months** <br>**Ended**<br>| **Three Months** <br>**Ended**<br>| **Six Months** <br>**Ended**<br>|
| Net income (loss) | $44813 | $92414 | $(9021) | $(9528) |
| Depreciation and amortization of real <br>estate assets<br>| 36047 | 69458 | 942 | 1996 |
| Impairment of real estate |  |  | 8673 | 8673 |
| Funds from operations | $80860 | $161872 | $594 | $1141 |

---

**Gross assets**

Gross assets are calculated as total assets plus accumulated depreciation:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(In thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Total assets | $37623629 | $37600428 | $37527449 | $38488128 | $37847865 |
| Accumulated depreciation | 6146378 | 5886561 | 5625179 | 5624642 | 5457414 |
| Gross assets | $43770007 | $43486989 | $43152628 | $44112770 | $43305279 |

---

**Incremental annual net operating income on development and redevelopment projects**

Incremental annual net operating income represents the amount of net operating income, on

an annual basis, expected to be realized upon a project being placed into service and achieving full

occupancy. Incremental annual net operating income is calculated as the initial stabilized yield multiplied

by the project's total cost at completion.

**Initial stabilized yield (unlevered)**

Initial stabilized yield is calculated as the estimated amounts of net operating income at

stabilization divided by our investment in the property. For this calculation, we exclude any tenant-

funded and tenant-built landlord improvements from our investment in the property. Our initial stabilized

yield excludes the benefit of leverage. Our cash rents related to our development and redevelopment

projects are generally expected to increase over time due to contractual annual rent escalations. Our

estimates for initial stabilized yields, initial stabilized yields (cash basis), and total costs at completion

represent our initial estimates at the commencement of the project. We expect to update this information

upon completion of the project, or sooner if there are significant changes to the expected project yields

or costs.

• Initial stabilized yield reflects rental income, including contractual rent escalations and any rent

concessions over the term(s) of the lease(s), calculated on a straight-line basis, and any

amortization of deferred revenue related to tenant-funded and tenant-built landlord improvements.

• Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental

concessions, if any, have elapsed and our total cash investment in the property.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 64 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Investment-grade or publicly traded large cap tenants**

Investment-grade or publicly traded large cap tenants represent tenants that are investment-

grade rated or publicly traded companies with an average daily market capitalization greater than $10

billion for the twelve months ended June 30, 2025, as reported by Bloomberg Professional Services.

Credit ratings from Moody's Ratings and S&P Global Ratings reflect credit ratings of the tenant's parent

entity, and there can be no assurance that a tenant's parent entity will satisfy the tenant's lease

obligation upon such tenant's default. We monitor the credit quality and related material changes of our

tenants. Material changes that cause a tenant's market capitalization to decrease below $10 billion,

which are not immediately reflected in the twelve-month average, may result in their exclusion from this

measure.

**Investments**

We hold investments in publicly traded companies and privately held entities primarily

involved in the life science industry. We recognize, measure, present, and disclose these investments as

follows:

---

| | | | |
|:---|:---|:---|:---|
|  | | Statements of Operations | Statements of Operations |
|  | <br>Balance Sheet | Gains and Losses | Gains and Losses |
|  | Carrying Amount | Unrealized | Realized |
|  |  |  | Difference between <br>proceeds received upon <br>disposition and historical <br>cost |
| Publicly traded <br>companies<br>| Fair value | Changes in fair <br>value<br>| Difference between <br>proceeds received upon <br>disposition and historical <br>cost |
| Privately held entities <br>without readily <br>determinable fair <br>values that:<br>|  |  | Difference between <br>proceeds received upon <br>disposition and historical <br>cost |
| Report NAV | Fair value, using NAV <br>as a practical <br>expedient<br>| Changes in NAV, as <br>a practical expedient <br>to fair value<br>| Difference between <br>proceeds received upon <br>disposition and historical <br>cost |
|  |  |  | Difference between <br>proceeds received upon <br>disposition and historical <br>cost |
| Do not report NAV | Cost, adjusted for <br>observable price <br>changes and <br>impairments<sup>(1)</sup><br>| Observable price <br>changes<sup>(1)</sup><br>| Impairments to reduce costs <br>to fair value, which result in <br>an adjusted cost basis and <br>the differences between <br>proceeds received upon <br>disposition and adjusted or <br>historical cost<br>|
| Equity method <br>investments<br>| Contributions, <br>adjusted for our share <br>of the investee's <br>earnings or losses, <br>less distributions <br>received, reduced by <br>other-than-temporary <br>impairments <br>| Our share of <br>unrealized gains or <br>losses reported by <br>the investee<br>| Our share of realized gains <br>or losses reported by the <br>investee, and other-than-<br>temporary impairments<br>|

---

(1)An observable price is a price observed in an orderly transaction for an identical or similar investment of the same

issuer. Observable price changes result from, among other things, equity transactions for the same issuer with

similar rights and obligations executed during the reporting period, including subsequent equity offerings or other

reported equity transactions related to the same issuer.

**Investments in real estate**

The following table reconciles our investments in real estate as of June 30, 2025:

---

| | |
|:---|:---|
| *(In thousands)* | **Investments in** <br>**Real Estate**<br>|
| Gross investments in real estate | $38306978 |
| Less: accumulated depreciation | (6146378) |
| Investments in real estate | $32160600 |

---

The following table presents our new Class A/A+ development and redevelopment pipeline,

excluding properties held for sale, as a percentage of gross assets and as a percentage of annual rental

revenue as of June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
|  |  | **Percentage of** | **Percentage of** |
| *(Dollars in thousands)* | **Book Value** | **Gross** <br>**Assets**<br>| **Annual Rental** <br>**Revenue**<br>|
| Under construction and committed near-term projects | $3806346 | 9% | —% |
| Income-producing/potential cash flows/covered land play<sup>(1)</sup> | 3183092 | 7 | 1 |
| Land | 1553645 | 4 |  |
|  | $8543083 | 20% | 1% |

---

(1)Includes projects with existing buildings that are generating or can generate operating cash flows. Also includes

development rights associated with existing operating campuses.

Space Intentionally Blank

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 65 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Investments in real estate (continued)**

The square footage presented in the table below is classified as operating as of June 30,

2025. These lease expirations or vacant space at recently acquired properties represent future

opportunities for which we have the intent, subject to market conditions and leasing, to commence first-

time conversion from non-laboratory space to laboratory space, or to commence future ground-up

development:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Dev/**<br>**Redev** | **RSF of Lease Expirations Targeted for**<br>**Development and Redevelopment** | **RSF of Lease Expirations Targeted for**<br>**Development and Redevelopment** | **RSF of Lease Expirations Targeted for**<br>**Development and Redevelopment** | **RSF of Lease Expirations Targeted for**<br>**Development and Redevelopment** |
| <br>**Property/Submarket** | **Dev/**<br>**Redev** | **2025** | **2026** | **Thereafter**<sup>(1)</sup> | **Total** |
| Committed near-term project: |  |  |  |  |  |
| Campus Point by Alexandria/University Town Center | Dev |  |  | 52620 | 52620 |
| Future projects: |  |  |  |  |  |
| 446, 458, 500, and 550 Arsenal Street/Cambridge/<br>Inner Suburbs<br>| Dev |  |  | 365898 | 365898 |
| Other/Greater Boston | Redev |  |  | 167549 | 167549 |
| 1122 and 1150 El Camino Real/South San Francisco | Dev |  |  | 375232 | 375232 |
| 3875 Fabian Way/Greater Stanford | Dev |  |  | 228000 | 228000 |
| 2100 and 2200 Geng Road/Greater Stanford  | Dev |  |  | 62526 | 62526 |
| 960 Industrial Road/Greater Stanford | Dev |  |  | 112590 | 112590 |
| Campus Point by Alexandria/University Town Center | Dev |  |  | 96805 | 96805 |
| Sequence District by Alexandria/Sorrento Mesa | Dev/<br>Redev<br>|  |  | 555754 | 555754 |
| 410 West Harrison Street/Elliott Bay | Dev |  |  | 17205 | 17205 |
| Other/Seattle | Dev |  |  | 63057 | 63057 |
| 100 Capitola Drive/Research Triangle  | Dev |  |  | 34527 | 34527 |
| 1001 Trinity Street and 1020 Red River Street/Austin | Dev/<br>Redev<br>| 198972 |  |  | 198972 |
| Canada | Redev |  |  | 247743 | 247743 |
|  |  | 198972 |  | 2326886 | 2525858 |
| Total |  | 198972 |  | 2379506 | 2578478 |

---

(1)Includes vacant square footage as of June 30, 2025.

**Joint venture financial information**

We present components of balance sheet and operating results information related to our real

estate joint ventures, which are not presented, or intended to be presented, in accordance with GAAP.

We present the proportionate share of certain financial line items as follows: (i) for each real estate joint

venture that we consolidate in our financial statements, which are controlled by us through contractual

rights or majority voting rights, but of which we own less than 100%, we apply the noncontrolling interest

economic ownership percentage to each financial item to arrive at the amount of such cumulative

noncontrolling interest share of each component presented; and (ii) for each real estate joint venture that

we do not control and do not consolidate, which are instead controlled jointly or by our joint venture

partners through contractual rights or majority voting rights, we apply our economic ownership

percentage to each financial item to arrive at our proportionate share of each component presented.

The components of balance sheet and operating results information related to our real estate

joint ventures do not represent our legal claim to those items. For each entity that we do not wholly own,

the joint venture agreement generally determines what equity holders can receive upon capital events,

such as sales or refinancing, or in the event of a liquidation. Equity holders are normally entitled to their

respective legal ownership of any residual cash from a joint venture only after all liabilities, priority

distributions, and claims have been repaid or satisfied.

We believe that this information can help investors estimate the balance sheet and operating

results information related to our partially owned entities. Presenting this information provides a

perspective not immediately available from consolidated financial statements and one that can

supplement an understanding of the joint venture assets, liabilities, revenues, and expenses included in

our consolidated results.

The components of balance sheet and operating results information related to our real estate

joint ventures are limited as an analytical tool as the overall economic ownership interest does not

represent our legal claim to each of our joint ventures' assets, liabilities, or results of operations. In

addition, joint venture financial information may include financial information related to the

unconsolidated real estate joint ventures that we do not control. We believe that in order to facilitate for

investors a clear understanding of our operating results and our total assets and liabilities, joint venture

financial information should be examined in conjunction with our consolidated statements of operations

and balance sheets. Joint venture financial information should not be considered an alternative to our

consolidated financial statements, which are presented and prepared in accordance with GAAP.

Space Intentionally Blank

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 66 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Key items included in net income attributable to Alexandria's common stockholders**

We present a tabular comparison of items, whether gain or loss, that may facilitate a high-

level understanding of our results and provide context for the disclosures included in this Supplemental

Information, our most recent annual report on Form 10-K, and our subsequent quarterly reports on Form

10-Q. We believe that such tabular presentation promotes a better understanding for investors of the

corporate-level decisions made and activities performed that significantly affect comparison of our

operating results from period to period. We also believe that this tabular presentation will supplement for

investors an understanding of our disclosures and real estate operating results. Gains or losses on sales

of real estate and impairments of assets classified as held for sale are related to corporate-level

decisions to dispose of real estate. Gains or losses on early extinguishment of debt are related to

corporate-level financing decisions focused on our capital structure strategy. Significant realized and

unrealized gains or losses on non-real estate investments, impairments of real estate and non-real

estate investments, and acceleration of stock compensation expense due to the resignation of an

executive officer are not related to the operating performance of our real estate assets as they result

from strategic, corporate-level non-real estate investment decisions and external market conditions.

Impairments of non-real estate investments and changes in the provision for expected credit losses on

financial instruments are not related to the operating performance of our real estate as they represent

the write-down of non-real estate investments when their fair values decrease below their respective

carrying values due to changes in general market or other conditions outside of our control. Significant

items, whether a gain or loss, included in the tabular disclosure for current periods are described in

further detail in this Supplemental Information and accompanying Earnings Press Release.

**Megacampus™**

A Megacampus ecosystem is a cluster campus that consist of approximately 1 million RSF or

greater, including operating, active development/redevelopment, and land RSF less operating RSF

expected to be demolished. The following table reconciles our annual rental revenue and development

and redevelopment pipeline RSF as ofJune 30, 2025:

---

| | | |
|:---|:---|:---|
| *(Dollars in thousands)* | **Annual Rental** <br>**Revenue**<br>| **Development and** <br>**Redevelopment** <br>**Pipeline RSF**<br>|
| Megacampus | $1570877 | 20370529 |
| Core and non-core | 510353 | 7108567 |
| Total | $2081230 | 27479096 |
| Megacampus as a percentage of annual rental revenue and <br>of total development and redevelopment pipeline RSF<br>| 75% | 74% |

---

**Net cash provided by operating activities after dividends**

Net cash provided by operating activities after dividends is reduced by distributions to

noncontrolling interests and excludes changes in operating assets and liabilities as they represent timing

differences.

**Net debt and preferred stock to Adjusted EBITDA**

Net debt and preferred stock to Adjusted EBITDA is a non-GAAP financial measure that we

believe is useful to investors as a supplemental measure of evaluating our balance sheet leverage. Net

debt and preferred stock is equal to the sum of total consolidated debt less cash, cash equivalents, and

restricted cash, plus preferred stock outstanding as of the end of the period. Refer to the definition of

Adjusted EBITDA and Adjusted EBITDA margin for further information on the calculation of Adjusted

EBITDA.

The following table reconciles debt to net debt and preferred stock and computes the ratio to

Adjusted EBITDA:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(Dollars in thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Secured notes payable | $153500 | $150807 | $149909 | $145000 | $134942 |
| Unsecured senior notes payable  | 12042607 | 12640144 | 12094465 | 12092012 | 12089561 |
| Unsecured senior line of credit and <br>commercial paper<br>| 1097993 | 299883 |  | 454589 | 199552 |
| Unamortized deferred financing costs | 78574 | 80776 | 77649 | 79610 | 81942 |
| Cash and cash equivalents | (520545) | (476430) | (552146) | (562606) | (561021) |
| Restricted cash | (7403) | (7324) | (7701) | (17031) | (4832) |
| Preferred stock |  |  |  |  |  |
| Net debt and preferred stock | $12844726 | $12687856 | $11762176 | $12191574 | $11940144 |
| Adjusted EBITDA: |  |  |  |  |  |
| – quarter annualized | $2174160 | $2165632 | $2273480 | $2219632 | $2216144 |
| – trailing 12 months | $2208226 | $2218722 | $2228921 | $2184298 | $2122250 |
| Net debt and preferred stock to Adjusted EBITDA: | Net debt and preferred stock to Adjusted EBITDA: | Net debt and preferred stock to Adjusted EBITDA: |  |  |  |
| – quarter annualized | 5.9x | 5.9x | 5.2x | 5.5x | 5.4x |
| – trailing 12 months | 5.8x | 5.7x | 5.3x | 5.6x | 5.6x |

---

We are not able to forecast the net income of future periods without unreasonable effort and

therefore do not provide a reconciliation for net debt and preferred stock to Adjusted EBITDA on a

forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or amount of

items that depend on market conditions outside of our control, including the timing of dispositions,

capital events, and financing decisions, as well as quarterly components such as gain on sales of real

estate, unrealized gains or losses on non-real estate investments, impairment of real estate, impairment

of non-real estate investments, and provision for expected credit losses on financial instruments. Our

attempt to predict these amounts may produce significant but inaccurate estimates, which would be

potentially misleading for our investors.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 67 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Net operating income, net operating income (cash basis), and operating margin**

The following table reconciles net income (loss) to net operating income and net operating

income (cash basis) and computes operating margin:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| *(Dollars in thousands)* | **6/30/25** | **6/30/24** | **6/30/25** | **6/30/24** |
| Net (loss) income | $(62189) | $94049 | $(23527) | $313225 |
| Equity in losses (earnings) of unconsolidated real <br>estate joint ventures<br>| 9021 | (130) | 9528 | (285) |
| General and administrative expenses | 29128 | 44629 | 59803 | 91684 |
| Interest expense | 55296 | 45789 | 106172 | 86629 |
| Depreciation and amortization | 346123 | 290720 | 688185 | 578274 |
| Impairment of real estate | 129606 | 30763 | 161760 | 30763 |
| Gain on sales of real estate |  |  | (13165) | (392) |
| Investment loss | 30622 | 43660 | 80614 | 376 |
| Net operating income | 537607 | 549480 | 1069370 | 1100274 |
| Straight-line rent revenue | (18536) | (48338) | (40559) | (96589) |
| Amortization of deferred revenue related to tenant-<br>funded and - built landlord improvements<br>| (2401) |  | (4052) |  |
| Amortization of acquired below-market leases | (10196) | (22515) | (25418) | (52855) |
| Provision for expected credit losses on financial <br>instruments<br>|  |  | 285 |  |
| Net operating income (cash basis) | $506474 | $478627 | $999626 | $950830 |
| Net operating income (cash basis) – annualized | $2025896 | $1914508 | $1999252 | $1901660 |
| Net operating income (from above) | $537607 | $549480 | $1069370 | $1100274 |
| Total revenues | $762040 | $766734 | $1520198 | $1535842 |
| Operating margin | 71% | 72% | 70% | 72% |

---

Net operating income is a non-GAAP financial measure calculated as net income (loss), the

most directly comparable financial measure calculated and presented in accordance with GAAP,

excluding equity in the earnings of our unconsolidated real estate joint ventures, general and

administrative expenses, interest expense, depreciation and amortization, impairments of real estate,

gains or losses on early extinguishment of debt, gains or losses on sales of real estate, and investment

income or loss. We believe net operating income provides useful information to investors regarding our

financial condition and results of operations because it primarily reflects those income and expense

items that are incurred at the property level. Therefore, we believe net operating income is a useful

measure for investors to evaluate the operating performance of our consolidated real estate assets. Net

operating income on a cash basis is net operating income adjusted to exclude the effect of straight-line

rent, amortization of acquired above- and below-market lease revenue, amortization of deferred revenue

related to tenant-funded and tenant-built landlord improvements, and changes in the provision for

expected credit losses on financial instruments required by GAAP. We believe that net operating income

on a cash basis is helpful to investors as an additional measure of operating performance because it

eliminates straight-line rent revenue and the amortization of acquired above- and below-market leases

and tenant-funded and tenant-built landlord improvements.

**Net operating income, net operating income (cash basis), and operating margin (continued)**

Furthermore, we believe net operating income is useful to investors as a performance

measure of our consolidated properties because, when compared across periods, net operating income

reflects trends in occupancy rates, rental rates, and operating costs, which provide a perspective not

immediately apparent from net income or loss. Net operating income can be used to measure the initial

stabilized yields of our properties by calculating net operating income generated by a property divided by

our investment in the property. Net operating income excludes certain components from net income in

order to provide results that are more closely related to the results of operations of our properties. For

example, interest expense is not necessarily linked to the operating performance of a real estate asset

and is often incurred at the corporate level rather than at the property level. In addition, depreciation and

amortization, because of historical cost accounting and useful life estimates, may distort comparability of

operating performance at the property level. Impairments of real estate have been excluded in deriving

net operating income because we do not consider impairments of real estate to be property-level

operating expenses. Impairments of real estate relate to changes in the values of our assets and do not

reflect the current operating performance with respect to related revenues or expenses. Our

impairments of real estate represent the write-down in the value of the assets to the estimated fair value

less cost to sell. These impairments result from investing decisions or a deterioration in market

conditions. We also exclude realized and unrealized investment gain or loss, which results from

investment decisions that occur at the corporate level related to non-real estate investments in publicly

traded companies and certain privately held entities. Therefore, we do not consider these activities to be

an indication of operating performance of our real estate assets at the property level. Our calculation of

net operating income also excludes charges incurred from changes in certain financing decisions, such

as losses on early extinguishment of debt and changes in provision for expected credit losses on

financial instruments, as these charges often relate to corporate strategy. Property operating expenses

included in determining net operating income primarily consist of costs that are related to our operating

properties, such as utilities, repairs, and maintenance; rental expense related to ground leases;

contracted services, such as janitorial, engineering, and landscaping; property taxes and insurance; and

property-level salaries. General and administrative expenses consist primarily of accounting and

corporate compensation, corporate insurance, professional fees, rent, and supplies that are incurred as

part of corporate office management. We calculate operating margin as net operating income divided by

total revenues.

We believe that in order to facilitate for investors a clear understanding of our operating

results, net operating income should be examined in conjunction with net income or loss as presented in

our consolidated statements of operations. Net operating income should not be considered as an

alternative to net income or loss as an indication of our performance, nor as an alternative to cash flows

as a measure of our liquidity or our ability to make distributions.

**Operating statistics**

We present certain operating statistics related to our properties, including number of

properties, RSF, occupancy percentage, leasing activity, and contractual lease expirations as of the end

of the period. We believe these measures are useful to investors because they facilitate an

understanding of certain trends for our properties. We compute the number of properties, RSF,

occupancy percentage, leasing activity, and contractual lease expirations at 100%, excluding RSF at

properties classified as held for sale, for all properties in which we have an investment, including

properties owned by our consolidated and unconsolidated real estate joint ventures. For operating

metrics based on annual rental revenue, refer to the definition of annual rental revenue herein.

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 68 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Same property comparisons**

As a result of changes within our total property portfolio during the comparative periods

presented, including changes from assets acquired or sold, properties placed into development or

redevelopment, and development or redevelopment properties recently placed into service, the

consolidated total income from rentals, as well as rental operating expenses in our operating results, can

show significant changes from period to period. In order to supplement an evaluation of our results of

operations over a given quarterly or annual period, we analyze the operating performance for all

consolidated properties that were fully operating for the entirety of the comparative periods presented,

referred to as same properties. We separately present quarterly and year-to-date same property results

to align with the interim financial information required by the SEC in our management's discussion and

analysis of our financial condition and results of operations. These same properties are analyzed

separately from properties acquired subsequent to the first day in the earliest comparable quarterly or

year-to-date period presented, properties that underwent development or redevelopment at any time

during the comparative periods, unconsolidated real estate joint ventures, properties classified as held

for sale, and corporate entities (legal entities performing general and administrative functions), which are

excluded from same property results. Additionally, termination fees, if any, are excluded from the results

of same properties.

Space Intentionally Blank

**Same property comparisons (continued)**

The following table reconciles the number of same properties to total properties for the six

months ended June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| <br>**Development – under construction** | <br>**Properties** | **Redevelopment – placed into**<br>**service after January 1, 2024** | <br>**Properties** |
| 99 Coolidge Avenue | 1 | 840 Winter Street | 1 |
| 500 North Beacon Street and 4 Kingsbury <br>Avenue | 2 | Alexandria Center<sup>®</sup> for Advanced <br>Technologies – Monte Villa Parkway | 6 |
| 500 North Beacon Street and 4 Kingsbury <br>Avenue | 2 | Alexandria Center<sup>®</sup> for Advanced <br>Technologies – Monte Villa Parkway | 6 |
| 1450 Owens Street | 1 |  | 7 |
| 10935, 10945, and 10955 Alexandria <br>Way | 3 | **Acquisitions after January 1, 2024** | **Properties** |
| 10935, 10945, and 10955 Alexandria <br>Way | 3 | Other | 3 |
| 10075 Barnes Canyon Road | 1 |  | 3 |
| 421 Park Drive | 1 | Unconsolidated real estate JVs | 4 |
| 4135 Campus Point Court | 1 | Properties held for sale | 8 |
| 701 Dexter Avenue North | 1 | Total properties excluded from same <br>properties | 55 |
|  | 11 | Total properties excluded from same <br>properties | 55 |
| **Development – placed into** |  | Same properties | 329 |
| **service after January 1, 2024** | **Properties** | Total properties in North America as of <br>June 30, 2025 | 384 |
| 9810 Darnestown Road | 1 | Total properties in North America as of <br>June 30, 2025 | 384 |
| 9820 Darnestown Road | 1 |  |  |
| 1150 Eastlake Avenue East | 1 |  |  |
| 4155 Campus Point Court | 1 |  |  |
| 201 Brookline Avenue | 1 |  |  |
| 9808 Medical Center Drive | 1 |  |  |
| 230 Harriet Tubman Way | 1 |  |  |
|  | 7 |  |  |
| **Redevelopment – under construction** | **Properties** |  |  |
| 40, 50, and 60 Sylvan Road | 3 |  |  |
| 269 East Grand Avenue | 1 |  |  |
| 651 Gateway Boulevard | 1 |  |  |
| 401 Park Drive | 1 |  |  |
| 8800 Technology Forest Place | 1 |  |  |
| 311 Arsenal Street | 1 |  |  |
| One Hampshire Street | 1 |  |  |
| Canada | 4 |  |  |
| Other | 2 |  |  |
|  | 15 |  |  |

---

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 69 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Stabilized occupancy date**

The stabilized occupancy date represents the estimated date on which the project is expected

to reach occupancy of 95% or greater.

**Tenant recoveries**

Tenant recoveries represent revenues comprising reimbursement of real estate taxes,

insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses

and earned in the period during which the applicable expenses are incurred and the tenant's obligation

to reimburse us arises.

We classify rental revenues and tenant recoveries generated through the leasing of real

estate assets within revenues in income from rentals in our consolidated statements of operations. We

provide investors with a separate presentation of rental revenues and tenant recoveries in "Same

property performance" in this Supplemental Information because we believe it promotes investors'

understanding of our operating results. We believe that the presentation of tenant recoveries is useful to

investors as a supplemental measure of our ability to recover operating expenses under our triple net

leases, including recoveries of utilities, repairs and maintenance, insurance, property taxes, common

area expenses, and other operating expenses, and of our ability to mitigate the effect to net income for

any significant variability to components of our operating expenses.

The following table reconciles income from rentals to tenant recoveries:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| *(In thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** | **6/30/25** | **6/30/24** |
| Income from rentals | $737279 | $743175 | $763249 | $775744 | $755162 | $1480454 | $1510713 |
| Rental revenues | (553377) | (552112) | (566535) | (579569) | (576835) | (1105489) | (1158235) |
| Tenant recoveries | $183902 | $191063 | $196714 | $196175 | $178327 | $374965 | $352478 |

---

**Total equity capitalization**

Total equity capitalization is equal to the outstanding shares of common stock multiplied by the

closing price on the last trading day at the end of each period presented.

**Total market capitalization**

Total market capitalization is equal to the sum of total equity capitalization and total debt.

**Unencumbered net operating income as a percentage of total net operating income**

Unencumbered net operating income as a percentage of total net operating income is a non-

GAAP financial measure that we believe is useful to investors as a performance measure of the results

of operations of our unencumbered real estate assets as it reflects those income and expense items that

are incurred at the unencumbered property level. Unencumbered net operating income is derived from

assets classified in continuing operations, which are not subject to any mortgage, deed of trust, lien, or

other security interest, as of the period for which income is presented.

The following table summarizes unencumbered net operating income as a percentage of total

net operating income:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| *(Dollars in thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** |
| Unencumbered net operating income | $535766 | $530691 | $547921 | $553589 | $544268 |
| Encumbered net operating income | 1841 | 1072 | 592 | 4753 | 5212 |
| Total net operating income | $537607 | $531763 | $548513 | $558342 | $549480 |
| Unencumbered net operating income as a <br>percentage of total net operating income<br>| 99.7% | 99.8% | 99.9% | 99.1% | 99.1% |

---

**Weighted-average interest rate for capitalization of interest**

The weighted-average interest rate required for calculating capitalization of interest pursuant

to GAAP represents a weighted-average rate as of the end of the applicable period, based on the rates

applicable to borrowings outstanding during the period, including expense/income related to interest rate

hedge agreements, amortization of loan fees, amortization of debt premiums (discounts), and other bank

fees. A separate calculation is performed to determine our weighted-average interest rate for

capitalization for each month. The rate will vary each month due to changes in variable interest rates,

outstanding debt balances, the proportion of variable-rate debt to fixed-rate debt, the amount and terms

of interest rate hedge agreements, and the amount of loan fee and premium (discount) amortization.

Space Intentionally Blank

---

| | |
|:---|:---|
| [Alexandria Real Estate Equities, Inc. All Rights Reserved](#i97e12a746f8347daae03a6c076b22350_4).© 2025 | 70 |

---

---

| | |
|:---|:---|
|  | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| **Definitions and Reconciliations (continued)** | ![footerlogov2a.jpg](footerlogov2a.jpg) |
| June 30, 2025 | ![footerlogov2a.jpg](footerlogov2a.jpg) |

---

**Weighted-average shares of common stock outstanding – diluted**

From time to time, we enter into capital market transactions, including forward equity sales

agreements ("Forward Agreements"), to fund acquisitions, to fund construction of our development and

redevelopment projects, and for general working capital purposes. While the Forward Agreements are

outstanding, we are required to consider the potential dilutive effect of our Forward Agreements under

the treasury stock method. Under this method, we also include the dilutive effect of unvested restricted

stock awards ("RSAs") with forfeitable dividends in the calculation of diluted shares.

The weighted-average shares of common stock outstanding used in calculating EPS – diluted,

FFO per share – diluted, and FFO per share – diluted, as adjusted, during each period are calculated as

follows. Also shown are the weighted-average unvested shares associated with unvested RSAs with

nonforfeitable dividends used in calculating amounts allocable to these awards pursuant to the two-class

method for each of the respective periods presented below.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| *(In thousands)* | **6/30/25** | **3/31/25** | **12/31/24** | **9/30/24** | **6/30/24** | **6/30/25** | **6/30/24** |
| Basic shares for earnings per <br>share<br>| 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Unvested RSAs with <br>forfeitable dividends<br>|  |  |  |  |  |  |  |
| Diluted shares for earnings <br>per share<br>| 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Basic shares for funds from <br>operations per share and <br>funds from operations per <br>share, as adjusted<br>| 170135 | 170522 | 172262 | 172058 | 172013 | 170328 | 171981 |
| Unvested RSAs with <br>forfeitable dividends<br>| 57 | 77 |  |  |  | 62 |  |
| Diluted shares for funds from <br>operations per share and <br>funds from operations per <br>share, as adjusted<br>| 170192 | 170599 | 172262 | 172058 | 172013 | 170390 | 171981 |
| Weighted-average unvested <br>RSAs with nonforfeitable <br>dividends used in <br>calculating the allocations <br>of net income, funds from <br>operations, and funds from <br>operations, as adjusted<br>| 1998 | 2053 | 2417 | 2838 | 2878 | 2025 | 2933 |

---